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Abstract 
 
Keegan Sawyer: The Pulmonary Health Effects of Diesel Exhaust and 
Diesel Exhaust Particle Exposure: Evidence from Cellular In Vitro and 
Human Exposure Research 
(Under the direction of Dr. Michael C. Madden) 
 
 
 
The adverse health effects resulting from ambient air pollution exposure is 
an increasing concern worldwide. Globally, over two-hundred epidemiologic 
studies report that human exposure to ambient particulate matter (PM) has a 
deleterious effect on cardiopulmonary mortality and morbidity, including the 
exacerbation of pre-existing lung disease and the development of new 
respiratory infections. The contribution of diesel exhaust exposure to the 
observed health effects is a particular concern because diesel exhaust particles 
(DEP) are a significant portion of fine ambient PM in many US and international 
cities. Previous research demonstrates that DEP exposure may enhance 
pulmonary vulnerability to infection by suppressing innate lung responses and 
enhancing allergic inflammation, but the cellular pathways involved in these 
processes remain unclear. The goal of the research described herein was two-
fold: (1) to investigate the effects of particulate matter (PM) and diesel exhaust 
particle (DEP) exposure on human pulmonary inflammation; and (2) evaluate the 
general pathways that may be involved in DEP-induced effects. To this end, we 
conducted a series of in vitro experiments on human alveolar macrophages (AM) 
 iv 
as well as a human controlled DE exposure study in order to evaluate oxidative, 
inflammatory mediator, and phospholipid endpoints that may be involved in DEP-
induced effects. We found that DEP and ambient PM may enhance human 
vulnerability to lung infection by modulating alveolar macrophage (AM) oxidative 
and inflammatory cytokine responses to bacterial exposure. Our in vivo results 
demonstrated that DE exposure down-regulates TH1 cytokine concentration and 
stimulates TH2 cytokine concentrations in the bronchial fluid of exposed human 
volunteers, indicating that DE shifts pulmonary defense toward allergic-type 
mechanisms. DE exposure also decreased calcium concentration, a metal 
important to many immune mechanistic pathways, measured in human exhaled 
breath condensate. Finally, we demonstrate that in vivo DE exposure and DEP 
exposure in vitro alters AM phospholipid concentrations, thus potentially 
generating unique “fingerprints” of exposure. The results of our studies will 
contribute significantly to other toxicological, controlled exposure, and 
epidemiological studies, providing a strong data pool from which to determine the 
national standards that best protect public health and welfare. 
 v 
 
 
 
 
 
In Memory of Ruth Annetta Wesley
 vi 
 
 
 
 
 
Acknowledgements 
 
I have been blessed with outstanding mentorship and moral support 
throughout my doctoral studies. I do not have enough words to express my 
gratitude for the many professors, colleagues, family members, and friends who 
taught me, encouraged me, cried with me, prayed for me, and reminded me to 
laugh. I thank most greatly my research advisor Dr. Michael C. Madden for his 
guidance, wisdom, and extraordinary patience. He holds my deepest and 
sincerest respect. I am equally honored by the mentorship and kindness of Dr. 
Louise Ball, who enabled my admission into the doctoral program and has 
provided constant, candid support throughout my studies.   
 I also give thanks to my dissertation committee, Dr. Don Fox, Dr. Milan 
Hazucha, and Dr. David Leith for their valuable suggestions and insights.  
 I am indebted to Jack Whaley, who said to me on my very first day of 
school “zip up your backpack!” without him I would have lost my wallet, my keys, 
and my mind. I am grateful to Lisa Dailey and Joleen Soukup, without whose 
technical expertise I could not conduct a single experiment – and I would not 
have learned the words to so many country songs and “golden oldies”.  I am 
additionally grateful for Dr. Andrew Ghio, Rob Silbajoris, Tamara Tal, Emma 
Rose, Jackie Stonehurner, and many others at the U.S. EPA CRB lab  who 
provided technical expertise and emotional support.  
 And to my family and friends – there is no end to or proper expression for 
my gratitude. Juli, Lara, Elissa, Nneka, and Maurice thank you so much for your 
friendship and extra eyes. I hope I haven’t scared you away from doctoral 
students! Sacoby and Kera you are my inspirations, I would not have done this 
were it not for your examples. Monica, Leslie, Aricka, Kevin, Deric, Glenna, Erin, 
Tan, Patrick, Bob, and Buena your prayers sent me strength. Steven, who asked 
“what can I do?” your willing heart to help was enough. My family, I heard your 
 vii 
cheers all the way from California, Bermuda, New Mexico, and DC, thank you. 
Dad thank you for saying the things I need to hear “You can’t quit!” was one of 
them. Mom, thank you for teaching me to make my own path when the one I’m 
walking seems to end; you gift me with the perseverance and ingenuity that I 
need. And to my husband, Richard, who cooked, cleaned, did all the laundry, 
walked the dog, proofread, and sat up all night with me when I had writer’s block 
-- words fail me – you are my strength and energy, thank you so very, very much. 
 
 
 
 viii 
 
 
 
 
 
Table of Contents 
 
List of Tables ....................................................................................................x  
 
List of Figures ..................................................................................................xi  
 
List of Abbreviations..................................................................................... xiii  
 
Chapter 1 .......................................................................................................... 1  
 
1.1 Air Pollution ....................................................................................... 2 
1.2 Ambient Particulate Matter ............................................................... 4 
1.3 Diesel Exhaust as a Source of PM ................................................... 5 
1.4 Diesel-Induced Health Effects .......................................................... 6 
1.5 Human Lung Sampling Methods .................................................... 10 
1.6 Mechanisms of DEP-Induced Injury............................................... 13 
1.7 Scope of this Thesis ........................................................................ 17 
Chapter 2 ........................................................................................................ 19  
 
Abstract .................................................................................................. 20 
2.1 Introduction...................................................................................... 22 
2.2 Materials and Methods .................................................................... 25 
2.3 Results.............................................................................................. 31 
2.4 Discussion ....................................................................................... 52 
Chapter 3 ........................................................................................................ 61  
 
Abstract .................................................................................................. 62 
3.1 Introduction...................................................................................... 63 
 ix 
3.2 Materials and Methods .................................................................... 68 
3.3 Results.............................................................................................. 75 
Chapter 4 ........................................................................................................ 93  
 
Abstract .................................................................................................. 94 
4.1 Introduction...................................................................................... 96 
4.2 Methods.......................................................................................... 100 
4.3 Results............................................................................................ 107 
4.4 Discussion ..................................................................................... 123 
Chapter 5 ...................................................................................................... 131  
 
Appendix 1 ................................................................................................... 145  
 
Appendix 2 ................................................................................................... 146  
 
Appendix 3 ................................................................................................... 147  
 
Appendix 4 ................................................................................................... 148  
 
References ................................................................................................... 156 
 x 
List of Tables 
 
Table 3.1 The Twelve Evaluated Phopholipid Classes and Number of Individual 
Lipid Species........................................................................................................73 
 
Table 3.2 Total AM Lipid Mass (ηmol/2x106 cells) per Human Subject after In 
Vivo Exposure……………………………………………………………………….…77 
 
Table 3.3 Lipid Species Differences in Human AM after In Vivo Exposure……..80 
Table 3.4 Lipid Species Differences in Human AM after 1 hour LPS exposure In 
Vitro……………………………………………………………………………………..85 
 
Table 3.5 Lipid Species Differences in Human AM Exposed to LPS In Vitro…..87 
Table 5.1 Summary of Experiments Described in Dissertation…………………144 
 
 
 
 xi 
List of Figures 
 
Figure 1.1 Phospholipid Metabolism Involving Intracellular Calcium………...….18 
 
Figure 2.1 Effect of PM Exposure on O2 Production………....…..……………….33 
 
Figure 2.2 Effect of PM Exposure on Cytokine Release……………….......….…36 
 
Figure 2.3 Alteration of LPS-Induced TNF-α Response by Particulate 
Matter………………………………………………………………………………. 39-40 
 
Figure 2.4 Alteration of LPS-Induced IL-6 Response by Ambient PM and 
DEP………………………………………………………………………………….41-42 
 
Figure 2.5 Alteration of LPS-Induced IL-8 Response by Ambient PM and 
DEP………………………………………………………………………………….43-44 
 
Figure 2.6 Effect of BaP-Coated Ambient PM on LPS-Induced Cytokine 
Responses………………………………………………………………………..……46 
 
Figure 2.7 Effect of Season on IL-8 Production………………………………..49-50 
 
Figure 2.8 Comparison of PMA and A23817 Induced Cytokine 
Responses………………………………………………………………..……………51 
 
Figure 3.1  Lipid Cellular Mass Profile of Human AM after In Vivo Exposure to 
Filtered Air and DE……………………………………………..……………………..78 
 
Figure 3.2  Lipid Mole Percent Profile of Human AM after In Vivo Exposure….79 
 
Figure 3.3 Comparison of Lipid Species in Human AM after In Vivo Air and DE 
Exposure….…………………………………………………………..……………......81 
 
Figure 3.4 Lipid Cellular Mass Profile of Human AM exposed to LPS In Vitro...84 
 
Figure 3.5 Lipid Cellular Mass Profile of Human AM Exposed to LPS In Vitro…86 
 
Figure3.6 Lipid Mole Percent Changes in Human AM after 1 hour, 6 hour, and 
24 hour Exposure to LPS or PM In Vitro………………………….…………..…….89 
 
Figure 4.1 EBC Collection Device…………………………………………………103 
 
Figure 4.2 EBC Volume Reproducibility…………………………………………..109 
 
Figure 4.3 EBC Total Protein Concentration after Air and DE Exposure..….…110 
 
 xii 
Figure 4.4 Correlation between EBC Volume, Total Protein Concentration, and 
Calcium………………………………………………………………………………..111 
 
Figure 4.5 EBC Calcium, Iron, and Zinc Concentrations……….....….…………114 
 
Figure 4.6 BAL Calcium, Iron, and Zinc Concentrations…….……………….….115 
 
Figure 4.7 EBC Calcium and Zinc Correlation…………………….….………….116 
 
Figure 4.8 EBC TH1 Cytokine Concentrations. …………………….…………….118 
 
Figure 4.9 TH1 Cytokines in Bronchial Wash (BW). ……………………….……120 
 
Figure 4.10 TH2 Cytokines in BW …………………………………………………121 
 
Figure 4.11 TH2 Cytokines in BAL…………………………………………………122 
 
Figure A1.1 Effect of DEP and CB on IL-8 release from HL-60 cells and human 
alveolar macrophages (AM)…………………………………………………………145 
 
Figure A2.1 1 Effect of PM Exposure on Alveolar Macrophage Viability………146 
 
Figure A3.1 Phospholipid Detectability from differeing Numbers of Human 
Alveolar Macrophages …...................................................................................147 
 
Figure A4.1 Responses Measured in the Exhaled Breath of Human Volunteers 
Acutely Exposed to Ozone and Diesel Exhaust…………………………………..148 
 
 xiii 
List of Abbreviations 
 
A23817: Calcium Ionophore A23817 
AA: Arachidonic Acid 
AM: Alveolar macrophage 
ATII: Alveolar Type 2  
BaP: Benzo(a)pyrene 
BAL: Bronchoalveolar Lavage 
BW: Bronchial Wash 
Ca: Calcium 
CB: Carbon black 
cer: ceramide 
CHC: Chapel Hill coarse particles 
CHF: Chapel Hill fine particles 
CO: Carbon monoxide 
COPD: Chronic obstructive pulmonary disease 
COX: Cyclooxygenase 
BG: Background 
DE:  Diesel Exhaust 
DEP: Diesel Exhaust Particle  
e: ether-linked 
EBC: Exhaled Breath Condensate 
FBS: Fetal Bovine Serum 
Fe: Iron 
 xiv 
FEV1: Forced Expiratory Volume 
HBSS: Hank’s Balanced Salt Solution 
HEPA: High Efficiency Particulate Air 
HPLC: High Performance Liquid Chromatography 
IFN: Interferon 
IgE: Immunoglobulin E 
IgG: Immunoglobulin G 
IL: Interleukin 
IP3: Inositol Triphosphate 
IS: Induced Sputum 
LDH: Lactate Dehydrogenase 
LOX: Lipoxygenase 
LPS: Lipopolysaccharide 
LTA: Lipoteichoic Acid 
LTB4: Leukotriene B4 
NF-κB: Nuclear factor kappa B 
NO: Nitric oxide 
O2-: Superoxide Anion 
O3: Ozone 
PA: Phosphatidic Acid 
PAF: Platelet Activating Factor 
PAH: Polycyclic aromatic hydrocarbon 
Pb: Lead 
 xv 
PC: Phosphatidylcholine 
PE: Phosphatidylethanolamine 
PG: Phosphatidylglyceride 
PGE2: Prostaglandin E2 
PI: Phosphatidylinositol 
PI3: Phosphatidylinositol triphosphate 
PI3K: Phosphatidylinositol-3 kinase 
PLA2: Phospholipase A2 
PLD: Phospholipase D 
PM: Particulate matter 
PMA: Phorbol Myristate Acetate 
PMN: Polymorphonuclear cell 
PS: Phosphatidylserine 
RAU: Relative Absorbance Units 
RIPA: Radioimmunoprecipitation assay 
ROFA: Residual Oil Fly Ash 
ROS: Reactive oxygen species 
SM: Sphingomyelin 
SO2: Sulfur dioxide 
SOD: Superoxide Dismutase 
SP: Surfactant protein 
SRM: Standard Reference Material 
TH: T-helper 
 xvi 
TLC: Total Lung Capacity 
TLR: Toll-like Receptor 
TNF: Tumor Necrosis Factor 
TPC: Total Protein Concentration 
U.S. EPA: United States Environmental Protection Agency 
UD: Urban Dust 
VA: Volcanic Ash 
Zn: Zinc 
α: alpha 
β: beta 
γ: gamma 
η: nano 
μ: micro
 
 
 
 
 
Chapter 1 
 
 
 
 
Introduction 
 2 
1.1 Air Pollution 
The importance of clean air to human health is well-documented. Early 
and mid- twentieth century extreme air pollution events demonstrated that high 
ambient air pollution concentrations severely affect human health. The 1930 
contaminated fog in the Meuse Valley of Belgium, the 1948 fluoride smog in 
Donora, PA, and the 1952 Great London Smog caused excessive illness and 
mortality (Anderson 1999). The London Great Smog lasted for three days and 
claimed four thousand lives within one week. Over six thousand more lives were 
lost in ensuing weeks, largely due to pollutant-induced toxicity on lung tissue and 
severe pulmonary infections (Bell and Davis, 2001).  Although air quality in the 
twenty-first century is vastly improved , air pollution in many countries is a 
problem. For example, rapid development and industrialization contributes to 
significant air pollution in China (National Research Council, et al. 2004). Hence, 
there is world-wide concern that poor air quality will adversely affect the health of 
athletes competing in the 2008 Olympic Games being hosted in Beijing.  
 Epidemiology research demonstrates that human exposure to low ambient 
pollution concentrations contributes to adverse health outcomes. Research 
draws significant positive associations between ambient air pollution and 
elevated emergency room visits and hospital admissions for cardiopulmonary 
complications (Pope, et al. 1991; Schwartz, et al. 1996; Delfino, et al. 1997; Peel, 
et al. 2005; Wong, et al. 1999). Air pollution exposure can be exceptionally 
detrimental to pregnant women, children, the elderly, and populations with pre-
existing cardiopulmonary diseases (Norris, et al. 1999; Dockery, et al. 1989; Sun, 
 3 
et al. 2006). Accordingly, national and international air quality regulations that 
best protect sensitive populations are important.  
The United States Environmental Protection Agency (U.S. EPA) regulates 
the ambient concentrations of six common air pollutants called “criteria” 
pollutants: carbon monoxide (CO), lead (Pb), nitrogen oxides (NOx), ozone (O 3) 
sulfur dioxide (SO2), and particulate matter (PM). These pollutants are pervasive 
in the United States and in many other countries. The World Health Organization 
(WHO), the public health arm of the United Nations, also recommends air quality 
standards for many of the same pollutants. Criteria pollutants are generated by a 
variety of natural and anthropogenic sources, particularly motor vehicle exhaust, 
coal-fired power plants, industrial emissions, and certain agricultural practices, 
among other processes. Epidemiologic and experimental studies show that 
exposure to levels of some criteria pollutants is linked to lung inflammation, 
exacerbation of allergic and inflammatory diseases, and increased number of 
respiratory infections (Boldo, et al. 2006; Sandstrom, et al. 1991).  
U.S. regulations, especially those reducing vehicle emissions have led to 
decreased national average ambient concentrations of CO, SO 2, and PM (U.S. 
EPA 2000). However, regional and seasonal pollutant peaks can exceed current 
standards. In addition, current regulatory standards do not control for adverse 
health effects caused by pollutant mixtures or chronic exposure to low pollutant 
concentrations. Mounting evidence suggests that pollutant exposure at or below 
regulatory standards can result in adverse health outcomes (Bell, et al. 2006; 
Johnson and Graham 2006; Brunekreef, et al. 1995).  Continuing research 
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focuses on how either short-term exposure to peak pollution or longer-term 
exposure to pollutant concentrations below regulatory standards can contribute 
to acute and chronic health effects.  Much of this current research, however, is 
aimed at identifying factors, including genetic, nutritional, and behavioral, that 
may confer susceptibility or sensitivity to environmental air pollution.  
 
1.2 Ambient Particulate Matter 
 Particulate matter (PM) is not a single pollutant; therefore, it is unique 
among the six criteria pollutants.  PM is a mixture of many particles from different 
sources and has varying chemical compositions and sizes.  Ambient PM is 
regulated according to its aerodynamic diameter. Coarse PM (PM10) describes 
particles with an aerodynamic diameter between 2.5μm and 10μm. Fine PM 
(PM2.5) refers to particles with an aerodynamic diameter less than 2.5 μm. 
Ultrafine PM is an unregulated subset of PM 2.5 and is typically described as PM 
with an aerodynamic diameter less that 0.1μM. PM2.5 is a particular health 
concern because the small aerodynamic size allows a greater proportion of the 
PM2.5 to reach the deep regions of the lung and, subsequently, depositing at that 
site. In addition, high surface area enables PM 2.5 to carry many toxic compounds, 
which are absorbed on its surface, into the airways.  Epidemiology studies from 
many geographic areas demonstrate that PM2.5 exposure is associated with 
increased mortality and morbidity from respiratory causes (Pope, et al. 1995 ; 
Dominici, et al. 2006; Laden, et al. 2000; Fusco, et al. 2001; Abbey, et al. 1995).  
Animal and in vitro studies show that particle-associated metals, organic 
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chemicals, and biologic compounds (e.g., endotoxins) can generate reactive 
oxygen species (ROS), stimulate inflammatory cytokine production, and induce 
apoptosis in lung cells and tissues (Becker, et al. 1996; Ghio, et al. 1996; Lies 
1986; Carter, et al. 1997).   As a result, research and regulatory interest is 
focused upon pollution sources contributing to ambient PM.  
 
1.3 Diesel Exhaust as a Source of PM  
Diesel Exhaust (DE) is a pervasive source of ambient PM.  DE is 
produced after fuel combustion in diesel engines. DE is a complex mixture of 
gaseous and solid phase constituents that with sufficient exposure, can threaten 
human health.  Included among the hundreds of DE constituents are several of 
the U.S. EPA criteria pollutants as well as many other toxic compounds. 
Aldehydes, polycyclic aromatic hydrocarbons (PAHs), oxides of nitrogen, carbon, 
and sulfur are a few of the primary gaseous components (U.S. EPA 2002).   
PM2.5 dominates the solid phase DE components. In most modern vehicular 
diesel combustion engines, more than 80 percent of the diesel exhaust particle 
(DEP) mass is associated with particles that are 0.1μm or smaller, thus highly 
respirable and capable of depositing in the lower airways. The small particle size 
also enables DEP to remain airborne for longer durations than PM 2.5 and be 
capable of long-distance transport. DEP generally consists of a carbon core upon 
which metals (e.g. iron, copper, chromium, calcium, and nickel) and thousands of 
organic compounds are adsorbed (U.S. EPA 2002; Cohen and Higgins 1995). 
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The organic fraction includes aldehydes, carboxcylic acids, benzene, 
nitroaromatic compounds, quinones, PAHs, and nitro-PAHs. 
Diesel engines are widely used for trucks, railroad trains, agricultural 
equipment, school busses, and marine vessels because of their high fuel 
efficiency and durability. In addition, diesel engines produce less carbon 
monoxide, a gaseous pollutant believed to be a significant contributor to global 
warming, than their gasoline engine counterparts (U.S. EPA 2002). However, 
diesel exhaust generally contains significantly greater concentrations of NOx and 
PM (U.S. EPA 2002). The U.S. EPA estimates that diesel engines produce 
greater than 80 percent of the PM from mobile sources. Studies suggest that this 
impact is growing and that improvements in national concentrations of PM are 
offset by the increases in diesel engine use (Cohen and Higgins 1995). 
 
 
1.4 Diesel-Induced Health Effects 
1.4.1 Innate and Acquired Immunity 
Normal immune pulmonary responses involve innate (cell-mediated) and 
acquired (antigen-mediated) immune mechanisms. Innate lung mechanisms 
include a physical epithelial barrier, antimicrobial compounds found in lung lining 
fluid, and phagocytic lung cell activity that can induce inflammation. During 
acquired immunity, lung cells detect and respond to microbial antigens. Innate 
and acquired immune responses are regulated by T-helper (TH) cells.  TH 1 cells 
mediate innate immune activity while TH2 cells stimulate and maintain acquired 
immunity. TH1 and TH2 cells are distinguished by their pattern of cytokine 
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secretion. TH1 cells produce interleukin (IL)-2, interferon-gamma (IFN γ), and IL-
12. TH1 cytokines facilitate delayed hypersensitivity, macrophage activation and 
synthesis of IgG antibodies (Robbins and Cotran 1999). TH 2 cells secrete IL4, IL-
5, L-6, IL-10, and IL-13. TH2 cells can stimulate eosinophil activation and 
differentiation, and promote the production of IgE antibodies which are hallmarks 
of the development of allergy and asthma in the lung (Sanderson 1992; Coffman 
et al, 1986). In addition, several TH 2 cytokines, such as IL-4 and IL-13, are known 
to inhibit TNF-α production (te Velde, et al. 1990; Mijatovic, et al. 1997). Human 
exposure and experimental studies often monitor TH1 and TH2 cytokines in order 
to evaluate pollutant-induced immune mechanisms.  
 
1.4.2 Effect of DEP-Exposure on Alveolar Macrophage Response to Infection 
The alveolar macrophage (AM) plays a prominent role in innate immune 
response to lung infection.  AM are the primary lung cells that initially ingest and 
clear inhaled bacteria and PM via phagocytosis and the release of compounds 
that kill pathogens or stimulate inflammation (Sibille and Reynolds 1990).  AM 
initiate and resolve acute inflammatory responses through respiratory burst 
(reactive oxygen species [ROS] release) and the production of inflammatory 
mediators, including IL-6, IL-8, tumor necrosis factor alpha (TNF α), and 
eicosanoids (Baggiolini, et al. . 1989; Pueringer and Hunninghake 1992; Becker, 
et al. 2005; Alexis, et al. 2006). AM soluble mediator release also affects 
responses of other lung cells.  For instance, AM produce and release IL-12 and 
IL-8, cytokines that initiate and sustain TH 1 responses including neutrophil  
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attraction to a site of injury (Hsieh, et al. 1993; Rankin, et al. 1990). Thus, 
experimental research frequently focuses upon AM responses as in indicator of 
an innate pulmonary response to pollutants. 
Epidemiology studies show a positive association between ambient PM, 
increased incidence of respiratory infection and disease (Pope 1989; Delfino, et 
al. 1997; Ilbaca, et al. 1999; Dominici 2006), and exacerbation of infection-
induced respiratory symptoms (Fusco 2001; Chauhan and Johnston 2003).  DEP 
exposure can induce lung inflammatory responses such as neutrophilia in 
humans in vivo and in pulmonary lung cells exposed in vitro (Nightingale, et al. 
2000; Yang, et al. 1997). In vivo animal and in vitro cellular studies demonstrate 
that DEP-exposure can also suppress pulmonary immune responses to a variety 
of microbial stimuli (Yang, et al. 1999, Mundandhara, et al. 2005, Yin, et al. 2004; 
Saxena, et al. 2003a; Saxena, et al. 2003b).  Lipopolysaccharide 
(LPS;endotoxin), derived from gram negative bacterial cell walls, readily activates 
macrophage immune responses (Rankin, et al. 1990). However, DEP exposure 
inhibits pro-inflammatory cytokine release in rodent AM stimulated with LPS 
(Yang, et al. 1999; Castranova, et al. 2001; Amakawa, et al. 2003). Additional 
research presents evidence that DEP also inhibits the production of NO in murine 
AM stimulated with either LPS or Bacillus Calmette-Guerin (BCG), a 
mycobacterium used to produce systemic infections in mice (Saxena, et al. 
2003b).  Mundandhara and colleagues (2005) establish that DEP suppresses IL-
8, TNF-α, and prostaglandin E2 (PGE2) release from human AM stimulated with 
either LPS or lipoteichoic acid (LTA), a gram-positive bacterial product. The 
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combined animal model and in vitro research suggests that suppressed cytokine 
and oxidant release in response to microbial stimulation may enhance pulmonary 
susceptibility to lung infection.   
 
1.4.3 Pulmonary Responses in Humans Exposed to Diesel 
Research suggests that PM-induced lung injury is the combined result of 
oxidative stress and uncontrolled airway inflammation (Ghio and Devlin 2001; 
Tao, et al. 2003; Dick, et al. 2003; Nel, et al. 2001). DE may contribute to 
oxidative and inflammation-induced injury. Several studies show that short-term, 
controlled DE-exposure can alter lung function and stimulate mild lung 
inflammation in healthy human adults. Rudell and colleagues (1996) report 
increased eye and nose irritation as well as increased airway resistance in 
healthy human volunteers exposed to DE.  Increased lung neutrophilia is 
observed in the bronchoalveolar lavage fluid (BAL) of healthy human adults 
exposed to whole DE, i.e., with both particles and gases, with high (300 μg/m3) 
and low (100μg/m3) PM concentrations (Salvi, et al. 1999; Holgate, et al. 2003). 
In the same way, increased neutrophils are seen in induced sputum, derived 
from the central airways, of DE-exposed volunteers (Nordenhall, et al. 2000). 
These combined human studies demonstrate that short-term DE exposure can 
stimulate acute pulmonary health effects with both high and low associated DEP 
concentrations. 
Research also addresses the pulmonary effects of human exposure to 
DEP alone. Nightingale and colleagues (2000) show that controlled human 
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exposure to DEP (200μg/m3) can induce mild neutrophilia, similar to DE 
exposure. Unlike DE exposure, DEP had no effect on sputum IL-8 and TNF-α 
concentrations. A series of research studies (Diaz-Sanchez, et al. 1994, 1996, 
1997) demonstrate that DEP (300μg) nasal instillation induces TH 2 and 
suppresses TH1 cytokine responses. The investigators assume that immune 
response in the nose will reflect responses that occur in the lung. DEP exposure 
induces an increase in  the production of IgE and TH2 cytokines in the nasal 
mucosa of healthy volunteers, 18 hours after DEP exposure. In summary, DEP 
exposure can induce an acute inflammatory response in humans that may later 
shift to a humoral immune response. 
 
1.5 Human Lung Sampling Methods 
1.5.1. Bronchoalveolar Lavage and Induced Sputum 
The duration of DE-induced pulmonary effects in humans is unclear, 
because repeated measurement of human respiratory responses to air pollutant 
exposures is difficult. Biomarkers of oxidative stress and inflammation, among 
other lung responses, require lung fluid, cell, or tissue sampling. Traditional lung 
sampling methods are complex and invasive because the lung is a relatively 
inaccessible organ.  Bronchoalveolar lavage (BAL) and bronchial biopsies are 
two traditional methods that provide access to lung cells and soluble pulmonary 
mediators. Bronchoscopy, however, is an invasive, expensive, and technically 
difficult procedure which requires a trained physician with specialized equipment. 
Bronchoscopy may induce discomfort, airway inflammation, transient fever, and 
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potentially, in rare instances, death (Huang, et al. 2006). Thus, bronchoscopy is 
an inadequate and potentially unsafe procedure for repeated lung fluid sampling.   
Less invasive methods to measure pollutant-induced lung responses 
include induced sputum, lung physiology measurements, and surrogate organ 
system sampling, for example nasal lavage and biopsy, urine collection, or 
venipuncture. Induced sputum (IS) collection is a semi-invasive method to 
sample cells and soluble mediators from the bronchial airways (Alexis, et al . 
2005). One study investigated a time-course for inflammatory endpoints after 
human DE exposure (300μg/m3), via sputum induction (Nordenhall, et al. 2000). 
Neutrophil and other inflammatory endpoints increase in the IS 6 hours post DE 
exposure, but significant increases in neutrophils occur at 24 hours regardless of 
DE or air exposure. The research demonstrates that IS, itself, induces airway 
inflammation.  Additional research confirms that sputum induction can cause 
acute airway inflammation, thus preventing its use for repeated measurements 
within a short period of time (Antczak, et al. 2005; Holz, et al. 2000). Additionally, 
IS can not be performed by some subjects, and a physician is needed in case IS 
collection procedures induce severe bronchoconstriction.  Soluble mediators can 
be measured in plasma and urine, but these markers may reflect systemic 
inflammation rather than lung-specific responses. Investigators also test 
pulmonary function, such as forced expiratory volume (FEV 1) and total lung 
capacity (TLC). In general, lung function measurements do not provide 
information on pollutant mechanisms of action at a cellular level. As a result, 
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there is a need for noninvasive, nonconfounding, and repeatable methods by 
which to assess lung status. 
 
1.5.2 Exhaled Breath Condensate 
 Exhaled Breath Condensate (EBC) collection and analysis is a proposed, 
noninvasive lung sampling alternative to BAL and IS.  EBC collection is 
noninvasive, inexpensive, and an easily repeatable technique. EBC is also very 
safe to use. Condensate derives primarily from expired water vapor, but some 
volatile and multiple nonvolatile airway solutes have been detected in EBC. 
Rosenau and Amoss (1912) presented qualitative data to demonstrate the 
presence of organic matter in expired breath condensate at the beginning of the 
twentieth century.  Since that time, identified EBC compounds include pulmonary 
surfactant (Sidorenko, et al. 1980), lipid and protein inflammatory mediators 
(Scheideler, et al. 1993; Montuschi and Barnes 2002), electrolytes (Effros, et al . 
2002), oxidation products (Montuschi, et al. 1999), DNA (Gessner, et al. 2004; 
Carpagnano, et al. 2005), and metals (Mutti, et al. 2006). Repeated EBC 
collections during controlled air pollution exposure studies may provide airway 
biology information unattainable from a single BAL or IS collection. 
In one study, EBC was collected from Italian Coast Guard diesel-engine 
workers, before and after an 8 hour sea patrol (Baretto, et al. 2006). Total 
protein, 8-isoprostane, and nitrosothiols increased in the post-navigation EBC of 
engine workers who were smokers when off duty. Inflammatory and oxidative 
stress markers in EBC of non-smoking volunteers did not change after the 8 hour 
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sea patrol. The findings do not specifically address the time-course of DE-
induced effects, but the results demonstrate that EBC can be safely used for 
repeated lung sampling. 
 
1.6 Mechanisms of DEP-Induced Injury  
1.6.1 Phospholipids 
Particulate matter may induce lung injury by two inter-related pathways, 
oxidative stress and uncontrolled inflammation. DEP exposure generates 
reactive oxygen species in exposed pulmonary cells, including alveolar 
macrophages and bronchial epithelial cells (Sagai, et al. 1993;  Arimoto, et al. 
2005).  DEP exposure also stimulates acute inflammatory responses 
characterized by the production of inflammatory mediators in lung cells and by 
neutrophil influx into the airways (Nightingale, et al. 2000).  Yet, the exact 
mechanisms by which diesel exposure interferes with the lung’s ability to regulate 
oxidative and inflammatory responses are unclear.    
Research suggests DEP exposure may induce lung injury by manipulating 
phospholipid metabolic pathways.  Phospholipids are predominantly membrane 
lipids that play important roles in cellular structure and signal transduction. They 
consist of a polar head group (choline, inositol, ethanolamine, glycerol, or serine), 
a glycerol backbone, and one (lyso) or two fatty acid tails. Release of fatty acids 
from phospholipids can result in fatty acid metabolism into more potent, 
oxygenated species.  One example is the release of arachidonic acid (AA) from a 
phospholipid where the free arachidonic acid can be converted by 
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cyclooxygenases (COX) or lipoxygenases (LOX) into prostaglandins or 
leukotrienes, respectively (Figure 1.1).  AA release also results in a 
lysophospholipid structure. Lysophospholipids can also be metabolized into a 
more potent biological species. For example, lysophosphatidylcholine is 
acetylated into platelet activating factor (PAF), a potent neutrophil activating lipid. 
Phospholipids and their metabolites are involved in a variety of lung responses 
including acute lung inflammation and injury (Fukunaga, et al. 2005; Bonnans 
and Levy 2007), cellular apoptosis (Fadok, et al. 1992 ; Monick, et al. 2001; 
Huber, et al. 2007), adult respiratory distress syndrome (Bernard, et al. 1991), 
and asthma (Levy 2005).  
 
1.6.2 Effect of DEP and PM Exposure on Phospholipids and Phospholipid 
Metabolites 
Research demonstrates that DEP and PM exposure adversely affect 
several lipid metabolic pathways.  Studies show that ultrafine carbon black 
particles and PM10 promote inflammation by stimulating calcium (Ca2+) influx into 
lung cells (Brown, et al. 2007; Brown, et al. 2004; Stone, et al. 2000).  Increased 
intracellular Ca 2+ initiates respiratory burst and inflammatory cytokine production 
(Finkel, et al 1987). Ca 2+ release is triggered by the formation of 
phosphotidylinositol triphosphate (PI 3), the cleaved head-group of 
phosphatidylinositol (PI).  Residual oil fly ash (ROFA), a metal rich PM type 
derived from oil combustion, has been shown to increase prostaglandin E 2 
(PGE2) release from cultured human airway epithelial cells (Samet, et al. 1996).  
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In a rodent model of PM-induced lung injury, intratracheal instillation of ROFA 
induces an increase in lung total protein concentration and lactate 
dehydrogenase (LDH) activity in lavage fluid.  The increased lung injury is 
accompanied by an increase in lavage fluid PGE 2 and COX2, an enzyme that 
converts free AA into prostaglandins, in airway epithelial sections (Samet, et al. 
2000).  Pretreatment of rats with NS-398, a COX2 inhibitor, prior to ROFA 
instillation attenuates ROFA-induced lung damage.  
DEP-exposed macrophages secrete less PGE2 in response to LPS 
stimulation in comparison to unexposed AM (Mundandhara, et al. 2005). PGE 2 is 
an AA metabolite that attenuates lung oxidative and inflammatory responses 
(Monick, et al. 1987; Beck-Speier, et al. 2001; Takahashi, et al. 1995; Standiford, 
et al.1992; Bonnans and Levy 2007).  Suppressed PGE 2 release suggests that 
DEP exposure inhibits pathways that attenuate bacterial-induced oxidative and 
inflammatory damage.  
DEP exposure also causes alveolar type II (ATII) cells to increase 
phosphotidylcholine (PC) secretion (Juvin, et al. 2002).  Increased PC 
concentrations are also seen in alveolar lung fluid of DEP exposed rats 
(Eskelson 1984). ATII cells produce pulmonary surfactant which maintains 
alveolar fluid balance and prevents alveolar collapse during expiration. 
Pulmonary surfactant also contains innate proteins, surfactant proteins (SP)-A 
and (SP)-D, that fight lung infection (McCormack and Whitesett 2002). An 
increased PC concentration alters surfactant chemistry, and thus may impair gas 
exchange and host vulnerability to lung infection (Levine, et al. 2000; Wu, et al. 
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2003). The collective data suggests PM induces lung injury by modulating lipid 
metabolic pathways. 
1.6.3 Lipidomics 
Lipidomics is a promising method to investigate the coordinated cellular 
lipid response to PM exposure. Lipidomics, a subcategory of metabolomics, is 
the global study of lipids and their metabolites. Comprehensive analyses of 
potential alterations in lipid species induced by a pollutant may provide 
information about the uniqueness of the lipid response, or “fingerprint” of the 
toxicant effect on the biological system being examined.  Additionally, the 
mechanism(s) of action of the pollutant could possibly be deduced, including 
pathways that are not considered by a likely “candidate” approach. Lipid 
metabolism is dependent on lipid structure, metabolizing enzymes, and gene 
regulation.  Phospholipid metabolism is complex (Figure 1.1). For example, 
phospholipase C (PLC) cleaves PI to produce PI 3 and induce Ca2+ release.  
Research shows that SP-A can stimulate Ca2+ release through the PLC-PI3 
pathway (Beharka, et al. 2005). Ca2+ activates phospholipase A2 (PLA2) which 
cleaves AA from phosphatidylcholine.  
Lipidomics can be used to discern and confirm biochemical mechanisms 
of altered lipid pathway metabolism. One study reports on the depletion of the 
lipid cardiolipin and precursor substances in a murine model of diabetes (Han, et 
al., 2005).  DEP exposure may adversely affect any or all of the described lipid 
metabolic relationships. Thus, DEP exposure may produce a unique lipid 
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“fingerprint” that highlights diesel-induced mechanisms of pulmonary injury.  To 
date, lipidomic approaches to PM-induced toxicity has not been utilized. 
 
1.7 Scope of this Thesis 
The goal of the research described herein was two-fold: (1) to investigate 
the effects of particulate matter (PM) and diesel exhaust (DE) exposure on 
human pulmonary inflammation; and (2) evaluate the general pathways that may 
be involved in DE-induced effects.  To this end, Chapter 2 compares oxidative 
and inflammatory responses of human alveolar macrophages exposed to diesel 
exhaust particles (DEP) and ambient PM.  This study evaluates broad 
mechanistic pathways and PM characteristics that contribute to DEP-induced AM 
cytokine suppression in response to lipopolysaccharide (LPS) stimulation.  
Chapter 2 is being prepared for submission to the Journal of Toxicology and 
Environmental Health Part A.  Chapter 3 employs lipidomics to (1) identify the 
effect DE exposure in vivo on AM phospholipid composition; and (2) compare the 
in vitro effects of LPS, ambient PM, and DEP on AM phospholipid concentration 
in order to better evaluate the uniqueness of each exposure-induced lipid 
“fingerprint”. The data from Chapter 3 will be presented at the 2009 annual 
Society of Toxicology meeting in Baltimore, Maryland. Finally, Chapter 4 
examines the effects of human exposure to diesel exhaust on TH1 and TH2 
pulmonary cytokine concentrations and whether repeated lung sampling via 
exhaled breath condensate (EBC) collection can provide additional insight on the 
time-dependent effects of DE exposure.  
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Figure 1.1 Phospholipid Metabolism Involving Intracellular Calcium. PLA 2, 
phospholipase A2; PLC, phospholipase C; PLD, phospholipase D; COX, 
cyclooxygenase; LOX, lipoxygenase; lysoPC, lyspophosphatidylcholine; PA, 
phosphatidic acid; PI, phosphatidylinositol; IP 3, inositol triphosphate; PGE 2, 
prostaglandin E2; LTB4, leukotriene B4; PAF, platelet activating factor; Ca, 
calcium. Figure adapted from Eyster, et al. 2007. 
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Chapter 2 
 
 
 
 
The Effect of Ambient Particulate Matter on Human Alveolar 
Macrophage Oxidative and Inflammatory Responses 
 20 
Abstract 
Epidemiological and occupational studies demonstrate that ambient PM and DEP 
have deleterious effects on human cardiopulmonary health including 
exacerbation of pre-existing lung disease and development of respiratory 
infections. The primary research focus is the effects of DEP on lung cell 
responsiveness to microbial exposure, but the effects of ambient PM on lung cell 
responsiveness are relatively unknown. In our studies, human alveolar 
macrophages (AM) were exposed to SRM 1649 (Washington, DC urban dust; 
UD), SRM 2975 (forklift diesel exhaust particles; DEP), and fine and coarse 
ambient PM collected in Chapel Hill, North Carolina during the late fall 
(November 2001) and early summer (June 2002). AM were subsequently 
incubated with lipopolysaccharide (LPS), phorbol-myristate acetate (PMA), or 
calcium ionophore A23817 for 6 or 24 hours after PM exposure. UD and DEP 
similarly suppressed O2- release 24 hours post PM exposure (p<0.01). UD 
exposure suppressed TNF-α (p<0.05), IL-6 (p<0.01), and IL-8 (p<0.05) release 
after exposure to 1-ng/mLLPS. DEP suppressed only TNF-α (p<0.01) and IL-6 
release (p<0.01). Suppressed cytokine release appears to be the result of an 
inhibited cytokine release from the AM, but may also be caused by reduced total 
cytokine production. The data suggest that the decreased cytokine release is not 
caused by the presence of benzo(a)pyrene, a polycyclic aromatic hydrocarbon. 
Comparison of TNF-α release after LPS, PMA, or A23817, reveals that the 
suppressive effects of UD is LPS-dependent, whereas, suppressive effect of 
DEP may work across multiple mechanistic pathways. November and June 
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Chapel Hill PM exposure stimulated TNF-α and IL-8 release before LPS 
exposure. Fine (p<0.01) and coarse (p<0.05) November PM exposure 
suppressed TNF-α release 6 hours after LPS stimulation, but appeared to cause 
stimulatory effect on IL-8 24 hours after LPS exposure. June fine and coarse PM 
suppressed IL-8 release after LPS exposure. These data suggest that seasonal 
influences on PM composition can affect AM inflammatory response before and 
after bacterial exposure. Overall, delayed or inhibited AM immune responses to 
LPS after PM exposure suggests human exposure to ambient PM may enhance 
pulmonary susceptibility to respiratory infections. 
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2.1 Introduction 
The exact pathophysiological mechanisms resulting in the adverse health 
outcomes from PM exposure are unknown. Research suggests that oxidant 
stress and inflammation associated injury may be the predominant mechanisms 
directing PM-induced health effects (Dick, et al. 2003; Tao, et al. 2003; Ghio and 
Devlin 2001; Nel, et al. 2001). A key player in the pulmonary immune response to 
PM is the alveolar macrophage (AM). AM are phagocytic lung cells essential to 
the uptake, inactivation, and clearance of inhaled bacteria and PM (Sibille and 
Reynolds 1990; Zhang, et al. 2000). A vital macrophage defense mechanism 
against PM and xenobiotic assault is the production, release, and regulation of 
inflammatory mediators, including reactive oxygen species (ROS), nitric oxide 
(NO), and such inflammatory cytokines as interleukin-1 (IL-1), interleukin-6, 
interleukin-8 (IL-8), and tumor necrosis factor- α (TNFα) (Baggiolini, et al . 1989; 
Yang, et al. 1997; Zhang, et al. 2000; Ishii, et al. 2004; Alexis, et al . 2006).  
Lipopolysaccharide (LPS; endotoxin), is a powerful macrophage activator 
(Rankin, et al. 1990) and can induce lung injury and aggravate preexisting lung 
disease (Bringham and Meyrick 1986; Schwartz, et al. 1994; Reed and Milton 
2001). Animal and in vitro research demonstrates that particulate matter can alter 
AM responsiveness to LPS. Diesel exhaust particles (DEP) suppress cytokine 
release in rodent AM stimulated with LPS (Yang, et al. 1999; Castranova, et al. 
2001; Takano, et al. 2002; Amakawa, et al. 2003). DEP also inhibits the 
production of NO in murine AM stimulated with either LPS or Bacillus Calmette-
Guerin (BCG), a mycobacterium used to produce systemic infections in mice 
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(Saxena, et al. 2003). Recently, Mundandhara and colleagues (2005) established 
that DEP suppresses IL-8, TNF-α, and prostaglandin E2 (PGE2) release from 
human AM stimulated with either LPS or Lipoteichoic acid (LTA), a gram-positive 
bacterial product. Suppressed cytokine and oxidant release in response to 
microbial stimulation may be an important mechanism by which particle exposure 
induces adverse respiratory health effects.  
The comparative effects of ambient PM and DEP exposure on 
macrophage response to microbial stimulation are unknown. Ambient PM, 
particularly from environments where diesel exhaust is a major source of air 
pollution, may induce similar suppressive effects as DEP. Becker and colleagues 
(2005) report that coarse and fine PM size fractions suppress total TNF- α 
production in response to LPS. The investigators suggest that ambient PM and 
DEP exposure may induce TNF-α suppression by different mechanisms (Becker, 
et al. 2005). Research demonstrates that ambient PM composition is influenced 
by season, and that seasonal variations in PM composition can alter pulmonary 
oxidant and cytokine responses (Becker, et al. 2005; Hetland, et al. 2005). For 
instance, polycyclic aromatic hydrocarbons (PAH), an organic class of PM 
components, differ in concentration between summer and winter seasons 
(Binkova, et al. 2003). Exposure to organic (PAH) PM components exposure can 
generate a variety of pulmonary oxidative and inflammatory responses including 
increased immunoglobulin E (IgE), hemeoxygenase-1, and inflammatory cytokine 
expression. (Tsien, et al. 1997; Li, et al. 2000; Schober, et al. 2007).  
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The present study compared oxidant and cytokine production in human 
alveolar macrophages exposed to ambient PM and DEP. We explored the 
contribution of particle-associated benzo(a)pyrene (B(a)P), a PAH, to LPS-
induced inflammatory responses. We also investigated the contribution of fine 
and coarse ambient PM collected during different seasons on macrophage 
responsiveness to LPS. Our research findings suggested that both ambient PM 
and DEP-exposure suppressed macrophage inflammatory response to microbial 
stimulation. Ambient PM-induced effects varied by season and were not 
attributable to BaP content. Finally, the broad mechanistic pathways by which 
ambient PM and DEP suppressed AM responsiveness were different.  
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2.2 Materials and Methods 
2.2.1 Reagents and Chemicals 
RPMI, Hanks Balanced Salt Solution (HBSS), benzo(a)pyrene (BaP), LPS 
(Salmonella typhimurium), phorbol myristate acetate (PMA), and calcium 
ionophore A23187 (A23817) were purchased from Sigma (St Louis, MO). We 
obtained superoxide dismutase (SOD) and ferric cytochrome C (horse heart) 
from Fisher Scientific (Pittsburgh, PA). Fetal bovine serum (FBS) and gentamycin 
were purchased from Invitrogen (Carlsbad, CA). C 18 Sep Pak columns were 
purchased from Waters Associates (Milford, MA). 
 
2.2.2 Particles 
Standard Reference Material (SRM) 1649 (Urban Dust; UD) and SRM 
2975 (DEP) were purchased from the National Institute of Standards and 
Technology (NIST, Gaithersburg, MD). UD was collected over a one year period 
(1976-1977) by baghouse in the Washington, DC area 
[https://srmors.nist.gov/certificates/1649A.pdf ]. A subset of UD particles were 
vapor-coated with 1.00±0.05μg BaP/mg particle (provided by Dr. Jane Gallagher, 
U.S. EPA, RTP, NC) DEP was collected from a diesel-powered forklift using a 
specialized filtering system for forklifts [ https://srmors.nist.gov/certificates/ 
2975.pdf]. 
Chapel Hill coarse (CHC) and fine (CHF) particles were collected during 
November 2001 and July 2002 in Chapel Hill, North Carolina according to a 
previously described procedure (Becker, et al. 2005). Briefly, ambient particles 
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were collected  onto polyurethane foam (PUF; McMaster-Carr, Atlanta, GA) using 
a ChemVol model 2400 high-volume cascade impactor (Rupprecht & Patashnick 
Co., Albany, NY) with both a coarse (PM10) and a fine (PM2.5) stage. The 
particles were removed by sonication for 1 hour in a water bath (FS220; Fisher 
Scientific, Pittsburgh, PA). Once the foam was removed, particles were 
lyophilized and re-suspended 5mg/mL and stored at -80ºC. Particle collection 
took place on the roof of the U.S. Environmental Protection Agency (U.S. EPA) 
Human Studies Facility in Chapel Hill, NC.  
Volcanic ash (VA) particles were sampled for the U.S. EPA from Mount St. 
Helens at Washtucna, WA on May 19, 1980. Carbon black (CB) particles were 
obtained from stocks used in previous research (Mundandhara, et al. 2005). 
  
2.2.3 Particle Preparation  
Each particle type was suspended in RPMI with gentamycin and 2.5% 
FBS at concentrations of 400μg/mL and 200μg/mL. PM suspensions were 
vortexed vigorously for 5 minutes within 1 hour of AM exposure in order to 
reduce leaching of PM components into the exposure media. Final particle 
concentration was 100μg/mL for all PM exposures unless otherwise noted. 
  
2.2.4 Isolation of Human AMs 
Human alveolar macrophages were obtained from the bronchoalveolar 
lavage (BAL) of healthy, non-smoking, young adults (18-35 years of age) under a 
research protocol and consent form approved by the Institutional Review Board 
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at the University of North Carolina Medical School and the U.S. Environmental 
Protection Agency. BAL was collected according to procedures published by 
Ghio and associates (1998). Collected AM are washed with ice-cold RPMI 
containing gentamycin (50μg/mL). Cells are counted in a hemocytometer and a 
small portion centrifuged onto microscopic slides, stained with Diff quick and 
checked for AM purity. Cellular viability was assessed by trypan blue exclusion.  
 
2.2.5 AM Stimulation 
Alveolar macrophages (2.5 x 106 in 1mL of RPMI 1640 supplemented with 
2.5% FBS) were exposed to PM in sterile 5mL polypropylene culture tubes at 
37°C with 5% CO2. After a 24 hour exposure period, AM were centrifuged 
(500xg) for 10 minutes at 4°C, and 800μL of conditioned media was collected. 
Fresh media (800μL) containing LPS, PMA, or A23817 was then added with final 
concentration of 10ηg/mL, 100ηg/mL, and 10μM respectively. Conditioned cell 
supernatant was collected 6 hour or 24 hour post stimulation. Remaining cells 
were incubated in a radioimmunoprecipitation (RIPA) cell lysis buffer for 1 hour at 
room temperature. The cell framents were centrifuged at 1600 x g for 10 minutes 
at 4°C and cell lysates and supernatants collected. Cell supernatants and lysates 
were stored at -80° until cytokine analysis. 
 
2.2.6 Cellular Cytoxicity  
Cellular cytotoxicity was determined by lactate dehydrogenase (LDH) 
activity (Cytotox 96 NonRadioactive Assay kit; Promega; Madison, WI). LDH 
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released upon cell lysis converts tetrazolium salt (INT) into a red formazan 
product. Light absorbance is measured after formazan formation and compared 
to a LDH positive enzyme (LDH+) control. LDH enzyme was derived from bovine 
heart cells and corresponds to 13,500 lysed L929 fibroblast cells. Cell viability by 
trypan blue exclusion was conducted in a subsample of replicates in order to 
confirm LDH results.  
 
2.2.7 Superoxide Anion Analysis 
Superoxide anion (O2-) concentration was measured according to 
procedure by Pick and Keisari (1981). Duplicate tubes of AM were incubated with 
PM (100μg/mL) for 24 hours. Cell supernatant was removed and AM were 
washed with cold HBSS. AM were then incubated in a ferric cytochrome C 
(80μm) and PMA (100ηg/mL) solution with and without 3.2U/mL SOD for 1 hour. 
O2- concentration was calculated from the difference in absorbance (550 ηm) 
between solutions with and without SOD.  
 
2.2.8 Aldehyde Analysis 
Intra- and extra-cellular aldehydes were examined as end products of lipid 
peroxidation (Madden et al., 1999). AM were incubated with PM (100μg/mL) for 
24 hours. Following incubation, AM were centrifuged (500 x g) and 800μL 
conditioned media removed and saved in a glass vial. The AM pellet was rinsed 
with 1mL HBSS, centrifuged, and 800μL of rinsate added to conditioned media. 
AM were transferred in to a separate glass vial. Cells and conditioned media 
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were treated with 2,4-dinitrophenylhydrazine (DNPH;  0.125% in acteonitrile) to 
derivatize aldehydes into dinitrophenylhydrazones. Aldehyde derivatives were 
isolated through C18 SepPak extraction. Dinitrophenylhydrazone detection was 
conducted according to a previously described method (Madden, et al. 2003). 
Cell and conditioned media samples were analyzed for  dinitrophenylhydrazone 
content on a reverse phase Waters Associates HPLC System with both mass 
spectrophotometry (MS) and ultraviolet light (UV; 365 nm confimatory 
wavelength) detection. These m/z values measured under selective ion 
monitoring correspond to the parent ions for C 2 through C12 
dinitrophenylhydrazones and the derivative of 11-cis-hexadecenal (m/z 417) 
which was added as an internal standard. Twenty microliters (20μL) out of 200μL 
final sample volume was injected, and data corrected to the total sample volume. 
Data were analyzed using Waters Associates MassLynx software. 
 
2.2.9 Cytokine Analysis 
Intra- and extra-cellular cytokine concentrations were measured as 
indicators of cytokine retention and cytokine release, respectively. Intra- and 
extra-cellular IL-8 concentrations was measured 24 hours post stimulation by 
quantitative sandwich enzyme-linked immunoassay (ELISA; R&D Systems Inc; 
Minneapolis, MN). Average IL-8 minimum detectable concentration is 3.5ρg/mL. 
Intra- and extra-cellular IL-6 and TNF-α were analyzed 6 hours post stimulation 
with the electro-chemiluminescence multiplex detector Sector 2400 (MesoScale 
Discovery; Gaithersburg, MD) in a 96-well plate. Minimum detectable 
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concentrations were 0.2ρg/mL and 0.15ρg/mL, respectively with a 3:1 signal to 
noise ratio. 
 
2.2.10 Statistics 
Statistical analysis was performed using Prism 4.0 (GraphPad Software 
Inc.; San Diego, CA). Data are reported as mean ± SE. Two-way ANOVA was 
used to analyze superoxide anion production in AM stratified into “high” and “low” 
O2- release groups. We compared data across multiple particle exposures using 
1-way ANOVA followed by Dunnet’s single-comparison to a control exposure. 
Chapel Hill PM exposure was analyzed separately by 1-way ANOVA followed by 
Tukey’s multiple-comparison post-hoc test in order to compare effect of PM 
exposure concentration, size, and collection season.  
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2.3 Results 
 
2.3.1 Cytotoxicity 
Alveolar macrophages were exposed to UD, CHC, CHF, DEP, CB, and 
VA for 24 hour. LDH activity in the supernatant was used to monitor cellular 
cytotoxicity after PM incubation as well as post-stimulation with LPS, PMA, or 
A23817. The average LDH enzyme alone (positive control) was 1.70 ± 0.09 
relative absorbance units (rau). AM control (without PM) LDH activity averaged 
0.28 ± 0.02 rau after the initial 24 hour incubation. LDH activity in AM exposed to 
various PM at 100ug/mL concentrations or LPS did not differ significantly from 
particle-free control LDH activity at 6 hour or 24 hour. PMA and A23817 
stimulation did not increase LDH activity at 6 hour post stimulation time-points. 
Trypan blue exclusion analysis in select experiments demonstrated 90% or 
greater cell viability across all particle treatments and controls.  
 
2.3.2 Effect of PM Exposure on Superoxide Anion Production 
Superoxide (O2-) production was measured as an indicator of oxidative 
stress and macrophage function. Data were stratified into “high” and “low” groups 
(n=4 per group) based upon relative O 2- release with and without stimulation. AM 
were assigned to the “low” group if they exhibited a 2-fold or greater increase in 
O2- production after stimulation with 10ng/nL PMA (Figure 2.1). AM were 
assigned to the “high” group if they exhibited less than a 2-fold increase O 2- 
production after stimulation with 10ng/nL PMA. On average, AM assigned to the 
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“high” release group exhibited less than 12.5 (± 8.5)% increase in O 2- release 
post PMA stimulation due to a greater unstimulated (i.e., no PMA) O2- release. 
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Figure 2.1 Effect of PM Exposure on O2- Production.  AM were incubated with 
PM or vehicle for 24 hours. PMA, phorbol myristate acetate; UD, urban dust; 
DEP, diesel exhaust particle; CB, carbon black; VA, volcanic ash. AMs were 
centrifuged and cell media was changed and replaced with HBSS containing 
PMA and Ferric Cytochrome C, with or without SOD. Cell media was collected 
after 1 hour and O2- measured by absorbance. # and ## indicate statistically 
significant difference at p<0.01 and p<0.001, respectively, from +PMA in the low 
release group by  2-way ANOVA and Bonferroni’s post hoc test; n=4 and n=4 for 
high and low O2- release groups, respectively. 
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In this set of experiments, AM were exposed to 100 μg/mL PM 
concentrations. UD and DEP exposed AM in the “low” group released 
significantly less O 2- (p<0.01) relative to the +PMA control (Figure 2.1). The same 
trend was observed among AM with “high” O2- background, but the observed 
effect was not statistically significant. CB and VA had no effect on O2- production 
in either “low” or “high” background groups. The data suggests UD and DEP 
suppress normal AM oxidative response to PMA stimulation. 
2.3.3 Effect of PM Exposure on Aldeyhyde Production 
 Extra- and intra-cellular aldehyde production was measured as an 
indicator of lipid peroxidation. Eight of twelve measured straight chain aldehydes 
(C1-C12) were detectable in conditioned media (extra-cellular) and lysed cells 
(intra-cellular). Butanal (C 4), pentanal (C5), octanal (C8), and undecanal (C11) 
were undetectable in most samples. Formaldehyde (C1) and acetaldehyde (C2) 
contributed to greater than 70 percent of both extra- and intra-cellular total 
aldehyde concentrations regardless of PM exposure. C 1 values were not used as 
an indicator of peroxidation due to the highly variable presence of C 1 in blanks, 
due in part to background contamination. The average total intra-cellular 
aldehyde production (C2-C12) after DEP and UD exposure were 2032 ± 418 
nmoles and 1558 + 107 nmoles, respectively. DEP and UD induced aldehyde 
production was not statistically different from the average total production of 
unstimulated control AM (2034 ±15 nmoles). A non-significant increase (p=0.06) 
was observed in intra-cellular nonanal (C 9) post DEP exposure (26±5 nmoles) 
relative to unstimulated control (18±2 nmoles). Total extra-cellular aldehyde 
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content also was not significantly altered by either DEP (1215 +  109 nmoles) or 
UD (1458 + 201 nmoles) exposures relative to control (1061 +  51 nmoles). The 
combined data suggests that DEP and UD exposures did not increase intra-
cellular or extra-cellular aldehyde production to a significant level after 24 hours.  
 
2.3.4  Effect of PM Exposure on Cytokine Response 
AM were incubated with different PM types or 24 hours. Extra-cellular 
TNF-α, IL-6, and IL-8 were measured after the 24 hour incubation. AM exposed 
to UD released elevated concentrations of TNF-α (p<0.01), IL-6 (p<0.05), and IL-
8 (p<0.05) relative to the AM control without PM exposure (Figure 2.2). We 
observed slight increases in TNF-α release from November CHF-exposed AM, 
but the increase was not statistically significant. The low concentration of 
November CHF stimulated a significant (p<0.05) release of IL-8 from AM. Both 
concentrations of November CHC stimulated significant (p<0.01) TNF- α and IL-8 
(p<0.01) releases relative to the AM control. IL-8 release was significantly 
elevated in the high concentration of June CHF (p<0.01) exposed AM relative to 
the control AM. AM exposure to June CHC also elevated IL-8 release (p<0.01) 
relative to the control. In contrast, DEP, CB, and VA did not stimulate cytokine 
release relative to the AM control, after 24 hour PM incubation. These data 
suggested ambient PM was capable of stimulating AM inflammatory responses, 
whereas DEP, CB, and volcanic ash (ambient PM from natural source) did not 
stimulate an inflammatory response from AM.  
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Figure 2.2 Effect of PM Exposure on Cytokine Release. AM were incubated with 
PM (100μg/m unless otherwise indicated as 50μg/mL) for 24 hours at 37°C. UD, 
urban dust; DEP, diesel exhaust particle; CB, carbon black; VA, volcanic ash; 
CHF, Chapel Hill fine particles; CHC, Chapel Hill coarse particles. AMs were 
centrifuged and media collected for cytokine analysis. # and * indicate statistically 
significant differences at  p<0.01 and p<0.05, respectively, from AM Control by 1-
way ANOVA and Dunnet’s post-hoc test (A) TNF-α, n= 5-19  (B) IL-8, n=3-19.  
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We also evaluated cytokine release between fine and coarse Chapel Hill 
particles at high (100μg/mL) and low (50μg/mL) exposure concentrations (Figure 
2.2b). Both high and low concentrations of November CHC stimulated greater 
than a 6-fold TNF-α release from AM over the November CHF (p<0.001) 
exposure. November CHC- exposed AM, also, released a larger IL-8 
concentration than November CHF- exposed AM, but the trend was not 
statistically significant. AM exposed to high concentration June CHC particles 
released a 2-fold greater IL-8 than AM exposed to the June CHF particles 
(p<0.001). The low concentration of June CHC also stimulated more IL-8 release 
than the low June fine PM, but the trend was not statistically significant. June 
ambient PM appear to stimulate greater IL-8 releases than November ambient 
PM, but the observation is not statistically significant. These data suggested that 
coarse ambient PM induced a greater inflammatory effect on AM than fine 
ambient PM. In addition, seasonal influences on PM composition may affect AM 
inflammatory responses.  
 
2.3.5 Alteration of LPS-Induced Cytokine Response by Ambient PM and DEP 
Alveolar macrophages were exposed to PM for 24 hours and 
subsequently incubated for 6 or 24 hour with LPS. TNF-α (Figure 2.3) and IL-6 
(Figure 2.4) release and intra-cellular retention were measured 6 hours post LPS 
stimulation. Relative to the LPS-stimulated control (+LPS; no particle exposure), 
DEP and VA suppressed TNF-α release from AM by 43.8 ± 22.0percent (p<0.01) 
and 31.5 ± 15.4 percent (p<0.05), respectively (Figure 2.3A). Both high 
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concentrations of November CHF and November CHC particles also significantly 
suppressed TNF-α release by 43.8 ± 22.0 percent and 38.7±12.9 percent, 
respectively. The mechanisms reducing TNF-α release may be different among 
the different PM exposures and associated cytokine production. DEP exposure 
significantly increased TNF-α intra-cellular retention (Figure 2.3B), whereas 
November CHF particles exhibit decreased total TNF-α production (release + 
intra-cellular) (Figure 2.3C). Similarly, UD and DEP exposure reduced AM IL-6 
release by 56.2 ± 10.3 percent and 50.6 ± 11.9 percent, respectively (p<0.01) 
(Figure 2.4A). The decreased production of IL-6 induced by DEP exposure 
appears to be due to a combination of increased retention (p=0.05) and 
decreased release (Figures 2.4B and 2.4C).  
 IL-8 cellular release and intra-cellular retention were measured 24 hours 
post LPS stimulation. 24 hours was a more optimal time point to assess IL-8 
production compared to 6 hours. UD exposure reduced IL-8 release by 44.2 ± 
13.0 percent relative to the +LPS control (p<0.05) (Figure 2.5A). DEP and 
November Chapel Hill PM exposure appeared to stimulate IL-8 release relative to 
the +LPS control, although the responses were highly variable among individual 
subjects. Analysis of total cytokine production revealed that UD, DEP, and VA 
exposed AM retained a greater percentage (>10 percent) of total produced IL-8 
than the LPS-stimulated control (5.3 ±0.5 percent), but only UD-induced retention 
was statistically significant (p<0.05). 
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Figure 2.3 Alteration of LPS-Induced TNF-α Response by Particulate Matter. AM 
were incubated with PM (100μg/mL unless otherwise indicated as 50μg/mL) for 
24 hours at 37°C. AMs were then centrifuged and cell media was changed and 
replaced with fresh media containing 10ng/mLLPS (final concentration). After at 6 
hour incubation at 37°C, cell media and cell lysate were collected for cytokine 
analysis. LPS, lypopolysaccharide; UD, urban dust; DEP, diesel exhaust particle; 
CB, carbon black; VA, volcanic ash; CHF, Chapel Hill fine particles; CHC, Chapel 
Hill coarse particles. (A) Percent difference in TNF- α release into cellular media 
relative to the control (+LPS). Dotted line indicates the +LPS control (without PM) 
response. (B) Percent of total TNF-α remaining within the AM (intra-cellular 
retention) (C) Total TNF-α  production (release + intra-cellular). # and * indicate 
statistically significant differences, p<0.01 and p<0.05, respectively, from AM 
Control by 1-way ANOVA and Dunnet’s post-hoc test; n=6-19. 
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Figure 2.4 Alteration of LPS-Induced IL-6 Response by Ambient PM and DEP. 
AM were incubated with PM at 100μg/mL for 24 hours at 37°C. AMs were then 
centrifuged and cell media was changed and replaced with fresh media 
containing 10ng/mLLPS (final concentration). After at 6 hour incubation at 37°C, 
cell media, and cell lysate were collected for cytokine analysis. LPS, 
lypopolysaccharide; UD, urban dust; DEP, diesel exhaust particle; CB, carbon 
black; VA, volcanic ash  (A) Percent difference in IL-6 release into cellular media 
relative to the control (+LPS). Dotted line indicates the +LPS control (without PM) 
response. (B) Percent of total IL-6 remaining within the AM (intra-cellular 
retention) (C) Total IL-6 production (release + intra-cellular). # and * indicate 
statistically significant differences, p<0.01 and p<0.05, respectively from AM 
Control by 1-way ANOVA and Dunnet’s post-hoc test; n=5-9. 
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Figure 2.5 Alteration of LPS-Induced IL-8 Response by Ambient PM and DEP. 
AM were incubated with PM (100μg/mL unless otherwise indicated as 50μg/mL) 
for 24 hours at 37°C. AMs were then centrifuged and cell media was changed 
and replaced with fresh media containing 10ng/mLLPS (final concentration). After 
a  24 hour incubation at 37°C, cell media and cell lysate were collected for 
cytokine analysis. LPS, lypopolysaccharide; UD, urban dust; DEP, diesel exhaust 
particle; CB, carbon black; VA, volcanic ash ; CHF, Chapel Hill fine particles; 
CHC, Chapel Hill coarse particles. (A) Percent difference in IL-8 release into 
cellular media relative to the control (+LPS). Dotted line indicates the +LPS 
control (without PM) response. (B) Percent of total IL-8 remaining within the AM 
(intra-cellular retention) (C) Total IL-8 production (release + intra-cellular). # and * 
indicate statistically significant differences, p<0.01 and p<0.05, respectively from 
AM Control by 1-way ANOVA and Dunnet’s post-hoc test (n=5-13). 
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2.3.6   Effect of BaP-Coated PM on LPS-Induced Cytokine Production 
 In order to examine whether PM with increased PAH content exacerbates 
the decreased AM responsiveness to LPS (in terms of cytokine release), we 
compared cellular TNF-α and IL-8 production in AM exposed to UD, UD coated 
with BaP (UD+BaP), and free BaP (10μg/mL) at 6 and 24 hour post LPS 
stimulation (Figure 2.6). UD and UD+BaP had similar effects on cytokine 
response. At 6 hours post LPS stimulation, UD and UD+BaP significantly 
suppressed TNF-α release (-21.9+9.5% and -37.0.6±25.6, respectively), but did 
not have a significant effect on intra-cellular retention or total TNF- α production. 
Likewise, at 24 hour post LPS stimulation, UD and UD+BaP significantly 
suppressed IL-8 release (44.2+13.0 percent and 48.4±18.5 percent, 
respectively). UD and UD+BaP also induced a significant increase in IL-8 intra-
cellular retention (19.5±7.6 percent and 18.7±7.7 percent, respectively). Free 
BaP did not change TNF-α and IL-8 release, intra-cellular retention, or total 
production relative to +LPS control.  
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Figure 2.6 Effect of BaP-Coated Ambient PM on LPS-Induced Cytokine 
Responses. AM were incubated with PM (100μg/mL) for 24 hours at 37°C. AMs 
were centrifuged and cell media was changed and replaced with fresh media 
containing 10ng/mLLPS (final concentration). After a 6 hour or 24 hour incubation 
at 37°C, cell media were collected for cytokine analysis. LPS, 
lypopolysaccharide; UD, urban dust; DEP, diesel exhaust particle; BaP, 
benzo(a)pyrene. Dotted line indicates the +LPS control response.                     
(A) Percent difference in TNF-α release into cellular media relative to the control 
after 6 hours (B) Percent difference in IL-8 release into cellular media relative to 
control after 24 hours. # and * indicate statistically significant differences, p<0.01 
and p<0.05, respectively from AM Control by 1-way ANOVA and Dunnet’s post-
hoc test; n=4-13. 
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2.3.7 Seasonal Effects of PM on IL-8 Release 
 We compared cellular IL-8 production 24 hours post LPS stimulation in 
AM exposed to PM collected during the November 2001 (late fall) and June 2002 
(early summer) in Chapel Hill, NC. AM were exposed to two concentrations, 
100μg/mL (high) and 50μg/mL (low), of fine and coarse particles. November 
particle exposure did not have significant effect on IL-8 release or intra-cellular 
retention relative to the +LPS control, with a non-significant stimulation of IL-8 
release after LPS activation. June fine and coarse PM, however, significantly 
suppressed LPS-induced IL-8 release by 40 percent or more (Figure 2.7). 
Increased intra-cellular retention (>10%) appeared to be responsible for 
decreased IL-8 release from June-exposed AM, but results were not statistically 
significant.  
 
2.3.8 Comparison of LPS, PMA, and A23817-Induced Responses 
AM were exposed to PM for 24 hours followed by a 6 hour incubation with 
LPS, PMA, or A23817. Longer incubations were not examined due to a decrease 
in AM viability at 24 hours with exposures to PMA and A23187. As previously 
described, DEP and UD inhibited AM TNF-α release in response to LPS 
stimulation. UD did not suppress cytokine release in response to PMA or A23817 
stimulation (Figure 2.8A and 2.8B), but rather increased AM TNF-α release after 
PMA or A23817 stimulation by 135.8±62.7 percent and 172.3±90.6 percent, 
respectively (p<0.05). The data suggest that the suppressive effect of UD on AM 
cytokine release is LPS-dependent. DEP exposure reduced TNF-α release (-
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40±10 percent) in response to LPS (p<0.01). DEP exposure caused a similar 
magnitude of TNFα decrease in response to PMA (-39±6 percent) and A23817 (-
24±68 percent) though not statistically significant. The data suggests that DEP 
exerts suppressive effects across multiple signal transduction pathways. 
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Figure 2.7 Effect of Season on IL-8 Production. AM were incubated with coarse 
and fine Chapel Hill PM (100μg/mL unless otherwise indicated as 50 μg/mL) for 
24 hours at 37°C. AMs were centrifuged and cell media was changed and 
replaced with fresh media containing 10ng/mLLPS (final concentration). After a  6 
hour incubation at 37°C, cell media and cell lysate were collected for cytokine 
analysis. Dotted line indicates +LPS Control Response. LPS, lypopolysaccharide; 
CHF, Chapel Hill fine particles; CHC, Chapel Hill coarse particles. (A) Percent 
difference in IL-8 release into cellular media relative to the control (+LPS) (B) 
Percent of total IL-8 remaining within the AM (intra-cellular retention) (C) Total IL-
8 production (release + intra-cellular). # and * indicate statistically significant 
differences, p<0.01 and p<0.05, respectively from AM Control by 1-way ANOVA 
and Dunnet’s post-hoc test; n=3-19. 
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Figure 2.8 Comparison of PMA and A23817 Induced Cytokine Responses. AM 
were incubated with PM (100μg/mL) for 24 hours at 37°C. AMs were centrifuged 
and cell media was changed and replaced with fresh media containing AM 
activator. After 6 hour incubation at 37°C, cell media were collected for TNF-α 
analysis. PMA, phorbol myristate acetate; A23817, calcium ionophore; UD, urban 
dust; DEP, diesel exhaust particle; CB, carbon black; VA, volcanic ash. Dotted 
line indicates +A23817 (A) PMA induced response: Percent change in TNF-α 
release into cellular media relative to the control (B) A23817-induced response: 
percent change in TNF-α release into cellular media relative to control. * 
indicates statistically significant differences, (p<0.05) from AM Control by 1-way 
ANOVA and Dunnet’s post-hoc test (n=4). 
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2.4 Discussion 
Epidemiology studies link exposure to high concentrations of ambient PM 
with the exacerbation of pre-existing inflammatory disease and increased 
hospitalization rates for asthma symptoms and respiratory infections (Schwartz, 
et al. 1993; Schwartz 1996; Ramieu, et al. 1996; Delfino, et al. 1997; Ilbaca, et al. 
1999). The primary objective of this study was to examine in vitro the possible 
effects of ambient PM on the ability of AM to respond to bacterial insult with 
regards to cytokine release. Previous work demonstrates a decreased LPS-
induced cytokine release from AM pre-exposed to DEP (Mundandhara et al. 
2005), but ambient PM was not examined. This study, also, explored the broad 
mechanisms that may explain how ambient PM exerts its effects on AM. 
Because alterations in oxidative metabolism and inflammation are most likely 
involved, we examined both O2- release as well as the production and release of 
several inflammatory cytokines.  
We chose standardized ambient PM and diesel particles from NIST in 
order to enable comparability across multiple studies. In addition, UD and DEP 
have similar mean diameter, surface area, and size distribution (NIST 2001, 
2008). Coarse and fine PM elicit different oxidative and inflammatory responses 
from exposed lung cells in vitro (Becker, et al. 2003). We chose UD and DEP in 
order to speculate upon the contribution of particle composition rather than size. 
The total extractable organic mass for DEP and UD are 2.7±0.2 percent and 
4.6±0.2 percent, respectively (NIST 2001, 2008). UD and DEP also differ in PAH, 
PCB, and metal composition. Given size and mass distribution similarities, the 
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effects of UD and DEP exposure may be attributable to differing organic 
constituents associated with each respective particle. Carbon black was chosen 
in order to evaluate effects of the DEP carbonaceous core. Fine and coarse PM 
collected in Chapel Hill, NC were selected because diesel exhaust is a significant 
contributor to ambient PM in this collection area (Becker, et al. 2005). Volcanic 
ash from the 1980 Mt. St. Helen’s eruption was added to this study to represent a 
natural source of ambient PM.  
UD and DEP exposure significantly suppressed human AM O2-  relative to 
a particle-free stimulated (+PMA) control in AM from subjects with a relatively low 
unstimulated constitutive release (Figure 2.1). Oxidant radical generation can be 
a protective response to xenobiotic exposure, although over-production can lead 
to lung injury (Maier 1993; Lohman-Matthes, et al. 1994; Nakashima, et al. 1991; 
Chabot, et al. 1998). If PM exposure suppresses O2- release, AM may be 
incapable of adequately initiating the appropriate oxidative host-defense against 
infection. Several investigators measured oxidant radical generation, indicated as 
increased chemiluminescence, in rat and human AM exposed to diesel PM and a 
variety of urban air particles (Becker, et al. 2005, Kleinman, et al. 2003; Becker, 
et al. 1996). AM incubated with diesel PM or standard reference material 1648 
(St Louis, MO urban dust) generate an oxidative response similar to an un-
stimulated control (Kleinman, et al. 2003; Becker, et al. 1996). However, AM 
incubated with urban air particles from other sources generate increased 
oxidative responses relative to unstimulated cells (Becker, et al. 2005; Becker, et 
al. 1996). The ability of certain ambient air PM to generate an oxidative response 
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may be related to PM size or composition. For example, coarse PM collected in 
Chapel Hill, NC had a greater stimulatory effect on reactive oxygen species 
(ROS) generation than fine Chapel Hill PM (Becker, et al. 2005). Aam and 
investigators (2007) measured ROS generation (as evidenced by 
chemiluminescence) in rat AM exposed to SRM 1975, the dichloromethane 
extract of SRM 2975 (DEP). Their results show that SRM 1975 exposure reduces 
AM ROS release, suggesting organic composition of DEP is responsible for 
induced oxidative effects. Intra-cellular ROS generation is attributed to fine and 
ultrafine size fractions and their associated PAH and metal composition (Hiura, et 
al. 1999; Li, et al. 2002; Ntziachristos, et al. 2007). We did not evaluate PM 
characteristics responsible for the O 2- results in this study. The effect of ambient 
PM on AM responsiveness just prior to LPS stimulation was our primary focus. 
To this end, we established that UD and DEP similarly altered an immune 
function, O2- release, necessary for defense against microbial infection.  
DEP exposure did not enhance lipid peroxidation as evidenced by intra-
cellular and extra-cellular aldehyde production. We observed a trend increase in 
intra-cellular aldehyde production, particularly in C 9 (nonanal), in DEP exposed 
AM, but the sample size (n=3) was insufficient to detect a statistical difference. 
Other research groups have observed DEP-induced increases in intra-cellular 
ROS. For instance, DEP induces apoptosis through the generation of intra-
cellular ROS in the murine AM and human monocyte cell lines, RAW 264.7 and 
THP-1, respectively (Hiura, et al. 1999). It may be that this type of DEP does not 
induce oxidative stress in human alveolar macrophages or that a wider variety of 
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oxidative stress biomarkers need to be examined with different optimal sampling 
times.  
In our study, UD, DEP, and Chapel Hill PM suppressed cytokine release in 
response to lipopolysaccaride (LPS), a cell wall constituent of gram-negative 
bacteria (Figure 2.3A – 2.5A). Investigators have established that in vitro DEP 
exposure suppresses AM cytokine release after microbial stimulation  (Amakawa, 
et al. 2003; Mundandhara, et al. 2005). DEP exposure also suppresses microbial 
immune response and bacterial clearance in rodents (Yang, et al. 2001; Yin et al. 
2004). Ambient PM suppressed human AM responsiveness to LPS, similar to the 
suppression caused by DEP. Cellular exposure to SRM 1649 (Washington, DC 
UD) and SRM 1648 (St Louis, MO UD) shifts human AM phenotype ratio to favor 
immune stimulation (Holian, et al. 1998). Indeed, UD and coarse and fine Chapel 
Hill PM in the current study stimulated cytokine release prior to LPS exposure 
(Figure 2.2). Particle-associated LPS may be responsible for AM initial release of 
inflammatory cytokines (Becker et al. 1996). Polymyxin B, an LPS inhibitor, 
partially reduces AM cytokine response to St. Louis UD which contains 60-500 ρg 
LPS per milligram of particle. Polymyxin B also inhibits cytokine production in 
human monocytes exposed to Chapel Hill coarse and fine PM (Monn and Becker 
1999). We did not test for PM-associated LPS in this study. However, LPS may 
have pre-primed the AM exposed to UD in our experiments, possibly attenuating 
AM cytokine response to additional LPS exposure. Sub-threshold LPS exposures 
that result in the inability of lung cells to respond to additional LPS exposure is a 
well-documented condition known as “endotoxin-tolerance” (Dobrovolskaia and 
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Vogel 2002). In contrast, ambient PM can exacerbate pre-existing lung 
inflammation, modeled by 20 hour AM pre-incubation with LPS followed by PM 
exposure (Imrich, et al. 1999). Human AMs primed with 10-1000 ng/mLLPS 
dramatically increase (up to 10-fold) TNF-α  release following exposure to 
Washington, DC UD and concentrated air particles (CAPs), collected in Boston, 
MA. The different responses observed in our results may be explained by particle 
type and exposure model characteristics. As previously mentioned, the amount 
of particle-associated endotoxin in Washington, DC UD is not known, and may 
not be in sufficient quantity to attenuate LPS-induced responses in our study. In 
addition, the combined interactions of UD components may affect AM differently 
than a system exposing AM first to free LPS. Nonetheless, the results of our 
study and that of Imrich and colleagues (1999) are not mutually exclusive. The 
results from the two experiments indicate that PM exposure is capable of 
disrupting immune cell homeostasis. Ambient PM can exacerbate pre-existing 
inflammation, eventually causing inflammation-induced injury. Our results 
indicated ambient PM can also suppress oxidative and inflammatory responses 
in healthy AM when PM exposure precedes bacterial exposure, thus leaving the 
lung vulnerable to microbial infection.  
Our results suggest that ambient PM and DEP may alter AM ability to 
produce or release inflammatory cytokines in response to LPS exposure. Two 
patterns emerged from the data: (1) suppressed cytokine release, indicated by 
increased intra-cellular cytokine retention; and (2) suppressed total cytokine 
production. For example, UD and DEP exposure caused comparable decreases 
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in IL-6 release (Figure 2.4A). Decreased total cytokine production caused the 
observed “decrease” (Figure 2.4C). Only UD exposure decreased IL-8 release 
(2.5A), which was attributed to increased IL-8 intra-cellular retention (2.5B). The 
findings suggest that PM exposure can delay inflammatory response by 
suppressing cytokine release or, prevent an inflammatory response all together 
by inhibiting cytokine production.  
Benzo[a] pyrene (BaP), a polycyclic aromatic hydrocarbon (PaH), is a 
constituent of both the UD and DEP used in our experiments. BaP is typically 
noted for its mutagenic properties. The current study explored the effect of BaP 
to acute macrophage inflammatory responses. We exposed human AM to UD, 
UD coated with BaP, and free BaP. The mass fraction of BaP on the coated 
particles is near 400-fold higher than uncoated UD. Both the coated and 
uncoated UD significantly suppressed TNF-α and IL-8 release (Figure 2.6) . The 
magnitude of suppression was similar between the coated and uncoated UD. AM 
cytokine response to free BaP mimicked the responses elicited by our positive 
control (+LPS). Results indicated that particle associated BaP does not explain 
the depressed cytokine concentrations in the supernatant of UD and DEP 
exposed AM.  
The season had an effect on ambient PM-induced cytokine responses. 
Our results demonstrated that AM exposed to ambient PM collected during an 
early summer month (June) stimulated IL-8 release from human AM (Figure 
2.2B). PM collected during the late fall (November) also stimulated IL-8 release, 
but to a lesser degree. We also found that June coarse and fine PM exposure 
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suppressed the ability of human AM to respond to LPS, while November PM 
exposure did not inhibit AM IL-8 release (Figure 2.7). In general, coarse particles 
exhibited greater potency than fine particles. Our observations parallel previous 
findings that coarse Chapel Hill PM are more potent in AM than fine and ultrafine 
fractions (Becker, et al. 2003, 2005). The literature also shows that elemental 
metal composition and size fraction are better predictors of IL-6 release from 
human AM than season, although considerable variation exists from month-to-
month (Becker, et al. 2005). Other investigators have not investigated the effect 
of ambient PM on the ability of human AM to respond to LPS. Our results 
suggest that PM exposure during warmer months may enhance human 
susceptibility to respiratory infection. Epidemiology studies report a higher 
association between ambient PM-induced morbidity and mortality during warmer 
months than during cooler months (Stieb, et al. 2002, Moolgavkar 2003). Peel 
and colleagues (2005) showed an association between increased hospital visits 
for pneumonia and ambient PM2.5 levels in Atlanta.  Research that compares 
effects of ambient PM collected over several years and seasons would better 
address questions about seasonal effects.  
We examined different immune-response signaling pathways by 
comparing TNF-α release from particle-exposed AM stimulated with LPS, PMA, 
or A23187. LPS, PMA, and A23817 are well-known macrophage activators that 
can ultimately stimulate the production of inflammatory cytokine including TNF- α. 
Each activator, to some extent, induces different signaling mechanisms that lead 
to cytokine production. UD and DEP both suppress AM TNF-α response to LPS. 
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If both UD and DEP exposure suppress TNF-α in response to PMA or A23817, 
this would suggest that UD and DEP similarly disrupt multiple signaling 
mechanisms. For example, LPS enters the cell via a receptor-ligand binding 
pathway by forming a complex with  LPS-binding protein, endogenous in serum, 
and then binding to cellular membrane receptors CD14 and Toll-like receptor 4 
(TLR4) (Wright, et al. 1990;  Lien, et al. 2000; Maris, et al. 2006). Once bound to 
TLR4, LPS initiates an intra-cellular signaling cascade that can lead to the 
activation of nuclear factor-κβ (NFκβ), a transcription factor that controls the gene 
expression of TNF-α and other inflammatory cytokines (Carter, et al. 1998; 
Baldwin 2001). PMA activates macrophages via an oxygen-consuming electron-
transport chain. PMA activates NADHPH oxidase which then catalyzes the 
production of extra-cellular O 2- and reactive O2- derivatives. ROS can initiate a 
multitude of signaling cascades including the activation of NF κβ (Kaul and 
Forman 1996). Calcium ionophore A23817 allows extra-cellular Ca 2+ influx into 
the cell by opening calcium-dependent ion channels in the cellular membrane. 
Increased intra-cellular Ca 2+ concentration can induce multiple signaling 
cascades including those involving phospholipase C activity, inositol phosphate 
production, and NFκβ activation (Taylor, et al. 1990; Raddassi, et al. 1994; 
Dolmetsch, et al. 1998). UD exerted a suppressive effect in AM stimulated with 
LPS. Neither PMA nor A23817 stimulation replicated the pattern of TNFα 
suppression in UD-exposed macrophages (Figure 2.8). The results suggested 
that the ability of UD exposure to suppress TNF-α release is dependent upon 
factors unique to the LPS-induced signaling cascade. We observed a strong, but 
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non-significant, trend in DEP exposed-AM to suppress TNF-α release whether 
stimulated with LPS, PMA, or A23817. The trend indicates that DEP-exposure 
disrupted several different cellular immune pathways.  
These combined data suggest that UD and DEP exposure have significant 
effects on human immune responses. Ambient PM suppressed AM oxidant 
response to PMA stimulation, as well as inflammatory cytokine response to LPS 
stimulation. DEP exposure also induced suppressed oxidant and inflammatory 
responses, but the effect is likely induced by different mechanistic pathways than 
UD. DEP appeared to delay AM cytokine release, whereas the effect of ambient 
PM exposure was variable. In addition, DEP exposure appeared to influence a 
wider array of mechanistic pathways, whereas the observed ambient PM effects 
are related to LPS-induced pathways. PM-induced effects were not linked to 
BaP, but may be related to seasonal influences on other PM components. Fine 
and coarse PM collected during a warmer month had a greater effect on ambient 
PM inflammatory responses than PM collected during a cooler month. The 
capability of ambient PM and DEP exposure to suppress immune responses to 
LPS indicated that human exposure to PM may enhance pulmonary susceptibility 
to lung infection in vivo. Further study is needed to better understand the 
relationships between PM composition, seasonal predilection, and the effected 
immune mechanistic pathways. 
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Abstract 
Human studies demonstrate that acute exposure to diesel exhaust (DE) 
stimulates mild airway inflammation, characterized by the production of 
inflammatory mediators and neutrophil influx into the airways. The mechanism by 
which diesel exposure induces lung inflammation and injury is unclear, but may 
involve manipulation of phospholipid metabolic pathways.  In this study we 
employ a lipidomics approach to evaluate the effect of an in vivo DE exposure 
and an in vitro DEP exposure on human alveolar macrophage phospholipid 
concentration.  Healthy human adults were exposed to DE (100μg/m3) and to 
filtered air for two hours with intermittent exercise. Twenty hours after exposure, 
bronchoalveolar lavage was performed and alveolar macrophages (AM) 
collected. Phospholipids were extracted (2x10 6AM/sample) and then identified by 
electrospray ionization tandem mass spectrometry. DE exposure induced 
singnificant decreases in AM lysophospholipid classes as well as altered the 
concentration of several individual lipid species (~5.1% of 411 lipid species 
examined). Preliminary results from in vitro studies demonstrate that 
lipopolysaccharide, diesel exhaust particles, and urban dust exposure may 
generate unique phospholipid “fingerprints” that may be used to identify 
exposure-specific lipid metabolic pathways.  Our study demonstrates that a 
lipidomics approach may be useful to identify biochemical mechanisms in 
response to environmental exposure, and would contribute to a better 
understanding on changes in the metabolome in response to pollutant 
exposures.  
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3.1 Introduction 
Substantial epidemiologic evidence links chronic and peak seasonal levels 
of ambient air pollution exposure to cardiopulmonary mortality and morbidity (US 
U.S. EPA, 2002). Diesel exhaust (DE) can significantly contribute to air pollution, 
particularly in urban environments. The US U.S. EPA estimates that on-road and 
off-road combustion of diesel fuel can contribute up to 23 percent of fine ambient 
PM (PM2.5) in US cities. Diesel exhaust particles (DEP) can contribute to as much 
as 80 percent of the PM2.5 generated from motor vehicles. Because DEP is a 
significant contributor to PM, DEP may contribute to PM-induced adverse health 
effects. 
Human exposure and experimental research demonstrates that DE 
exposure can induce a variety of pulmonary responses. DE exposure (at a 
particle mass concentration range of 100-300µg/m 3) initiates acute airway 
inflammation in healthy human subjects in studies that sample airway fluids 4 to 
6 hours after exposure (Salvi, et al. 1999; Holgate, et al. 2003; Nordenhall, et al. 
2000). Pulmonary inflammation is demonstrated by increased neutrophilia and 
inflammatory cytokine production in the alveolar and central bronchial airways of 
exposed volunteers (Salvi, et al. 1999; Holgate, et al. 2003; Nordenhall, et al. 
2000). One study reports that DE exposure increased interleukin-13, a TH 2 
cytokine, in the bronchial epithelial tissue of exposed volunteers (Pourazar, et al. 
2004). Nasal instillation of DEP (300μg) elevates IgE production and TH2 
cytokine mRNA expression in human nasal mucosa 18 hours after exposure 
(Diaz-Sanchez, et al. 1997). Experimental animal models and in vitro research 
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suggests that DEP exposure can inhibit innate immune responses necessary to 
fight microbial infections (Castranova, et al. 2001; Mundandhara, et al. 2005). 
DEP inhibits antimicrobial oxidant production and bacterial clearance in Lysteria 
monocytogenes infected rodents (Yang, et al. 1999, 2001). Mundandhara and 
colleagues (2005) found that DEP exposure also inhibits human alveolar 
macrophage (AM) cytokine response to gram-negative and gram-positive 
bacterial compounds, lipopolysaccharide (LPS) and Lipoteichoic acid (LTA), 
respectively. AM are important innate immune lung cells that fight bacterial 
infection, in part, by phagocytosis and the release of inflammatory mediators 
(Sibille and Reynolds 1990). DEP-exposed AM are unable to release interleukin-
8, tumor necrosis factor-α, or prostaglandin E2 (PGE2) in response to LPS or LTA 
exposure (Mundandhara, et al. 2005). The combined human exposure and 
experimental data demonstrate that diesel exposure has an adverse effect on 
pulmonary immune responses. 
The cellular mechanisms that lead to DEP-induced pulmonary effects are 
unknown. Some research suggests that PM-induced lung injury is the result of 
altered phospholipid metabolism. Residual oil fly ash (ROFA) particles, derived 
from fuel combustion, increase cyclooxygenase-2 (COX  2) activity in exposed 
human bronchial epithelial cells and in Sprague-Dawley rats (Samet, et al. 1996, 
2000). COX 2 is a lipid metabolic enzyme that synthesizes prostaglandins from 
the arachidonic acid (AA), a lipid fatty acid cleaved from phosphatidylcholine. 
Application of a COX  2 inhibitor, NS-398, prior to ROFA exposure reduces lung 
injury as suggested by decreased total protein concentrations in lavage fluid  
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(Samet, et al. 2000). The study results suggest the involvement of prostaglandins 
in ROFA-induced lung injury. DE exposure of rats and mice increases the 
concentration of prostaglandin F2α (PGF2α) and leukotriene B4 (LTB4) in lung 
lavage fluid (Henderson, et al. 1988). Recently, research demonstrates increased 
COX2 expression and PGE2 release from human lung alveolar type II (ATII) cells 
exposed to DEP in vitro and also induced COX  2 expression in the lungs of mice 
exposed in vivo (Ahn, et al. 2008). DEP exposure also augments 
phosphatidylcholine (PC) concentration in chronically exposed rats (Eskelson, et 
al 1984). PC, a glycerophospholipid, is secreted from ATII, lung surfactant-
producing cells (Juvin, et al. 2002). Increased PC concentration in lung surfactant 
can impair gas exchange and enhance host vulnerability to lung infection 
(Levine, et al. 2000; Wu, et al. 2003). 
Pollutants and soluble mediators must transport messages across outer 
and inner cellular phospholipid membranes in order to activate immune signaling 
cascades. Hence, cellular immune mechanisms require the active participation of 
membrane lipids (Fernandis and Wenk 2007). Phospholipids and their 
metabolites are involved in pathways that stimulate alveolar surfactant 
production, pulmonary cell apoptosis, acute lung inflammation, adult respiratory 
distress syndrome, and asthma (Bernard, et al. 1991; Fadok, et al. 1992; Monick, 
et al. 2001; Levy 2005; Bonnans and Levy 2007; Huber, et al. 2007) For 
instance, the combined action of phosphatidylinositol 3-kinase (PI3) and 
ceramide, two phospholipid derivatives, promotes cell-survival pathways in AM 
exposure to LPS (Monick, et al. 2001). AM secrete many of the phospholipid 
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metabolites involved with lung immune responses including prostaglandins, 
leukotrienes, thromboxane, hydroxyeicosatetraenoic acids, and platelet activating 
factor in large quantities, especially in response to LPS exposure (Arnoux, et al. 
1981; Brown, et al. 1988). However, the vast majority of research on 
comprehensive (i.e., global) analysis of pollutant-induced airway inflammation 
and pulmonary disease development focuses on the metabolic roles of genes 
(genomics) and proteins (proteomics). 
Lipidomics, a subcategory of metabolomics, is a global approach to 
studying coordinated lipid metabolic responses to stimuli. The biological roles of 
lipids with respect to proteins and genes are not well-understood. Lipids are 
small, generally hydrophobic molecules traditionally known as critical 
components of cellular membrane structure and energy metabolism. Lipids, 
however, are also important signal transduction molecules (Fernandis and Wenk 
2007; Eyster 2007). Phospholipids, abundant in cellular membranes, and their 
metabolites play important roles in cellular function and host immune defense. 
Phospholipids consist of a polar head group, glycerol backbone, and fatty acid 
tails. Metabolism of the polar head group or the fatty acid tails (e.g. arachidonic 
acid) gives rise to many important secondary signaling messengers (Berridge, et 
al. 1984; Wood, et al. 2005; Eyster 2007). In air pollution research, global 
evaluation of relative phospholipid changes after pollutant exposure may provide 
unique lipid “fingerprints”. These fingerprints may help characterize specific 
pollutant exposure and associated biological responses. The lipid fingerprint may 
provide a very specific biomarker of pollutant-induced exposure and effects.  
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Thus, lipidomics is a promising method to investigate the coordinated lipid 
response to exogenous compounds. 
The purpose of this study is two-fold. First, we evaluated the effect of 
diesel exhaust exposure on AM phospholipids. AM were collected from healthy 
human subjects who underwent DE or filtered air exposure. Second, we 
evaluated the effect of DEP exposure on human AM phospholipids in vitro. The 
combined human chamber and in vitro experiments allowed us to compare the 
effects of whole DE and DEP on AM phospholipid changes. We found that diesel 
exposure altered a variety of phospholipid species in exposed AM. 
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3.2 Materials and Methods 
 
3.2.1 Reagents and Chemicals 
LPS (Salmonella typhimurium), RPMI, and Hanks Balanced Salt Solution 
(HBSS) were purchased from Sigma (St Louis, MO). Fetal bovine serum (FBS) 
and gentamycin were purchased from Invitrogen (Carlsbad, CA). We purchased 
spectrophotometry grade chloroform and methanol from Burdick and Jackson 
(Muskegon, MI). SRM 1649 (Urban Dust; UD) and SRM 2975 (DEP) were 
purchased from National Institute of Standards and Technology (NIST, 
Gaithersburg, MD). UD was collected over a one year period (1976-1977) by 
baghouse in the Washington, DC area [ https://srmors.nist.gov/certificates/ 
1649A.pdf]. DEP was collected from a diesel-powered forklift using a specialized 
filtering system for forklifts [https://srmors.nist.gov/ certificates/2975.pdf]. Carbon 
black (CB) particles were obtained from stocks used in previous research 
(Mundandhara, et al. 2005) 
 
3.2.2 DE Exposure Study Subject Recruitment 
Ten subjects (4 male, 6 female), 19 to 30 years of age were included in 
the DE exposure study. Included subjects were healthy, non-smoking (<1 pack-
year over a lifetime), with normal lung function. Included volunteers did not have 
a history of respiratory or allergic diseases, active medical conditions, active 
allergies within two weeks of exposure, nor respiratory infections or flu-like 
symptoms within 6 weeks of exposure. NSAID use was not allowed within 48 
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hours of exposures, and subjects were not taking corticosteroids.  The study was 
approved by the medical institutional review board at the University of North 
Carolina at Chapel Hill. Prior to enrollment in the study, possible risks to the 
subject were explained, and written consent was subsequently obtained from all 
individuals. 
 
3.2.3 DE Exposure Protocol 
Healthy volunteers were exposed to DE or filtered air according to a 
randomized, double-blind exposure protocol. The DE exposure system is 
described in further detail in Sawyer, et al. 2008b. Healthy volunteers underwent 
a 2 hour exposure to filtered air or DE (100μg/m3 PM10) while performing 
moderate, intermittent bicycle exercise (VE≈20 L/min/m2). Average DEP 
exposure was 106±9 μg/m3 (target concentration was 100 μg/m3). DE was 
generated by a light-duty truck containing a 1999 Cummins ISB engine. The 
truck engine was kept at idle (“low load”) for the duration of exposure. 
Bronchoalveolar lavage (BAL) was collected 20 hours post air and DE according 
to previously described procedures (Ghio, et al.1998). Subjects were instructed 
to not ingest food or liquid after midnight before the BAL procedure. DE and 
filtered air exposures were separated by a minimum of 3 weeks. Lavaged lung 
cells from the second and third saline instillations (i.e., primarily bronchoalveolar 
in origin) were washed with ice-cold RPMI containing gentamycin (50 μg/mL). 
Cells were counted in a hemocytometer and a small portion centrifuged onto 
microscope slides, stained with Diff quick and checked for macrophage purity. 
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Two million AM were extracted for lipids. There were no significant differences 
between DE and filtered air BAL cell populations, with differential cell counts 
revealing the macrophages to be 91.1 + 5.1 percent and 91.4+ 4.6 percent AM 
after filtered air and DE exposures,  respectively. BAL lymphocytes comprised 6.8 
percent and 6.7 percent after filtered air and DE exposures, respectively, while 
neutrophils were less than 1.5 percent in BAL after either exposure.  
 
3.2.4 Particle Preparation for AM In Vitro Exposure 
Each particle type was suspended in RPMI with gentamycin and 2.5 
percent FBS at concentrations of 400μg/mL and 200μg/mL. PM suspensions 
were vortexed vigorously for 5 minutes within 1 hour of AM exposure in order to 
reduce leaching of PM components into the exposure media. Final UD and CB 
concentration was 100μg/mL. Final DEP concentrations were 200μg/mL (DEP 
200) and 100μg/mL (DEP 100). 
 
3.2.5 Exposure of Human AMs to LPS and PM In Vitro                 
BAL was obtained from unexposed, healthy, non-smoking, young adults 
(18-25 years of age) for a series of separate in vitro experiments. The cell 
population was >80 percent AM, and with >90 percent viability as judged by 
trypan blue dye exclusion. Alveolar macrophages (2.5 x 105 in 1mL of RPMI 1640 
supplemented with 2.5% FBS) were exposed to PM or LPS (10ηg/mL) for 1, 6, 
and 24 hours in sterile 5mL polypropylene tubes at 37°C with 5 percent CO 2. 
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Each AM treatment was conducted in replicates of 8 for a final AM total of 2.0 x 
106 cells.  
 
3.2.6 Lipid Extraction and Analysis 
AM were centrifuged at 500 x g for 10 minutes at 4°C following incubation 
with PM or LPS. Conditioned media was discarded and remaining cell pellet 
washed with 2mL cold HBSS and transferred to 10mL sterile glass tube. AM 
were centrifuged a second time at 500 x g for 10 minutes at 4°C, and re-
suspended in HBSS (0.8mL) prior to lipid extraction. Phospholipid extraction was 
conducted similar to procedures developed by Bligh and Dyer (1959) to allow 
high overall recovery of most phospholipid classes. Chloroform-methanol (2:1) 
was added to the AM homogenate and vortexed. Chloroform-deionized water 
(1:1) was added next, and the chloroform layer (containing lipids) was removed 
acted and stored in a sterile glass tube. After 3 CHCl 3 additions and subsequent 
lipid extractions, the combined lipid layers were washed with potassium chloride 
(KCl) followed by deionized water. Lipid extracts were dried under nitrogen (N 2) 
gas then sent on dry ice to Kansas State University Lipidomics Research Center 
(KLRC; Manhattan, KS) for analysis. Lipids were analyzed with electrospray 
ionization tandem mass spectrometry (ESI-MS/MS) to identify and quantify 411 
animal phospholipid species (Welti and Wang 2004). Precursor and neutral loss 
scans are used to analyze the charged ions produced by polar phospholipids. 
Internal 13C standards were added to each sample to monitor lipid recovery. AM 
lipids were identified from the chromatograms and categorized into 12 distinct 
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lipid classes and subclasses listed in Table 3.1. AM lipid mass is calculated as 
ηmol of lipid per 2 x 106 cells. Lipid class or individual species lipid mass was 
normalized by determining the fractional mole percent (mol percent) of a single 
lipid group or species out of the total lipid mass for each replicate. 
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Lipid Class Abbreviation 
Evaluated 
Species* 
# Total 
Species 
Phosphatidic Acid PA 32:4 to 40:5 22 
Phosphatidylcholine PC 28:1 to 44:2 54 
Ether-linked Phosphatidylcholine ePC 32:3 to 40:2 14 
Lysophosphatidylcholine LysoPC 16:1 to 22:5 53 
Phosphatidylethanolamine PE 28:1 to 44:2 27 
Ether-linked Phosphatidylethanolamine ePE 32:5 to 40:2 53 
Lysophosphatidylethanolamine LysoPE 16:1 to 22:5 14 
Phosphatidylethanolamine-ceramide PE-cer 16:1 to 24:0 5 
Phosphatidylinositol PI 34:4 to 44:2 46 
Phosphatidylglyceride PG 30:0 to 40:4 44 
Phosphatidylserine PS 32:1 to 44:2 68 
Sphingomyelin SM 16:1 to 24:0 11 
Grand Total  of Individual Species 411 
 
Table 3.1 Phopholipid Classes and Number of Individual Lipid Species Evaluated 
in AM. *lipid indentification =  no. of carbons: no. of double bonds. 
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3.2.7 Statistical Analysis 
Data were analyzed using Graphpad Prism 4.0 (GraphPad Software Inc.; 
San Diego, CA). Data are expressed as mean±SE. Paired Student’s t-test was 
used to compare lipids 20 hour post- filtered air and 20 hour post- DE exposure. 
Unpaired t-test was used to analyze lipid responses in vitro. Data was considered 
significant if p<0.05. Observational in vitro data is represented graphically due to 
insufficient replicates for statistical analysis at some analyzed time-points. 
Control (-LPS) n=2-3, +LPS n=2-4, UD n=1-3, DEP 20 n=1-2. 
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3.3 Results 
3.3.1 Human DE Exposure Study: AM Lipid Abundance and Distribution 
Human alveolar macrophages (AM) were isolated from BAL fluid 20 hours 
after subject exposure to filtered air or DE. For these studies, the average total 
lipid mass concentration was 85.61±5.72 ηmo/2 x 106 cells. Table 3.2 provides 
total cellular lipid mass per exposed subject. Subject AM average lipid mass per 
lipid class were similar and ranged from 0.002-67.0 ηmo/2 x 106 cells and 0.002-
68.0ηmo/2 x 106 cells in the 20 hour Air and DE samples, respectively (Figure 
3.1). PC (56.91±1.76ηmo/2 x 106ηmo/2 x 106) species were the most abundant 
detected lipids and PE-cer (0.002±0.00ηmo/2 x 106) the least detected. DE 
exposure significantly decreased total lysoPE lipid cellular concentration. LysoPC 
lipid cellular concentration also decreased after DE exposure, but the effect was 
not signficant (p=0.07).  Figure 3.2 shows comparative effects of filtered air and 
DE exposures on cell lipids  expressed as a mole percent (mol percent). LysoPC 
significantly declined (Figure 3.2A) after DE exposure (0.52± 0.05 mol percent) 
relative to the filtered air exposure (0.75±0.12 mol percent). A non-significant 
decrease was observed in the lysoPE group (p=0.054). No significant changes 
were observed across the other lipid classes. 
We examined the effect of filtered air and DE exposure on individual lipid 
species. Statistically significant changes were detected in 11 individual species of 
the PC, ePC, ePE, lysoPC, lysoPE, PG, and PS classes expressed as mol 
percent (Table 3.3). Statistically non-significant trends (p≤0.10), using a two 
tailed test), were detected in 9 other individual lipid species. Greater than 65 
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percent of the significant and trend changes occurred in lipid species from the 
PC, lysoPC and ePC classes. DE exposure caused significant increases in 5 of 7 
PC species. DE exposure also caused a significant increase in PS 36:2. DE 
exposure caused non-significant trend decreases in the remaining 15 lipid 
species. Figure 3.3 contains examples of significant and trend changes in 
individual lipid species. No significant changes were detected in PI, PE-cer, or 
PA species. 
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Subject # Total Air Total DE   Air + DE 
1 49.79 34.67 84.46 
2 45.70 42.89 88.59 
3 36.25 43.01 79.26 
4 64.87 37.47 102.34 
5 26.79 30.09 56.89 
6 46.92 36.28 83.19 
7 36.17 43.18 79.35 
8 54.69 56.10 110.79 
Average 45.15 40.46 85.61 
SE 4.23 2.78 5.72 
 
Table 3.2 Total AM Lipid Mass per Human Subject after In Vivo Exposure. Lipid 
Mass units are expressed as ηmol/2x106 cells. AM collected by BAL 20 hours 
after healthy human adults were exposed to filtered air (Air) and diesel exhaust 
(DE). 
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Figure 3.1 Lipid Cellular Mass Profile of Human AM after In Vivo Exposure to 
Filtered Air and DE. AM were collected by BAL 20 hours after healthy human 
adults were exposed to filtered air (Air) and diesel exhaust (DE). (A) Six highest 
abundant lipid groups;(B) Six lowest abundant lipid groups. Lipid cellular mass 
compared after Air and DE exposure was analyzed by Student’s Paired T-test, 2-
tailed. * signifies p<0.05; n=8. 
(A)   
(B)   
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Figure 3.2 Lipid Mole Percent Profile of Human AM after In Vivo Exposure. AM 
collected by BAL 20 hours after healthy human adults were exposed to filtered air 
(Air) and diesel exhaust (DE). (A) Six highest abundant lipid groups; (B) Six 
lowest abundant lipid groups. Lipid cellular mass compared after Air and DE 
exposure was analyzed by Student’s Paired T-test, 2-tailed. * signifies p<0.05; 
n=8. 
 
(A)   
(B)   
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Lipid Group Species Air DE Inc/Dec P-value 
PC 32:2 0.289±0.029 0.309±0.028 é 0.011* 
  36:4 3.668±0.397 3.875±0.314 é 0.012* 
  38:6 0.294±0.025 0.368±0.024 é 0.029* 
  40:8 0.067±0.007 0.079±0.005 é 0.012* 
  42:7 0.010±0.003 0.004±0.001 ê 0.057 
  42:2 0.008±0.003 0.015±0.002 é 0.021* 
  44:9 0.003±0.001 0.001±0.0 ê 0.068 
ePC 32:0 1.536±0.166 1.274±0.105 ê 0.039* 
  34:1 1.341±0.077 1.238±0.065 ê 0.05 
  34:0 0.891±0.043 0.771±0.070 ê 0.097 
ePE 38:6 0.225±0.031 0.179±0.02 ê 0.069 
  38:4 0.502±0.064 0.375±0.079 ê 0.010* 
SM 16:1 0.055±0.004 0.035±0.008 ê 0.057 
PI No Change in PI Species 
lysoPC 16:0 0.384±0104 0.254±0.044 ê 0.102 
  20:4 0.160±0.028 0.118±0.015 ê 0.06 
  20:1 0.008±0.003 0.003±0.001 ê 0.025* 
  22:5 0.009±0.002 0.001±9.40x10-4 ê 0.009* 
lysoPE 20:5 0.004±0.002 2.160x10-6±0.00 ê 0.09 
  20:4 0.2235±0.035 0.171±0.029 ê 0.096 
PG 36:1 0.020±0.006 0.005±0.002 ê 0.035* 
PS 36:2 0.019±0.005 0.030±0.006 é 0.036* 
PA No Change in PA Species 
PE-cer No Change in PE-cer Species 
 
Table 3.3 Lipid Species Differences in Human AM after In Vivo Exposure. AM 
collected from healthy adults 20 hours after filtered air (Air) or diesel exhaust 
(DE) exposure. Twenty-one lipid species demonstrated trend or significant 
changes. Data analyzed with paired Student’s t-test; * signifies p<0.05, n=8. 
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Figure 3.3 Comparison of Lipid Species in Human AM after In Vivo Air and DE 
Exposures. AM collected by BAL 20 hours after healthy human adults were 
exposed to filtered air (Air) and diesel exhaust (DE). (A) sphingomyelin (SM) 
16:1, p=0.059; (B) Phosphotidylcholine (PC) 42:2, p=0.021; (C) LysoPC 
20:1,p=0.025; (D) ester-linked phosphphotidylethanolamine (ePE) 38:4, p=0.01; 
(E) Phosphotidylglycerol (PG) 36:1, p=0.035; (F) Phosphotidylserine (PS) 36:2, 
p=0.036. Data analyzed by paired Student’s t-test, 2 tail; n=8. 
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3.3.2 In Vitro LPS Exposure on AM Phospholipids 
Human AM were incubated with (+) and without (-) LPS for up to 6 hours 
in order to evaluate the effect of a known bacterial stimulus on AM lipid 
responses. After 1 hour incubation, the average total cellular lipid masses for   
-LPS (unstimulated control) and +LPS classes were 42.78±7.77ηmol/2x106 cells 
and 53.02ηmol/2x106 cells, respectively. PC was the most abundant lipid class 
with both treatments. PC concentrations ranged from 9.2 to 48.3ηmol/2x106 cells 
(Figure 3.4). LPS exposure had no significant effect on either the total lipid 
cellular mass, the lipid mass of the 12 lipid classes, or lipid class mole percent, 
relative to the control. LPS exposure induced a significant decrease in 4 
individual lipid species: PC 44:6, PC 44:2, PI 38:4, and PS 38:1 (Table 3.4). We 
also detected non-significant decreases in 13 other lipid species. LPS exposure 
elevated one lipid species, LysoPE 20:1, but the increase was not significant 
(p=0.05). 
We compared the effect of 6 hour LPS exposure to the 1 hour lipid results  
on the 12 lipid classes and individual lipid species (Figure 3.5). Total ePE lipid 
mass was significantly higher 6 hours after +LPS exposure (1.15±0.069 
ηmol/2x106cells) than 1 hour after +LPS exposure (0.687±0.095 ηmol/2x106). 6 
hour +LPS also elevated total PE and PA lipid mass in comparison to 1 hour 
+LPS exposure, but the increase was non-significant. Four lipid species, ePC 
34:1, ePE 40:5, PI 40:6, and PA 36:2, were significantly elevated 6 hours after 
+LPS exposure relative to the 1 hour +LPS exposure (Table 3.5). We also 
detected non-significant increases in 13 other lipid species. 6 hour +LPS 
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exposure caused a significant decrease in one lipid species, lysoPE 20:1, in 
comparison to 1 hour +LPS exposure. 6 hour +LPS also caused a non-significant 
decrease (p=0.076) in one lipid species, PS 38:1. 
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Figure 3.4 Lipid Cellular Mass Profile of Human AM exposed to LPS In Vitro. 
Human AM were incubated with LPS (+LPS) or without (-LPS) for 1 hour. (A) Six 
highest abundant lipid groups; (B) Six lowest abundant lipid groups. Lipid mol 
percent comparison between +LPS and –LPS for each lipid groups was analyzed 
by Student’s unpaired t-test, 2-tailed. *signifies p<0.05; n=3. 
(A)   
(B)   
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Lipid Group Species -LPS 1 hour +LPS 1 hour Inc/Dec P-value 
PC 30:1 0.0282±0.0142 0±0 ê 0.0637 
  34:1 8.1261±0.2365 7.3349±0.2191 ê 0.0597 
  38:3 0.265±0.0278 0.2053±0.0204 ê 0.1347 
  42:2 0.0145±0.0053 0.0039±0.0017 ê 0.0811 
  44:6 0.0028±0.0009 0.0006±0.0004 ê 0.0453* 
  44:2 0.0028±0.0008 0±0 ê 0.0099* 
ePC No Change in ePC Species 
ePE 34:1 0.0064±0.0032 0.0003±0.0003 ê 0.0772 
  36:3 0.0138±0.0087 0±0 ê 0.1176 
DSM 22:0 0.0173±0.0109 0±0 ê 0.1176 
PI 36:4 0.1695±0.0128 0.1301±0.0143 ê 0.1060 
  38:4 2.0259±0.2673 1.0712±0.2103 ê 0.0357* 
  38:3 0.1240±0.0071 0.0466±0.171 ê 0.0145 
lysoPC No Change in lysoPC Species 
lysoPE 18:1 0.098±0.0064 0.069±0.0099 ê 0.0742 
  20:5 0.1895±0.0357 0.1312±0.0058 ê 0.1153 
  20:1 0±0 0.0011±0.0004 é 0.0528 
PG No Change in PG Species 
PS 38:4 0.0479±0.0085 0.021±0.0046 ê 0.0298* 
  38:1 0.0076±0.0025 0.0022±0.0013 ê 0.0953 
PA No Change in PA Species 
PE 36:4 0.2116±0.0382 0.116±0.0032 ê 0.1180 
PE-cer No Change in PE-cer Species 
 
Table 3.4 Lipid Species Differences in Human AM after 1 hour LPS exposure In 
Vitro. AM incubated in vitro in cellular growth medium (-LPS; control) or with LPS 
(10ηg/mL; +LPS) for 1 hour. Eighteen lipid species demonstrated trend or 
significant difference after 1 hour +LPS exposure relative to 1 hour –LPS 
exposure. Data analyzed with Student’s t-test; * signifies p<0.05, n=3-4. 
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Figure 3.5 Lipid Cellular Mass Profile of Human AM Exposed to LPS In Vitro. 
Human AM were incubated with (+LPS) for 1 hour or 6 hours. PE, p= 0.06; ePE, 
p=0.01; PA, p=0.11; 1 hour +LPS and 6 hour +LPS data analyzed by Student’s 
T-test, 2-tailed.* signifies p<0.05; n=3-4. 
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Lipid Group Species +LPS 1 hour +LPS 6 hour Inc/Dec P-value 
PC 42:5 0.0086±0.0022 0.0141±0.0014 é 0.1165 
  44:2 0±0 0.0008±0.0005 é 0.1079 
ePC 32:3 0.0036±0.0016 0.0088±0.0023 é 0.1118 
  34:1 1.1017±0.0628 1.4777±0.0488 é 0.0486* 
  36:2 0.465±0.3221 0.5353±0.0396 é 0.1287 
  36:1 0.0476±0.0174 0.3678±0.0171 é 0.1280 
  40:2 0.0249±0.0055 0.0446±0.0072 é 0.0777 
ePE 36:2 0.0046±0.0027 0.184±0.008 é 0.1223 
  40:5 0.0632±0.0254 0.1805±0.0381 é 0.044* 
SM No Change in SM Species 
PI 34:3 0±0 0.131±0.0345 é 0.0905 
  34:2 0.0089±0.0051 0.2312±0.0308 é 0.0924 
  40:6 0.0082±0.005 0.0273±0.0026 é 0.0292* 
lysoPC 20:2 0.0011±0.0006 0.0052±0.0027 é 0.1109 
lysoPE 20:1 0.011±0.0004 0.005±0.0016 ê 0.0387* 
PG No Change in PG Species 
PS 38:4 0.021±0.0046 0.0444±0.0104 é 0.0715 
38:1 0.0054±0.002 0±0 ê 0.0763 
  (ePS) 34:2  0±0 0.0008±0.0005 é 0.1346 
PA 34:1 0.0049±0.0028 0.0375±0.0193 é 0.1053 
  36:2 0.0012±0.0012 0.0340±0.013 é 0.0304* 
PE-cer No Change in PE-cer Species 
 
Table 3.5 Lipid Species Differences in Human AM Exposed to LPS In Vitro. AM 
incubated with LPS ((10ηg/mL) in vitro for 1 hour and 6 hours. Nineteen lipid 
species demonstrated trend or significant changes 6 hour after +LPS exposure 
relative to 1 hour after +LPS exposure.  Data analyzed with Student’s t-test; * 
signifies p<0.05, n=3-4. 
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3.3.3  Effect of PM In Vitro Exposure on AM Phospholipids  
We evaluated the effect of LPS, UD, and DEP on AM lipid response after 
1 hour, 6 hour, and 24 hour incubations. The combined total lipid mass 
(ηmol/2.0x106cells) after 1 hour, 6 hour, or 24 hour incubation was 46.32±5.75, 
66.99±5.01, and 54.86±8.72ηmol/2.0x106 cells (p=nonsignficant). Graphical data 
(Figure 3.6) suggested that 24 hour UD exposure decreased the total PE mol 
percent relative to the other treatments. 6 hour DEP exposure appeared to 
decrease lysoPC mol percent and PG mol percent relative to the other 
treatments. The data is treated as observational due to insufficient replicates 
(n=1-4). Further evaluation of the effects of UD and DEP on individual lipid 
species was not conducted due to the small sample replications.  
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Figure 3.6 Lipid Mole Percent Changes in Human AM after 1 hour, 6 hour, and 
24 hour Exposure to LPS or PM In Vitro. LPS=10ηg/mL; UD=100μg/mL; 
DEP=200μg/mL. (A) SM mol percent (B) PG mol percent (C) LysoPC mol 
percent (D) PE mol percent; n=1-4. 
0 1 2
0
5
10
15
20
25
30
35
-LPS
+LPS
UD
DEP
6 12 18 244
Time (hr)
SM
 m
ol
%
0 1 2
3
4
5
6
7
8
9
-LPS
+LPS
UD
DEP-200
6 12 18 244
Time (hr)
PE
 m
ol
%
0 1 2
0.0
0.5
1.0
1.5
2.0
-LPS
+LPS
UD
DEP-200
6 12 18 244
Time (hr)
PG
 m
ol
%
0 1 2
0.0
0.5
1.0
1.5
2.0
2.5
-LPS
+LPS
UD
DEP-200
6 12 18 244
Time (hr)
Ly
so
PC
 m
ol
%
(A)   
(C)   
(B)   
(D)   
 90 
3.4 Discussion 
The data presented in this study demonstrated that diesel exhaust and 
LPS alter the phospholipid concentrations of human alveolar macrophages (AMs) 
after respective in vivo and in vitro exposures. We collected human AM 20 hours 
after human exposure to diesel exhaust (100μg/m3). Diesel exhaust induced a 
significant decrease of the lysophphosphatidyl (lysoPC) and lysophosphatidyl-
ethanolamine (lysoPE) lipid classes. Lysophospholipids are generated when 
phospholipases, lipid metabolic enzymes, cleave one ester-linked fatty acid tail 
from the phospholipid backbone. Thus, the phopholipase activity generates a 
free fatty acid and a lysophopholipid. The remaining fatty acid attached to a 
lysophospholipid is usually in the sn-1 position. LysoPC 20:4 is a well known 
lysophopholipid that is generated when phospholipase A 2 (PLA2) releases 
arachidonic acid (AA; 20:4) from phosphatylcholine (PC).  
There is limited information on the biological significance of decreased 
lysophospholipids. In addition, our data only provided a snapshot of DE-induced 
effects 20 hours post exposure. The decreased lysoPC and lysoPA are likely the 
result of metabolic processes that preceded our snapshot sample. For example, 
DE exposure can increase the concentration of prostaglandin E 2 (PGE2), 
leukotriene B4 (LTB4), thromboxane and other AA metabolites in the lung fluid of 
exposed rodents (Henderson, et al. 1988). In our study, PGE2 concentrations in 
BAL and BW, obtained at the same time point as the AM, were not altered by DE 
exposure (data not shown). Decreased lysoPC concentrations could indicate an 
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attenuation of fatty acid metabolism that occurred at an earlier time point. We, 
however, are unable to confirm this conjecture with our data.  
Diesel exhaust exposure in vitro also alters AM concentration of individual 
phospholipid species. The AM species alterations by human exposure to DE do 
not exhibit the same trends. Several PC species and a phophatidylserine (PS) 
species increase in response to DE exposure, while the remaining phospholipid 
species decrease in concentration. We detected changes in 21 of 411 (5.1 
percent) analyzed lipid species. The lack of broad-scale species alterations may 
suggest a controlled AM response to DE exposure rather than massive, 
uncontrolled cellular injury. AM recovered from humans eighteen hours after a 2 
hour exposure to high ozone concentrations (0.4 ppm) with subjects exercising 
(i.e., a similar  protocol design as our study) demonstrates small changes, 13.9 
percent,  in protein synthesis from ~900 proteins (Devlin and Koren, 1990). The 
ozone study and our data support the conjecture that air pollutant exposures tend 
to initially target specific cellular biomolecules, rather than induce wide scale 
changes in specific lipid and protein concentrations. 
We also evaluated the in vitro effects of lipopolysaccharide (LPS) on 
human AM phospholipids. LPS, a cell-wall constituent of gram-negative bacteria, 
is a potent AM activator. LPS stimulates AM production and release of reactive 
oxygen species, inflammatory cytokines, and lipid metabolites (Brown, et al. 1988 
Badger, et al. 1986, Becker, et al. 1989). LPS exposure did not alter phospholipid 
class changes in human AM relative to non-stimulated AM. However, a 6 hour 
LPS exposure induced a significant ether-linked (e) PE increase in comparison to 
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the 1 hour LPS exposure. Accordingly, we observed increases in individual lipid 
species.  
Preliminary data that compared lipid class changes in AM exposed to 
LPS, urban dust (UD) and diesel exhaust particles (DEP) indicated that these 
three stimuli may exert differing effects on AM phospholipid concentrations. 
Notably, the DEP and UD induced effects on AM phospholipid classes differ from 
one another. This result mimics previous findings in our laboratory (Sawyer, et 
al., 2008a) that DEP and UD exposure induce different AM cytokine responses 
from one another at 6 and 24 hour time-points. Further analysis is needed to 
evaluate the time-related effects of LPS, DEP, and UD exposure. 
In summary, these data represent the first step toward developing a 
phospholipid fingerprint using a lipidomics approach. Already, lipidomics analysis 
demonstrates mitochondial phospholipid metabolism defects in a murine model 
of diabetes (Han, et al. 2005). Han and colleagues (2005) show depletion of 
critical lipid molecules and precursor molecules, thereby possibly allowing design 
and implementation of therapeutic approaches to compensate for the altered 
phospholipid levels. It remains to be seen whether a lipidomics approach can 
discern biochemical mechanism in response to environmental exposure. In vitro 
replicates are still being processed by the KLRC laboratory and will provide 
critical information regarding these analyses.
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Pulmonary Cytokine and Metal Analysis of 
Exhaled Breath Condensate from Healthy Human Adults 
Exposed to Diesel Exhaust 
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Abstract 
Epidemiology studies link human exposure to ambient air pollution with 
the development and exacerbation of cardiopulmonary disease. Diesel exhaust 
(DE) is a significant source of ambient pollution, and thus may contribute to 
adverse pulmonary health effects. Previous human research demonstrates that 
DE stimulates acute airway inflammation, measured as increased lung 
neutrophilia, 6 hours after an acute DE exposure. In this study, we evaluate 
whether DE can stimulate airway inflammation in humans 20 hours after 
exposure. In addition we evaluate whether repeated non-invasive lung sampling 
with exhaled breath condensate (EBC), can provide additional information about 
lung inflammatory responses. Human volunteers were exposed to DE (100μg/m3) 
and filtered air for 2 hours with intermittent exercise. EBC was collected pre-, 
immediately post, and 20 hours post DE exposure, followed by 20 hour 
bronchoalveolar lavage (BAL). BAL and EBC were analyzed for elemental metals 
and TH2 and TH2 cytokines. Our data demonstrated elevated 20 hour EBC IL-1β 
concentrations regardless of DE or filtered air exposure, suggesting a latent 
exercise-induced effect. Other TH1 and TH2 cytokines were relatively 
undetectable in EBC. The absence of TH1  and TH2 cytokines in EBC suggested 
a need for more research on factors contributing to EBC dilution. EBC calcium 
concentrations decrease immediately post DE exposure, but the effect was 
attenuated 20 hours post DE exposure. DE exposure did not influence BAL metal 
concentrations. DE exposure significantly decreased TH 1 cytokine concentrations 
and elevated TH2 cytokines concentrations in lavage fluids 20 hours after 
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exposure. Decreased TH1 and increased TH2 cytokines in BW and BAL indicated 
that DE can shift the pulmonary immune response toward an allergic-type 
response 20 hours after exposure.   
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4.1 Introduction 
Epidemiology studies link human exposure to ambient air pollution with 
the development and exacerbation of cardiopulmonary disease (Pope, et al. 
1995; Schwartz 1996; Delfino, et al. 1997). In many urban areas, gaseous and 
particulate pollutants generated from the combustion of diesel fuel are significant 
contributors to ambient air pollution. Diesel exhaust particles (DEP) account for 
nearly 20 percent of the fine particulate matter (<2.5 μm) nationwide (U.S. EPA 
2002). The epidemiologic association between air pollution and adverse 
cardiopulmonary health effects may be due in part to the components of diesel 
exhaust (DE).    
An increasing body of evidence highlights inflammation and oxidative 
stress as important acute biochemical responses in the pathogenesis of air 
pollutants (Ghio and Devlin 2001; Tao, et al. 2003). Controlled human exposures 
to DE demonstrate increased airway resistance and inflammatory mediator 
changes consistent with lung inflammation (Rudell, et al. 1996; Salvi, et al . 1999; 
Nightingale, et al. 2000; Holgate, et al. 2003). Neutrophil counts and interleukin 
(IL)-8 concentrations increase in the broncheoalveolar lavage fluid (BAL) of 
healthy adults exposed to DE with a DEP concentration of 300μg/m3. A similar 
response takes place when healthy adults are exposed to DE with a 100 μg/m3 
DEP concentration (Holgate, et al. 2003). A series of studies by Diaz-Sanchez 
and colleagues (1994, 1996, 1997) demonstrates that nasal instillation of one 
DEP type (300µg) is also capable of stimulating an adaptive immune response. 
Immunoglobulin E (IgE) expression and T-helper 2 (TH2) cytokine concentrations 
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increase in the nasal mucosa of DEP-exposed volunteers. The combined human 
exposure research provides evidence of early, acute inflammatory and allergic 
response to DE.  
Few studies explore the time-course of DE-induced pulmonary responses 
in humans. One study compared inflammatory endpoints in induced sputum (IS) 
6 and 24 hours after human exposure to DE or filtered air (Nordenhall, et al. 
2000). Consistent with studies analyzing BAL, the results show DE exposure 
increases neutrophil and other inflammatory IS endpoints 6 hours post DE 
exposure relative to air exposure. However, neutrophils also increased 24 hours 
in comparison to 6 hours regardless of exposure which suggests that IS, itself, 
induces airway inflammation. In addition, BAL and bronchial biopsy also 
significantly alter airway chemistry (Huang, et al. 2006). BAL and bronchial 
biopsy are highly invasive, technically difficult procedures that require a trained 
physician. In environmental exposure research, BAL may only be used to sample 
airways of healthy adults and individuals with relatively mild disease states. As a 
result, human soluble mediator responses to DE exposure using repeated 
measurements are unknown. 
Exhaled breath condensate (EBC) collection is a noninvasive, repeatable 
technique used to evaluate lung biomarkers of effect and environmental 
exposure (Mutlu, et al. 2001; Mutti and Corradi 2006). Collection occurs during 
passive exhalation over a cooled tube. Exhaled water droplets and associated 
solutes condense on the cooled surface. Identified EBC compounds include 
surfactants (Sidorenko, et al . 1980), lipid, and soluble protein  inflammatory 
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mediators (Scheideler, et al. 1993; Montuschi and Barnes 2002), electrolytes 
(Effros, et al. 2002), oxidation products (Montuschi, et al. . 1999), and DNA 
(Gessner, et al. 2004; Carpagano, et al. 2005). Thus, EBC collection is a suitable 
method for repeated lung sampling. Conversely, results obtained from EBC 
analysis draw criticism because analytical procedures for many EBC mediators 
lack standardization, sensitivity, or reproducibility. Investigations of the 
correlation between EBC and either sputum or lavage oxidative and inflammatory 
endpoints have variable results. A strong correlation exists between EBC and 
BAL cytokines in patients newly diagnosed with pulmonary sarcoidosis (Roxy, et 
al. 2006). No correlation exists between EBC and BAL oxidative or phospholipid 
endpoints in patients undergoing BAL for a variety of clinical reasons. However, 
investigators note that EBC analyte concentrations often reflect expected 
pulmonary responses to disease without a correlation to IS or BAL analytes 
(Carpagnano, et al. 2007; Moloney, et al. 2004). In addition, EBC volumes, total 
protein concentrations, and leukotriene B 4 (LTB4) concentrations are reproducible 
across multiple sampling time points (Gessner, et al. 2001; McCafferty, et al. 
2004; Bloeman, et al. 2006). Recently, Mutti and colleagues (2006) developed 
reproducible procedures to measure exhaled metallic elements in EBC of healthy 
non-smokers, healthy smokers, and COPD patients. The authors conclude that 
metallic elements may be useful EBC biomarkers of exposure or susceptibility.  
The aim of this present study is to evaluate the effects of diesel exhaust 
on the human pulmonary response through repeated EBC collection and a one 
time BAL collection. We compared EBC and BAL metal concentrations, T-helper 
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1 (TH1), and T-helper 2 (TH2) cytokine concentrations in order to evaluate DE 
exposure and DE exposure-induced inflammatory responses. Calcium, zinc, iron, 
and other metallic elements are abundant components in exhaust of both light 
and heavy-duty diesel truck engines (U.S. EPA 2002). Diesel exhaust metals in 
EBC or BAL may become important markers of diesel exposure. Evaluating TH1 
and TH2 cytokines may capture key information about innate and adaptive 
human immune response to DE exposure. Finally, repeated EBC measurements 
may elucidate important information about the initiation and progression of acute 
inflammatory response unattainable by a single BAL analysis alone.  
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4.2 Methods 
 
4.2.1 Subject Recruitment 
Ten subjects (4 male, 6 female), aged 24 ± 4 years old, participated in the 
study. Volunteers were healthy, non-smokers (<1 pack-year over lifetime), with 
normal lung function and ECG tracing. Subjects had no history of respiratory or 
allergic disease, active medical conditions, active allergies within two weeks of 
exposure, respiratory infections, or flu-like symptoms within 6 weeks of exposure. 
NSAID use was not allowed within 48 hours of the study. The medical 
institutional review board at the University of North Carolina at Chapel Hill 
approved the study and written informed-consent was obtained from each 
volunteer.  
 
4.2.2  Exposure Protocol  
Subjects were exposed to DE or filtered air according to a randomized, 
double-blind exposure protocol. Exposures were performed in a stainless steel 
chamber (6’x6’x7’) with an air flow of approximately 550 ft3/min. Clean, filtered air 
was created by passing ambient outdoor air through HEPA and charcoal filters. A 
Sterling light-duty six cylinder (5.9L displacement) truck containing a 1999 
Cummins ISB engine with 205 horsepower generated the DE. The truck engine 
was kept at idle (“low load”) for the duration of the DE exposure, and was run on 
certified #2 commercial diesel fuel (Chevron Phillips Chemical Co., Borger TX, 
0.05 LS Certification Fuel, type II) without after-treatment. DE was diluted in two 
stages of approximately 12.1-fold and 2.5 fold with clean filtered air before 
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reaching the exposure chamber. DE reached the chamber within 10 seconds of 
final dilution. The average DEP exposure was 106 ± 9 μg/m3 (target 
concentration =100μg/m3). DEP concentration was determined by Teflon filter 
weighing as described (Ghio, et al., 2003), but with a flow rate of approximately 
15 L/min. A real-time tapered element oscillating microbalance (TEOM; series 
1400a, Rupprecht and Patashnick, Albany, NY) measured DEP as 109 ± 5 
μg/m3. Other pollutant concentrations (mean±SD) within the exposure chamber 
were measured as follows:  2.8 + 0.9 ppm carbon monoxide (CO), 4.7 + 0.5 ppm 
nitric oxide (NO), 0.8 + 0.2 nitrogen dioxide (NO2), and 2.4 + 0.2 ppm total 
hydrocarbons (HC). Average particle size was 0.10 ± 0.02µm, as measured with 
a Scanning Mobility Particle Sizer (SMPS). A Condensate Particle Counter (CPC; 
TSI model 3022, St Paul, MN) was used to determine average particle volume: 
1.8±0.6 x 106 particles/cm3 Chamber temperature and relative humidity ranged 
from 21°C to 23°C and 37 percent to 43 percent, respectively.  
Prior to DE and filtered air exposures, EBC was collected for baseline 
analysis. We then exposed subjects with moderate, intermittent bicycle 
ergometer exercise (VE≈20 L/min/m2) to either DE (100μg/m3 PM10) or filtered air 
for 2 hours. EBC was collected immediately post exposure. Volunteers returned 
20 hours later and EBC was collected for a third time followed by a bronchoscopy 
as described by Ghio and colleagues (1998). Bronchial wash (BW) and 
broncoalveolar lavage (BAL) fluids were collected. We instructed subjects not to 
eat or drink after midnight before the bronchoscopy procedure. DE and filtered air 
exposures were separated by a minimum of three weeks. The maximum time 
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elapse between DE and filtered air exposures was six months. We conducted a 
total of 6 EBC collections per subject (3 per exposure).  
 
4.2.3  EBC Collection and Analysis 
EBC was collected using a previously described home-made device 
(Sawyer, et al. 2008). Briefly, a Tygon tube (1.5m x 2cm diameter) is coiled into 
an ice-salt mixture kept below 0°C (Figure 4.1). The tube terminated into a non-
rebreathing valve followed by a real-time pneumotachograph (EcoVent, Jaeger. 
Germany) that recorded exhaled breath volume, tidal volume (TV), peak 
expiratory flow, minute ventilation, and breathing frequency (bf). We instructed 
subjects to inhale passively through their nose and exhale into the EBC collection 
tube for 15 minutes. After the collection, the EBC tube was capped at the mouth 
and, a sterile 15mL polypropylene vial was fitted at the terminal end. The 
collected EBC was beaded into larger droplets by striking the EBC collection tube 
with a small piece of Tygon tubing. Centrifugal force was used to drive the 
beaded EBC into the polypropylene vial. Collected EBC was divided into 1mL 
aliquots and stored promptly at -80ºC. 
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Figure 4.1 EBC Collection Device. Subject passively inhales through the 
nose and exhales into “mouth” of tube for 15min. Uphill slope reduces salivary 
contamination. 1-way valve prevents re-breathing over collected condensate. 
Exhaled breath volume, tidal volume, peak expiratory flow, minute ventilation, 
and breath frequency are calculated by a digital real-time pneumotachograph. 
Ice-Salt mixture ≤ 0°C. 
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4.2.4  Amylase Detection 
 An α-amlyase activity detection assay (Biotron Diagnostics Inc, Hemet, 
CA) was used to detect salivary contamination in EBC. Amylase reacted with a 
prepared substrate to form 2-chloro-p-nitrophenol. The rate of change in UV light 
absorbance (ΔA) was measured. An absorbance rate change of 0.003ΔA/min 
corresponded to 9.53U/L α-amylase.  
 
4.2.5 Total Protein Analysis 
Total protein concentration was measured using a CBQCA Protein 
Quantitation Kit (Molecular Probes; Eugene, OR). A fluorescent tag binds to the 
primary amines in proteins. Final total protein ( ηg/mL) was based on a calibration 
curve. Detectable range extended between 66.7ng/mLand 1.0 x 104ηg/mL. 
 
4.2.6  Metal Analysis 
Transition metal concentration in BAL and EBC was determined by 
inductively coupled plasma-optical emission spectroscopy (ICP-OES; Perkin-
Elmer, Shelton, CT). Five metals were included in the analysis: Calcium (Ca), 
Copper (Cu), Iron (Fe), Nickel (Ni), and Zinc (Zn). The limit of detection for each 
of the five metals is 0.00036ppm (Ca), 0.0003ppm (Cu), 0.00013ppm (Fe), 
0.00059ppm (Ni), and 0.00017ppm (Zn). Metal analysis was conducted on sterile 
saline and deionized water in order to estimate background metal concentrations 
for BAL and EBC, respectively. Deionized water (3mL) was injected into the EBC 
collection tube and allowed to incubate at 0°C for 30 minutes, in order to mimic 
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the average time to collect, transport, and process EBC samples. Background 
metal concentrations in saline solution (used for BAL) were as follows:  
0.171ppm (Ca), 0.006ppm (Cu), 0.000ppm (Fe), 0.011ppm (Ni), and 0.011ppm 
(Zn). Background metal concentrations in deionized water were as follows: 
0.462ppm (Ca), 0.000ppm (Cu), 0.000ppm (Fe), 0.039ppm (Ni), and 0.165ppm 
(Zn). Reported metal concentrations exclude contribution from background 
levels.  
 
4.2.7 Cytokine Measurements 
EBC and BAL cytokine concentrations were measured with a 10-plex 
TH1/TH2 human cytokine kit in an electro-chemiluminescence multiplex detector 
Sector 2400 (MesoScale Discovery [MSD]; Gaithersburg, MD). The limit of 
quantification was calculated as three standard deviations below the lowest 
calibration value. The lower limits of quantification are as follows: IL-1 β (0.045 
ρg/mL), IL-2 (.241 ρg/mL), IL-4 (0.018 ρg/mL), IL-5 (0.06 ρg/mL), IL-8 (0.018 
ρg/mL), IL-10 (0.097 ρg/mL), IL-12 p70 (0.13 ρg/mL), IL-13 (0.528 ρg/mL), IFN-γ 
(0.084 ρg/mL), and TNF-α (0.063 ρg/mL). The upper limit of quantification used 
was 2500 ρg/mL for all cytokines. An EBC concentration step was not conducted 
prior to analysis. We evaluated a 10-fold concentration step that involved either 
lypholyzation or vacuum evaporation. Percent IL-8 and TNF α cytokine recovery 
was low, 25 to 80% percent and 0 to 30% percent respectively, from EBC spiked 
with known cytokine concentrations (i.e., 7, 28, and 114 ρg/mL). The percent 
recovered cytokine decreased with decreasing cytokine concentrations.  
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4.2.8 Statistical Analysis 
Data were analyzed using Graphpad Prism 4 (Graphpad Software Inc, 
San Diego, CA) statistical and graphing software. Data are expressed as mean ± 
SE. We compared EBC and BAL analytes by Spearman’s correlation. Friedman’s 
test (non-parametric equivalent to repeated-measures 1-way ANOVA), followed 
by Dunn’s multiple comparison test, was used to compare EBC values across 
filtered air and DE exposure days, respectively Wilcoxan-signed rank tests were 
used to compare BAL values 20 hour post air and 20 hour post DE. Gaussian-
approximated p-values and 95 percent confidence intervals are provided as 
appropriate. Data was considered significant if p-value <0.05. 
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4.3 Results 
Ten healthy volunteers were exposed to clean air and diesel exhaust. 
EBC was collected pre-, immediately post, and 20 hour post filtered air and DE 
exposures. One EBC sample from 2 subjects, #7 Air Day (Post) and #10 Air Day 
(Pre) were excluded from analysis due to salivary contamination in the samples. 
One subject declined to undergo bronchoscopy after their second exposure.  
 
4.3.1  EBC Measurement Volume: Reproducibility and Correlation  
EBC volume (Figure 4.2) was analyzed across the six collection time 
points (combined pre, post, and 20 hour for both DE and Air Exposures) for 
reproducibility. Considerable heterogeneity existed between individual collection 
volumes. Group collection volume ranged from 1.45mL to 5.23mL. The average 
EBC volume across all measurements was 3.12±0.13mL. No significant 
differences were observed within individual collection volumes or across all six 
collection time points, suggesting DE exposure did not influence EBC volume.  
 
4.3.2 EBC Total Protein Concentration  
The effect of filtered air and DE exposure on EBC total protein 
concentration (TPC; ηg/ml) was analyzed (Figure 4.3). Mean TPC pre-, 
immediately post-, and 20 hour post- filtered air exposure was 1736±433, 
1885±564, and 2004±560 ηg/ml, respectively. Mean TPC pre-, immediately post-
, and 20 hour post- DE exposure was 2020±659, 1413±336, and 2673±930 
ng/mL respectively. No significant differences were observed between clean air 
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and DE exposures days. A significant negative correlation emerged between 
EBC volume and TPC (r=-0.48; Figure 4.4A). TPC decreased with increasing 
EBC volume. The TPC of 2 subjects was beneath the limit of detection 
(66.7ηg/ml). Removal of these outlying data points did not affect statistical 
results. EBC volume and EBC calcium shared the same inversely proportional 
relationship (r=-0.57; Figure 4.4b). 
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Figure 4.2 EBC Collection Volume Reproducibility. EBC volumes compared 
across six collection time points. Each line corresponds to EBC volume 
measurement from an individual subject. Group collection volumes ranged from 
1.45mL to 5.23mL. Mean EBC Volume (mL): Air Pre 3.32±0.34; Air Post 
3.32±0.37; Air 20hr 3.04±0.42; DE Pre 3.14±0.26; DE Post 3.56±0.26; DE 20hr 
3.42±0.34.  Data analyzed by repeat measures 1-way ANOVA followed by 
Tukey’s multiple comparison post-test, p=0.56, n=8. 
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Figure 4.3 EBC Total Protein Concentrations after Air and DE Exposure. Each 
line corresponds to EBC volume measurement from an individual subject 
LOD=66.7ηg/ml. Mean TPC (ηg/mL): Air Pre 1736±433; Air Post 1885±564; Air 
20hr 2004±560; DE Pre 2020±659; DE Post 1413±336; DE 20hr 2673±930.  
Data analyzed by Friedman’s Test. Air day p=0.15; DE day p=0.35; n=8. 
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Figure 4.4 Correlation between EBC Volume, Total Protein Concentration, and 
Calcium. (A) EBC total protein, r=-0.48, 95% CI (-0.67,-0.25), n=56; and (B) 
calcium, r=-0.65, 95% CI (-0.79,-0.47), n=56; r calculated by Spearman’s 
correlation. 
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4.3.3  EBC Metal Analysis 
 
EBC and BAL samples were analyzed for the presence of 5 metals 
elements: calcium (Ca), zinc (Zn), iron (Fe), copper (Cu), and nickel (Ni). Ni and 
Cu were not detectable in most EBC samples and were not further analyzed.  Ca, 
Zn, and Fe were detectable in most or all EBC samples. Immediately post DE 
exposure, the  EBC Ca concentration decreased in comparison to immediate 
post air exposure, but the observation was non-significant (p=0.16) due to a 
single subject (Figure 4.5A). Removal of the subject made the decrease highly 
significant (p=0.02). The EBC Ca concentration immediately post DE was 
significantly lower than the pre- and 20 hour-post DE Ca concentrations 
(p<0.05,). EBC Zn concentration (Figure 4.5B) also decreased immediately post 
DE exposure in comparison to immediately post Air exposure, but the decrease 
was non-significant (p=0.10). EBC Zn concentration immediately post air 
exposure was significantly higher (overall p=0.048) than Zn concentrations 20 
hour post air exposure, but the increase could not be detected with Dunn’s post-
test. Elevated Zn levels immediately after air exposure possibly suggests an 
exercise-induced effect. EBC Fe concentration (Figure 4.5C) did not significantly 
differ between Air and DE exposure days. A strong positive correlation (r=0.61, 
95% CI [0.41, 0.76]), existed between EBC Ca and EBC Zn concentrations 
(Figure 4.6). BAL metal concentrations (Figure 4.7) did not differ significantly 20 
hours after air and DE exposure, nor did BAL metal concentrations correlate with 
one another. No correlations existed between EBC and BAL transition metal 
concentrations. The combined data suggested DE exposure has an immediate 
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effect on EBC calcium concentrations, but the effect is attenuated 20 hour post 
exposure. 
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Figure 4.5 EBC Calcium, Zinc, and Iron Concentrations. (A) EBC Ca (ppm): Air 
Pre 1.03±0.17, Air Post 1.01±0.17, Air 20hr 1.09±0.25, DE Pre 1.15±0.26, DE 
post 0.81±0.21, DE 20hr 0.98±0.23; p=0.008 (B) EBC Zn (ppm): Air Pre 
1.96±0.27, Air Post 2.50±0.22, Air 20hr 1.85±0.20, DE Pre 2.41±0.56, DE Post 
2.06±0.31, DE 20hr 2.31±0.39; p=nonsignficant (C ) EBC Fe (ppm): Air Pre 
0.004±0.003, Air Post 0.002±0.001, Air 20hr 0.001±0.000, DE Pre 0.006±0.005, 
DE Post 0.002±0.00, DE 20hr 0.003±0.003; p=nonsignficant. Data analyzed with 
Friedman’s paired test and Dunn’s post-test; *p<0.05 Dunn’s post-test; n=8 
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Figure 4.6  EBC Calcium and Zinc Correlation. Spearman’s r =0.60, 95% CI 
(0.39,0.75), p<0.0001, n=56. 
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Figure 4.7  BAL Calcium, Zinc, and Iron Concentrations. Metal concentrations 
analyzed in BAL fluid collected 20hr after filtered air or DE Exposure. (A) BAL Ca 
(ppm): Air 0.50±0.03, DE 0.52±0.04 (B) BAL Zn(ppm): Air 0.17± 0.01, DE 0.16± 
0.01(C) BAL Fe (ppm): Air 0.01±0.0, DE 0.01±0.0. Data analyzed with paired t-
test, p=nonsignficant, n=9. 
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4.3.4 EBC TH1 and TH2 Cytokine Concentrations 
EBC was collected pre, post, and 20 hours post filtered air and DE 
exposure. The lung samples were analyzed for six TH1 cytokines (IL-1β, IL-2, IL-
8, IL-12p70, TNF-α, IFN-γ) and four TH2 cytokines (IL-4, IL-5, IL-10, IL-13). Four 
TH1 cytokines, IL1B, IL-8, IL-12p70, and IFN-γ, were detectable in most EBC 
samples. Detectable EBC cytokines were primarily found in samples collected 20 
hours post air or DE exposure. EBC IL-1β concentrations were slightly elevated 
20 hours post air exposure, but the increase was not statistically significant 
(p=0.05; Figure 4.8A)).The data suggests EBC IL-1β concentration 20 hours post 
air exposure is greater than pre-air exposure values. Similarly, IL-1 β 
concentration increased 20 hours post DE exposure relative to pre-DE exposure, 
but the difference was non-significant due to another individual (subject 5). IL-1 β 
concentration 20 hours post air exposure was not significantly different from IL-
1β 20 hours post DE exposure, suggesting that the trend increase in 20 hours IL-
1β may be an exercise-induced effect. IL-8, IL-12p70, and IFNγ concentrations 
were not affected by DE exposure or exercise. No differences were observed 
between air and DE exposure among the other detectable EBC cytokines. TH 2 
cytokines were undetectable in greater than 95 percent of the EBC samples.  
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Figure 4.8  EBC TH1 Cytokine Concentrations. (A) IL-1β, Friedman’s overall 
(Air) p=0.0469 (B) IL-8 Pre, post, and 20 hour data analyzed by Friedman’s test 
and Dunn’s post-test, n=7; Paired-analysis (Air vs. DE) by Wilcoxan-signed rank 
test, n=9. 
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4.3.5  BAL TH1 and TH2 Cytokine Concentrations 
 All six TH1 cytokines were detectable in BW and BAL samples. DE 
exposure decreased BW IL-2 (p=0.0195) and IL-8 (p=0.0371) relative to air 
exposure (p<0.05; Figure 4.9). DE exposure also caused a non-significant 
decrease in BW TNF-α (p=0.0742). Statistical significance for TNF- α was 
prevented due to differing cytokine response of subjects 4 and 5. No significant 
TH1 cytokine differences were observed between BAL filtered air and DE 
exposure samples. The BW and BAL data suggests that DE exposure down-
regulated TH1 cytokine responses. 
All four TH2 cytokines were detectable in BW and BAL samples. DE 
exposure significantly increased BW IL-4 (p=0.0117; Figure 4.10). Conversely, 
BW IL-13 decreased (p=0.0488) after DE exposure. A trend increase was 
observed in BAL IL-5 (p=0.3439) and BAL IL-13 (p=0.0645), but the trend was 
opposed by two individuals, subjects 4 and 5 (Figure 4.11). Without these two 
individuals, the increased BAL IL-13 and IL-5 concentrations are highly 
significant (p=0.0078 and p=0.0095, respectively). A trend in the decrease in BAL 
IL-10 (p=0.0912) was also observed, but subjects 4 and 5 weakened statistical 
significance. BAL IL-10 decrease becomes significant (p=0.0312) if analysis is 
conducted without subjects 4 and 5. The combined BW and BAL data suggest 
DE-exposure may induce a TH2-mediated pulmonary immune response. 
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Figure 4.9 TH1 Cytokines in Bronchial Wash (BW). (A) IL-2 ( ρg/mL), Air 
21.2±3.2, DE 14.8±1.3, p=.0195; (B) IL-8 (ρg/mL), Air 125.7±33.1, DE 85.9 
±14.5, p=0.0371; (C) TNF-α (ρg/mL), Air 1.55±0.32, DE 1.03±0.16, p=0.0742; 
Data analyzed with Wilcoxan signed rank, 1-tailed test, *p<0.05, n=9. 
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Figure 4.10 TH2 Cytokines in BW (A) BW IL-4 ( ρg/mL), Air 0.28± 0.11, DE 
0.60±0.18, p=.0117 (B) BW IL-13, Air 49.7±10.6, DE 38.1±6.4, p=0.0488  
Data analyzed with Wilcoxan signed rank 1-tailed test, * p<0.05,  n=9. 
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Figure 4.11 TH2 Cytokines in BAL (A) BAL IL-5, Air 4.91±0.56, DE 5.0 p=0.3439 
w/ subjects 4 and 5, p=0.0095 w/o subjects 4 and 5 (B) BAL IL-10, Air 11.65 
±1.13 DE 10.95±2.15, p=0.0912 w/ subjects 4 and 5, p=0.0312 w/o subjects 4 
and 5 (C) IL-13 BAL, Air 28.9±7.61, DE 44.8±4.81, p=0.10 w/ subjects 4 and 5, 
p=0.008 w/o subjects 4 and 5. Data analyzed with Wilcoxan signed rank 1-tailed 
test, n=9 
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4.4 Discussion 
Our research objective was to investigate the effects of diesel exhaust 
(DE) exposure on pulmonary transition metals and inflammatory mediators 
through repeated EBC measurements. Collected EBC was analyzed for 
transition metals and cytokines through sensitive analytical procedures, ICP-OES 
and electro-chemiluminescence multiplex cytokine detection, respectively. 
Repeated EBC measurements not only enabled comparison of lung responses 
between air and DE exposure days, but also enabled evaluation of baseline 
pulmonary status (pre-exposure) and the immediate, acute effects of exposure.  
We first evaluated the effect of DE exposure on collection volume and 
total protein concentration, due to raised concerns over EBC reproducibility 
(Horvath, et al. 2007). DE exposure did not significantly alter intra-individual EBC 
volume or EBC total protein content. EBC volumes were reproducible regardless 
of these four essential components of our study protocol: time elapse between 
measurements (2 hours to 6 months); intermittent exercise; fasting; and 
exposure conditions. Likewise, EBC total protein content did not significantly 
differ across our six collection time points. Our findings are consistent, in part, 
with that of other investigators who examined conditions that may affect EBC 
volume, total protein, and other EBC measurements. Bloemen and colleagues 
(2006) observed reproducible intra- and inter-day EBC volumes over a 24 hour 
time period. The authors noted significantly decreased EBC volumes at the first 
collection time point, and attributed the decrease to test subject inexperience with 
the EBC collection technique. We did not observe significant changes in EBC 
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volume at any time points, likely because recruited subjects were coached prior 
to and monitored continuously during EBC collection. Intra-individual EBC 
volume reproducibility between measurements is particularly important because 
EBC volume significantly affected EBC total protein (TPC) and calcium 
concentrations in our study (Figure 4.3). Total protein concentration and calcium 
content became more dilute with increasing EBC volume. In contrast with our 
results, Gessner and colleagues (2001) observed a positive correlation between 
EBC volume and total protein. The difference in results may be ascribed to 
differences in sample volume or sample collection time. We collected a greater 
range of EBC volumes (1.5-5.0mL) than those reported by Gessner and 
colleagues (0.5-2.0mL). Regardless of the true relationship between EBC volume 
and TPC, results from both studies demonstrate that EBC volume may 
significantly effect soluble analyte concentrations. Because of the high intra-
subject volume reproducibility we can be reasonably assured that EBC volume 
did not contribute to variability of EBC constituents analyzed during this study  
EBC calcium concentration decreased immediately after DE exposure. DE 
exposure did not affect zinc or iron EBC and BAL concentrations. Decreased 
EBC calcium concentration was an unforeseen effect of DE exposure. Calcium 
and zinc are abundant metal components in diesel exhaust emissions (U.S. EPA 
2002); therefore, we expected an increase in EBC calcium following DE 
exposure. Goldoni and colleagues (2004) successfully measured EBC metal 
concentrations of factory workers who were occupationally exposed to hard 
metal powders and dusts. EBC cobalt and tungsten concentrations significantly 
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increase after an 8-hour work shift. EBC hard metal concentrations may reflect 
metal exposure as well as target tissue dose. We speculate that EBC calcium 
measured in this study may be a biomarker of effect rather than a marker of DE 
exposure. Unlike cobalt and tungsten, calcium is an endogenous metal involved 
in essential cellular signaling and immune pathways. Increased calcium 
concentration in the cytoplasm of lung cells can stimulate superoxide anion and 
other reactive oxygen species production (ROS), arachidonic acid (AA) 
metabolism, and nuclear factor kappa beta (NFκB) activation (Taylor, et al. 1990; 
Forman and Nelson 1983). ROS production, AA metabolism, and NFκB 
activation can lead to the production of cytokines and induction of immune 
defenses against particles and microbes. Recent evidence suggests that ultrafine 
particles induce extra-cellular calcium influx into rodent alveolar macrophages 
(Brown, et al. 2000). In addition, verapamil and BAPTA-AM, a calcium channel-
blocker and a calcium chelator, respectively, inhibits tumor necrosis factor-alpha 
(TNF-α) release from particle-exposed rodent AM and human blood monocytes 
(Brown, et al. 2000). Extra-cellular calcium influx also increases in rodent 
macrophages and human blood monocytes exposed in vitro to coarse PM 
(Brown, et al. 2007). Calcium influx is very rapid, peaking 600-800 seconds after 
a bolus in vitro PM exposure. Coarse PM exposure also induces TNF-α release 
and production of IL-1α mRNA, an effect that can be blocked by calcium 
antagonists (Brown, et al. 2007). Hence, ambient PM exposure may induce 
inflammatory immune responses through calcium-dependent pathways. 
Decreased EBC calcium immediately after DE exposure may signify increased 
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calcium uptake into pulmonary cells. EBC calcium concentrations 20 hours after 
DE exposure were not significantly different than EBC calcium concentrations 
prior to DE exposure, or 20 hours after filtered air exposure. Likewise, BAL 
calcium concentrations 20 hours after DE and filtered air exposures were not 
significantly different. We also found no correlations between the reduced EBC 
calcium concentrations and either EBC or BAL cytokine concentrations 
immediately after or 20 hours after DE exposure. However, the BAL sampling 
time and cytokine endpoints used in this study may be inadequate parameters to 
examine DE-induced calcium changes. As previously discussed, extra-cellular 
calcium influx rapidly induces ROS production and arachidonic-acid metabolism. 
Pulmonary measurements of superoxide anion, superoxide derivatives, or 
arachidonic acid metabolites, such as prostaglandin and leukotriene, shortly after 
DE exposure may have better elucidated our results.  
We found that DE exposure did not change EBC TH 1 cytokine 
concentrations relative to filtered air exposure. Only a few cytokines (IL-1 β, IL-8, 
TNF-α, IFNγ) were detectable in EBC. The few detectable EBC inflammatory 
cytokines were found primarily in samples collected 20 hours after filtered air 
exposure. The low cytokine concentrations in EBC are probably due to high 
water content of EBC. Effros and colleagues (2002) estimate that EBC is 20,000-
fold more dilute than respiratory fluids. This high level of dilution makes EBC 
cytokine-detection very difficult.  
Several exposure studies report increased neutrophils and cytokines in 
BAL 6 hours after human exposure to diesel exhaust (Nordenhall, et al. 2000; 
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Salvi, et al. 1999, Holgate, et al. 2003). For instance, IL-6 concentration, but not 
IL-8 or TNF-α, increases in induced sputum 6 hours after DE exposure 
(Nordenhall, et al. 2000). IL-8 concentration significantly increases in the 
bronchial epithelium 6 hours after DE exposure (Salvi, et al. 1999; Holgate, et al. 
2003). The combined results suggest different compartments of the lung have 
distinct inflammatory responses to DE exposure at the 6 hours time point. We 
evaluated a later time point (20 hour) in order to assess whether DE exposure 
can induce a sustained inflammatory response. In our study, BW data indicated 
that DE-exposure significantly decreased the TH 1 cytokines, IL-2 and IL-8. DE 
exposure also decreased BW TNF-α concentrations in 7 out of 9 subjects. 
Subjects, #4 and #5, had consistently opposing cytokine responses in 
comparison to the rest of the group, but the cause for these deviant responses 
remained undetermined. Our collective TH 1 results suggested that pro-
inflammatory response is down-regulated 20 hours post exposure DE exposure.  
Conversely, DE exposure may stimulate lung TH2 cytokine production. DE 
exposure significantly increased BW IL-4 concentration relative to air exposure. 
We also detected trend increases in BAL IL-13 and IL-5. IL-5 is a hallmark of 
allergic inflammation and asthma, because it promotes the maturation and 
release of eosinophils into the blood. IL-13 promotes the adaptive immune 
response by stimulating B cells (Zurawski, et al. 1994). IL-4 promotes a cell-
mediated immune response through the differentiation and proliferation of TH 2 
cells. Evidence suggests that IL-4 and IL-13 both inhibit the production and 
release of inflammatory cytokines, including TNF-α and IL-8 (Mossmann, et al. 
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1986; te Velde, et al. 1990; de Waal Malefyt, et al. 1993; Brown, et al. 1997; 
Mijatovic, et al. 1997). The decreased BW IL-8 and TNF- α concentration may be 
due, in part, to the anti-inflammatory actions of IL-4 and IL-13. In contrast, DE 
exposure appeared to cause a decrease in BW IL-13 concentration and BAL IL-
10 concentration. Decreased BW IL-13 may signify a declining TH 2 response in 
the upper pulmonary airways, whereas increased BAL IL-13 suggests continued 
TH2 response in lower airways. Our results are supported by that of Diaz-
Sanchez and colleagues (1996), who first demonstrated that DEP installation 
shifts nasal immune response towards a TH2-mediated, allergic-type response in 
the nasal mucosa. The investigators observed an increase in nasal lavage IL-4 
concentration 18 hours after DEP exposure. Pourazar and colleagues (2004) 
evaluated whether whole DE with high DEP content (300μg/mL) could also 
provoke a TH2 response. The investigators established that exposure to whole 
DE increases the expression of IL-13 in the bronchial epithelium. The results 
suggest that DE exposure stimulates a TH2-mediated response in healthy adults. 
However, we also observed a trend decrease in BAL IL-10 twenty hours after DE 
exposure. IL-10, like IL-4 and IL-13, inhibits the production of TH 1 cytokines and 
enhances B cell viability and proliferation. A decreased IL-10 concentration after 
DE exposure could indicate a decreasing TH 2 response. Holgate and colleagues 
(2003) also observed a trend decrease in IL-10 staining in the bronchial tissues 
of DE exposed healthy subjects while IL-10 staining significantly increased in 
mild asthmatics 6 hours after DE exposure. The investigators results indicated 
that DE exposure has differing effects on airway biochemistry of healthy adults 
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and mild asthmatics. Our results suggest that DE may stimulate an allergic or 
asthma-like lung response in healthy adults 20 hours after DE exposure via other 
TH2 cytokines. Further investigation is needed on role of IL-10 relative to IL-4, IL-
5, and IL-13. Our findings highlight the importance of using broad cytokine panels 
when investigating pulmonary responses to air pollutants.   
TH2 cytokines were undetectable in EBC. One possibility is that the 
concentration of EBC TH2 cytokines was too dilute, even though our evaluation 
techniques allowed for sub-picogram cytokine detection. For example, average 
EBC IL-1β concentrations were 15-fold less than average BAL concentrations 
collected from the same subjects at the 20 hour post-exposure time point. IL-1β 
was detectable in 27 of our 56 evaluated EBC samples, thus IL-1β was the most 
“detectable” of the evaluated cytokines in EBC. In contrast, average EBC IL-8 
concentrations were nearly 2000-fold less than BAL concentrations and only 
detectable in 14 of our collected samples. These findings illustrated that EBC 
“dilution” can vary highly between cytokines relative to BAL concentrations, and 
that variable dilution may render certain cytokines “undetectable”. To the best of 
our knowledge, no other study has attempted to measure TH2 cytokines in EBC.  
In summary, DE exposure caused significant changes in BW and BAL 
cytokines concentrations. Most measured TH1 and TH2 cytokines were 
undetectable in EBC samples. However, repeated EBC measurements allowed 
the detection of decreased EBC calcium immediately post DE exposure. The 
decreased EBC calcium may be due to increased uptake in pulmonary cells, but 
further study is needed to determine the mechanistic pathways involved. TH 1-
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type cytokines were not elevated in EBC or BAL samples 20 hours post DE 
exposure, suggesting the innate immune responses observed by other 
investigators at 6 hours is not sustained at 20 hours. Decreased TH 1 and 
increased TH2 cytokines in BW and BAL indicated that DE can shift the 
pulmonary immune response toward an allergic-type response 20 hours after 
exposure. However, further study is needed on the role of IL-10 relative to the 
other measured TH2 cytokines.  The absence of TH2 cytokines in EBC suggested 
a need for more research on factors contributing to EBC dilution. 
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Epidemiologic studies demonstrate significant association between 
ambient particulate matter (PM) and adverse health effects. Gaseous co-
pollutants have been postulated to potentially modulate PM-induced health 
effects (NRC, 1998). In the United States, diesel exhaust (DE) accounts for 
approximately 20 percent of the fine ambient PM and also contributes gaseous 
components to ambient air (U.S. EPA 2002). Many experimental studies 
demonstrate that diesel exhaust particles (DEP) and DE can have considerable 
and varied toxic effects on the lung (Gowdy, et al. 2008; Harrod, et al. 2005; 
Yang, et al. 2001; Castranova, et al. 2001; Yin, et al. 2002; Mundandhara, et al. 
2005). However, it is uncertain whether diesel exhaust particle (DEP)-induced 
effects contribute to PM-induced morbidity and mortality endpoints recorded in 
epidemiology studies. Hence, the first aim of the research described herein was 
to compare the effects of ambient PM to DEP-induced lung oxidant and 
inflammatory responses. We conducted our analyses in vitro using human 
alveolar macrophages (AM). We chose human AM for two primary reasons. First, 
the AM is an important lung immune cell type that is the first line of response to 
inhaled PM and bacteria. Second, human cell lines can behave differently to PM 
exposure than primary human lung cells. For example, DEP and carbon black 
(CB) stimulate IL-8 release from the human-leukemic (HL) cell line HL-60, but 
have no effect on human AM in comparison to un-exposed cells (Appendix I). 
External factors in daily exposures may mature AM to respond differently than 
relatively “naïve” (i.e., without ambient pollutant exposures). We concluded, 
therefore, to conduct our experiments on human AM.  
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AM are phagocytic lung cells essential to the uptake, inactivation, and 
clearance of inhaled bacteria and PM (Sibille and Reynolds 1990; Zhang, et al. 
2000). We found that urban dust particles (UD) and DEP could inhibit oxidant 
release for as long as twenty-four hours post-PM exposure.  These exposures 
were performed at PM lvels that did not decrease AM viability (Appendix 2) a 
measured by LDH release activity. In our study, DEP-induced suppression of O2- 
release was pronounced among AM exhibiting an initially “low” constitutive O 2- 
production relative to a positive stimulated control. Oxidant radical generation 
can be a protective response to xenobiotic exposure, although over-production 
can lead to lung injury (Maier 1993; Lohmann-Matthes, et al. 1994; Nakashima, 
et al. 1991; Chabot, et al. 1998). We found that the specific UD and DEP we 
utilized in these studies did not stimulate oxidant-induced injury (i.e., lipid 
peroxidation) in AM, evidenced by low intra- and extra-cellular carbonyl 
production, but instead UD and DEP suppressed the initial oxidant response 
needed to fight infections. In addition, ambient particles collected in Chapel Hill 
could suppress human alveolar macrophage (AM) cytokine response to 
lipopolysaccharide (LPS; gram-negative bacterial product). AM pre-exposed to 
UD were unable to release interleukin (IL)-8 six hours after subsequent 
stimulation with LPS. In the same way, AM pre-exposed to Chapel Hill PM were 
unable to release tumor necrosis factor (TNF)- α  six hours after LPS stimulation. 
IL-8 and TNF-α are T-helper 1 (TH1) inflammatory cytokines responsible for 
recruiting phagocytic inflammatory cells to the cite of injury and sustaining the 
inflammatory response. Suppressed TH1 inflammation upon initial exposure to 
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PM may enhance the lung’s vulnerability to infection (Steerenberg, et al., 2004). 
For example, DEP exposure in rats inhibits pulmonary ability to release the 
antimicrobial oxidants and inflammatory cytokines, necessary to clear a Listeria 
monocytogenes infection, resulting in decreased clearance of the bacteria (Yang, 
et al. 2001; Castranova, et al. 2001; Yin, et al. 2003; Steerenberg, et al., 2004). 
Another study demonstrates that a one-time DEP exposure in rodents can 
sustain the susceptibility of the lung to bacterial infection occurring at a later time 
(Yin, et al. 2005). Our results from PM-exposed human AM were consistent with 
results from the more extensive animal studies.  
We also compared the effect of ambient PM collected during different 
seasons. Monthly variation in air pollution is well-documented, and is accounted 
for in regulatory activities (U.S. EPA 2004 PM document). We found that the 
potency of PM collected during the summer (June 2002) differed from the effects 
of PM collected during the fall (November 2001). Summer particles suppressed 
human AM IL-8 release in response to subsequent LPS exposure. Fall PM 
exposure had no effect on LPS stimulated IL-8 release. The different responses 
may be due to seasonal influences on particle composition. For instance, 
polycyclic aromatic hydrocarbons (PAH), an organic class of PM components, 
can differ in concentration between summer and winter seasons (Binkova, et al. 
2003). In addition, several researchers demonstrate that organic constituents 
adsorbed onto DEP carbonaceous contribute to DEP-induced effects on alveolar 
macrophages (Tsien, et al. 1997; Li 2002; Siegel, et al. 2004, Schober 2007). 
Hence, we evaluated whether benzo(a)pyrene (BaP), a well-known PAH 
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component of PM and DEP, contributed to PM-induced responses. We exposed 
human AM to UD, UD coated with BaP, and free BaP. We found UD and coated-
UD had an equivalent effect on suppressed TNFα and IL-8 release from AM. 
Free BaP had no significant effect on cytokine release. We concluded that PM-
induced cytokine suppression can not be attributed solely to BaP, but other PAH 
or PAH-like compounds may effect cytokine suppression. . Finally, we evaluated 
mechanisms that may contribute to inflammatory cytokine suppression by 
utilizing two methods: (1) a comparison of extra-cellular cytokine release to intra-
cellular cytokine production; and (2) an evaluation of cytokine release after AM 
stimulation with activators known to induce different initial signaling mechanisms 
that lead to cytokine production. Several patterns emerged from the data: (1) 
suppressed cytokine release, indicated by increased intra-cellular cytokine 
retention; (2) suppressed total cytokine production; and (3) stimuli-dependent 
cytokine suppression. UD and DEP significantly increased intra-cellular IL-8 and 
TNF-α retention, respectively, relative to a no particle LPS stimulated control. 
Chapel Hill PM, however, reduced total TNF-α production relative to a no particle 
stimulated control. Hence, PM-suppressed cytokine release may inhibit 
production or delay cytokine release. We examined different immune-response 
signaling pathways by comparing TNF-α release from particle-exposed AM 
stimulated with LPS, phorbol myristate acetate (PMA), or calcium ionophore 
A23187. LPS, PMA, and A23817 are well-known macrophage activators that can 
ultimately stimulate the production of inflammatory cytokine including TNF- α 
(Brown, et al., 1988; Kaul and Forman 1996; Taylor, et al. 1990). Our data 
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demonstrated that UD-suppressed cytokine release occurs during an LPS-
stimulated pathway, because both PMA and A23817 stimulation augmented 
TNF-α release in UD-exposed macrophages. LPS enters the cell via a receptor-
ligand binding pathway and then binds to cellular membrane receptors CD14 and 
Toll-like receptor 4 (TLR4) (Wright, et al. 1990; Lien, et al. 2000; Maris, et al. 
2006). Once bound to TLR4, LPS initiates an intra-cellular signaling cascade that 
can lead to the activation of nuclear factor- κβ (NFκβ), a transcription factor that 
controls the gene expression of TNF-α and other inflammatory cytokines (Carter, 
et al. 1998; Baldwin, 2001). PMA, however, activates NADHPH oxidase which 
then catalyzes the production of extra-cellular O 2- and reactive O2- derivatives. 
ROS can initiate a multitude of signaling cascades including the activation of 
NFκβ (Kaul and Forman 1996). In contrast to LPS and PMA, calcium ionophore 
A23817 allows extra-cellular Ca 2+ influx into the cell by opening calcium-
dependent ion channels in the cellular membrane. Increased intra-cellular Ca 2+ 
concentration can induce multiple signaling cascades including those involving 
phospholipase C activity, inositol phosphate production, and NF κβ activation 
(Taylor, et al. 1990; Raddassi, et al. 1994; Dolmetsch, et al. 1998). Because all 
three agents eventually result in signal transduction involving NF κβ, it is 
conceivable that UD inhibition of LPS-induced cytokine release occurs upstream 
of NFκβ, or occurs through alteration of another signaling pathway. Meanwhile, 
DEP induced either a statistical significant or a trend (p<0.10) in the suppression 
of TNF-α in AM regardless of LPS, PMA, or A23817 stimulation, suggesting that 
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DEP is able to exert adverse effects across multiple immune mechanistic 
pathways.  
The exact mechanisms by which DEP exposure interferes with the lung’s 
ability to regulate oxidative and inflammatory responses are not clear. Research 
suggests DEP exposure may induce lung injury in part, by manipulating 
phospholipid metabolic pathways. Pollutants and soluble mediators must 
transport messages across outer and inner cellular phospholipid membranes in 
order to activate immune signaling cascades. Hence, cellular immune 
mechanisms require the active participation of membrane lipids (Fernandis and 
Wenk 2007). Therefore, the second research aim of this dissertation was to 
“fingerprint” comprehensive phospholipid changes induced by diesel exposure.  
We used a novel metabolomics approach, lipidomics, to capture lipid 
mass changes across broad phospholipid groups as well as individual 
phospholipid species. Prelimary experiments revealed that 2.0x10 5 AM was an 
optimal cell number to detect the majority of lipid species (56%; Appendix 3) and 
allow enough treatment conditions from a BAL collection (typically 6-12 x 10 6 AM) 
In our initial in vitro exposure studies, we observed that human AM exposure to 
LPS for one hour significantly altered the concentration of several phospholipid 
species in comparison to unstimulated AM. In addition, longer LPS exposure (six 
hours) continued to significantly affect phospholipid concentrations in comparison 
to LPS-induced effects observed after one hour. We demonstrated that a six hour 
LPS exposure significantly increased total ether-linked phosphatidylethanolamine 
(ePE), as well as individual lipid species within other lipid groups, including 
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species from phophatidylcholine (PC), phosphatidylinositol (PI), 
phosphatidylserine (PS), and phophatidic acid (PA) groups. Our preliminary 
results did not provide a clear indication of PM-induced phospholipid changes. 
However, we hypothesized that AM exposed to DEP, UD, and CB will also 
demonstrate significant phospholipid changes once we are able to analyze the 
lipid data from additional exposure replicates. A potential short-coming of the in 
vitro approach is that the results may not adequately reflect the in vivo 
environment due to missing factors in cell media and the presence of other cell 
types and associated secretions. Our hypothesis, however, is supported in part 
by the lipid results from human exposure to diesel exhaust. Alveolar 
macrophages (AM) collected from humans exposed in vivo to diesel exhaust 
exhibited significantly different phospholipid concentrations than AM from 
humans exposed to filtered air. Diesel exhaust exposure reduced total lyso 
(without a sn-2 fatty acid) PC and lysoPE concentrations. In addition, diesel 
exhaust exposure altered the concentration of many different lipid species. Diesel 
exposure reduced concentration of several species that contained or were 
derived from parent lipids that contained decanoic or eicosanoic fatty acids. 
Decanoic and eicosanoic fatty acids are of particular interest, because 
metabolism of these fatty acid classes are known to have important biological 
and physiological functions in lung cells. For example, arachidonic acid (20:4) 
metabolism gives rise to products involved lung inflammation and injury 
(Fukunaga, et al. 2005; Bonnans and Levy 2007), cellular apoptosis (Fadok, et 
al. 1992; Monick, et al. 2001; Huber, et al. 2007), adult respiratory distress 
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syndrome (Bernard, et al. 1991), and asthma (Levy 2005). Our results 
demonstrated that a lipidomics approach to investigating diesel effects on the 
lung provides novel information relevant to pollutant-induced toxicity.  
We further evaluated the effect of DE exposure on human airways through 
repeated measurement and a one time post exposure measurement of metal, T-
helper 1 (TH1), and T-helper 2 (TH2) cytokine concentrations. Repeated lung 
measurements are a challenge because traditional lung sampling techniques are 
complex, invasive, and stimulate acute airway inflammation. We measured metal 
and cytokine concentrations in the exhaled breath condensate of healthy adults 
pre, immediately post, and 20 hours post filtered air and DE exposure. Exhaled 
breath condensate is a safe, noninvasive, repeatable method to sample airway 
fluids and provided a means to compare baseline and acute pulmonary 
responses with pulmonary responses 20 hours after exposure. We found DE 
exposure significantly decreased EBC calcium concentration immediately after 
exposure in comparison to baseline calcium measurements. Calcium is a major 
metal constituent of DE. However, calcium is also an endogenous metal involved 
in essential cellular signaling and immune pathways. Notably, calcium-dependent 
pathways are highly involved in phospholipid metabolism. For example, the 
enzyme that cleaves arachidonic acid from phosphotidylcholine is activated in 
part by increases in intra-cellular calcium. Some studies demonstrate rapid 
calcium influx in monocytic and macrophage cell lines exposed to PM10 and 
ultrafine particles, followed by TNF-α release (Brown, et al. 2000; Brown, et al. 
2007). Our finding that decreased EBC calcium immediately after DE exposure 
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may indicate increased calcium uptake into pulmonary cells. However, we found 
no correlation between EBC calcium and EBC or BAL cytokine concentrations 
immediately after or 20 hours after DE exposure. The BAL sampling time and 
cytokine endpoints used in this study may be inadequate parameters to examine 
DE-induced calcium changes. As previously discussed, extra-cellular calcium 
influx rapidly induces ROS production and arachidonic-acid metabolism. 
Measurement of pulmonary ROS or arachidonic acid metabolite, such as 
prostaglandins and leukotrienes, measurements shortly after DE exposure may 
have better elucidated our results. Overall are findings indicated that EBC is a 
potentially useful method to collect metals for subsequent analyses.  
Our research found that the EBC analysis methods used in this study are 
unsuitable to extensively measure pulmonary TH1 and TH2 cytokine 
concentrations. We measured ten TH1 and TH2 cytokine concentrations in EBC, 
BW, and BAL: IL-2, IL-4, IL-5,IL-8, IL-10, IL-12p70, IL-13, TNF-α, and interferon 
(IFN)γ. All ten cytokines were detectable in lavage samples. EBC TH1 and TH2 
cytokine concentrations were either extremely low or undetectable in most of the 
EBC samples. Although our analytical techniques allowed for sub-picogram 
cytokine analysis, we only detected trace concentrations of IL1 β, IL-8, TNFα, and 
IFNγ. Concentrations of those four cytokines were found primarily in EBC 
samples collected 20 hours after exposure. Elevated EBC IL-1β 20 hours after 
both filtered air and DE exposure indicated a latent exercise induced effects. We 
were unable, however, to confirm this effect with other EBC cytokines. Other 
research groups use EBC to monitor inflammatory cytokines in patients with 
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pulmonary disease, but recommended EBC cytokine analysis is limited to those 
cytokines expected to have elevated concentrations (Horvath, et al. 2005).  
In contrast to EBC cytokine data, we discovered a significant effect of DE 
exposure on bronchial wash (BW) and BAL TH1 and TH2 cytokine concentrations. 
DE-exposure substantially decreased two BW TH 1 cytokines, IL-2 and IL-8. DE 
exposure also decreased BW TNF-α concentrations in 7 out of 9 subjects. 
Additionally, DE-exposure significantly elevated BW IL-4 concentration, a TH 2 
cytokine. DE exposure also increased BW IL-5 in 7 out of 9 subjects and BAL IL-
13 in 8 out of 9 subjects. These TH2 cytokines promote antigen-mediated 
immune pathways and suppress cell-mediated (TH1) immune pathways 
(Coffman, et al. 1986; te Velde, et al. 1990; Mijatovic, et al. 1997). Other studies 
indicate that diesel exposure stimulates TH 2 immune responses. DE exposure 
(300μg/m3) increases the expression of IL-13 in the bronchial epithelium 
(Pourazar, et al. 2004). Nasal instillation of DEP (300μg) stimulates 
immunoglobulin E (IgE) expression and T-helper 2 (TH2) cytokine concentrations 
increase in the nasal mucosa of exposed volunteers. Our data supported these 
other human exposure studies that demonstrate DE-exposure induces TH2 
mediated response, and demonstrated this effect at a lower associated particle 
concentration. Because investigators observe acute airway inflammation 6 hours 
after DE exposure, further study is need on DE-induced TH 1 and TH2 endpoints 
at earlier time points. 
A finding from our human exposure study was the relatively poor 
correlation of EBC and BAL values. Investigations of the correlation between 
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EBC and either sputum or lavage oxidative and inflammatory endpoints have 
variable results (Rozy, et al. 2006; Jackson, et al., 2007; Piotrowski, et al. 2007). 
Research has yet to verify the lung compartment(s) from which EBC is derived or 
the factors that may influence EBC generation and EBC-associated solutes. We 
found that average EBC IL-1β concentrations were 15-fold less than average 
BAL concentrations collected from the same subjects at the 20 hour post-
exposure time point. In contrast, average EBC IL-8 concentrations were nearly 
2000-fold less than BAL concentrations. These findings illustrated that EBC 
“dilution” can vary highly between cytokines relative to BAL concentrations, and 
that variable dilution may prevent correlation between these two lung sampling 
methods. Potential contamination from the oral cavity may be an additional 
confounding factor. Future studies are needed on methods that optimize EBC 
collection and analysis before EBC can reliably be used to assess pulmonary 
responses in pollutant-exposure research. 
A small pattern emerged during experimental analysis that potentially links 
the varied pulmonary responses to DEP exposure. DEP induced effects may 
involve calcium-dependent pathways. Intra-cellular calcium influx into immune 
cells can stimulate ROS release, inflammatory cytokine production, and 
phospholipid metabolism. Our in vitro results suggested that DEP may inhibit 
cytokine release through multiple mechanisms, including the pathways activated 
by calcium ionophore A23817. Human in vivo exposure to DE resulted in 
decreased EBC calcium concentrations immediately after exposure. Twenty 
hours after DE exposure, AM lysophospholipid concentrations significantly 
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decreased. Calcium is known to activate PLA2, the enzyme that cleaves 
phospholipids to form a lysophospholipid and a fatty acid. Although we can make 
no conclusions about the relatedness of these varied responses, we suggest 
future studies investigate the relationship between calcium and diesel-induced 
effects.  
The combined results of this dissertation demonstrate that DE and DEP 
exposure affect multiple pulmonary responses, including reactive oxygen species 
release, inflammatory cytokine production, and phospholipid metabolism 
(Summarized in Table 5.1). These results highlight the broad scope and 
complexity of diesel-induced effects. The altered biological responses observed 
in our studies may play important roles in the observed PM- and DE-induced 
health effects. 
 
 144 
 
Table 5.1 Summary of Experiments Described in Dissertation. * data for carbon 
black not included as carbon black did not significantly alter any of oxidative or 
inflammatory endpoints and was not included in the lipid research. ** PM or LPS 
data expressed as relative to an unexposed, unstimulated control. 
Exposure* Chapter 2 (in vitro) Chapter 3 (in vitro ** and 
in vivo) 
Chapter 4 (in vivo) 
Diesel Exhaust not evaluated Immed. Post 
n/a 
20hr Post 
↓ lysoPE, lysoPC 
↑ PS sp. and most PC sp. 
↓ other lipid sp. 
Immed. Post 
↓ EBC Ca  
20hr Post 
↓ BW IL-2, IL-8, TNFα  
↑ BW IL-4, ↓BW IL-13  
↓ BAL IL-10 
↑ BAL IL-5 and IL-13 
DEP Pre LPS Exposure** 
↓ O2- release 
~no effect on cytokine release relative to 
control 
6 hrs post LPS 
↓ IL-6, TNFα release    
↓ TNFα total production 
6hr Post PMA 
↓ TNFα release (trend) 
6hr Post A23817: 
↓ TNFα release (trend) 
observational data 
(lysoPC, PE, PG, and SM) 
1hr 
↑ PE 
 
6hr 
↑ PE, ↓ lyso PC, PG 
 
24hr 
↑ SM 
not evaluated 
UD Pre LPS Exposure** 
↓ O2- release 
↑ IL-6, IL8, TNFα 
6 hrs post LPS 
↓ IL-6, TNFα release 
24hr post LPS   
↓ IL-8 release, ↑ IL-8 retention 
6hr Post PMA 
↑ TNFα,  release 
6hr Post A23817 
↑ TNFα, release 
observational data 
(lysoPC, PE, PG, and SM) 
1hr 
↑ lysoPC 
 
6hr 
↑ PG 
 
24hr 
↓ PE 
not evaluated 
Chapel Hill 
PM* 
Pre LPS Exposure** 
Nov PM: ↑ IL-6, IL8, TNFα (coarse) 
June PM: ↑ IL-8 (IL-6,IL-8 not evaluated) 
6 hrs post LPS 
Nov PM: ↓ TNFα release and retention 
June PM:  not evaluated at this time-point 
24hr post LPS  
June PM: ↓ IL-8 release, ↑ IL-8 retention 
Nov PM: no diff. from control 
not evaluated not evaluated 
LPS 6hr Post 
↑ IL-6, TNFα release 
24hr Post 
↑ IL-8 release 
1hr 
↑ ePE; ↑PE, PA (trend) 
↓ lipid sp.  
6hr (observational) 
no differences 
24hr (observational) 
↓lysoPC 
not evaluated 
PMA 6hr Post 
↑ TNFα release 
not evaluated not evaluated 
A23817  6hr Post 
↑ TNFα release 
not evaluated not evaluated 
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Appendix 1 
 
 
 
 
 
 
 
 
 
Figure A1.1 Effect of DEP and CB on IL-8 release from HL-60 cells and human 
alveolar macrophages (AM). HL-60 cells and AM incubated with particles for 24 
hours followed by IL-8 analysis. DEP and CB concentrations are in μg/mL.   (A) 
HL-60, DEP and CB stimulated IL-8 release in comparison to unexposed cells 
(control); (B) human AM; DEP and CB did not stimulate IL-8 release in 
comparison to unexposed cells (control). HL-60 experiments n=3. 
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Appendix 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2.1 Effect of PM Exposure on Alveolar Macrophage Viability. AM were 
incubated with 100μg/mL PM unless otherwise indicated as 50μg/mL) for 24 
hours at 37°C. AMs were centrifuged and media collected for LDH analysis. AM 
were given fresh media with LPS and incubated an additional 24 hours at 37°C. 
LDH, lactate dehydrogenase; rau, relative absorbance units; LPS, lypopoly-
saccharide; UD, urban dust; DEP, diesel exhaust particle; CB, carbon black; VA, 
volcanic ash; CHF, Chapel Hill fine particle; CHC, Chapel Hill coarse particle; BG 
cell free background media. (A) 24-hour (pre LPS) incubation with PM (B) 24-
hour incubation post LPS; n-3-19 
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Appendix 3 
 
 
Figure A3.1 Phospholipid Detectability from Differing Numbers of Human 
Alveolar Macrophages. Human AM isolated from bronchoalveolar lavage. 
Methanol AM phopholipid extraction sent to KLRC for analysis. Average percent 
phospholipids detected was calculated from total of 349 possible phospholipids 
analyzed at that time.   
  Number of Macrophages 
Phospholipid Classes 2.5E+05 1.0E+06 2.0E+06 5.0E+06 
Phospholipids 33 41 51 63 
LysoPhospholipids 24 31 39 54 
Ether-linked Phospholipids 30 48 68 84 
Sphingolipids 17 35 35 42 
Average Total  
Phospholipids Detected 104 156 194 242 
Average Percent Detectability (%)  30 45 56 69 
 148 
Appendix 4 
 
 149 
 150 
 151 
 152 
 153 
 154 
 
 155 
 
 156 
References 
 
1. Aam, B.B. and Fonum, F ., “ROS Scavenging Effects of Organic Extracts 
of Diesel Exhaust Particles on Human Neutrophil Granulocytes and Rat 
Alveolar Macrophages,” Toxicology, vol. 230, pp. 207-218 (2007). 
 
 
2. Abbey, D. E., Ostro, B. E., Petersen, F ., and Burchette, R. J., “Chronic 
Respiratory Symptoms Associated with Estimated Long-term Ambient 
Concentrations of Fine Particulates less than 2.5 Microns in Aerodynamic 
Diameter (PM2.5) and other Air Pollutants,” Journal of Exposure Analysis 
and Environmental Epidemiology, vol. 5, No. 2, pp. 137-159 (1995). 
 
 
3. Ahn, E. K., Yoon, H. K., Jee, B. K., Ko, H. J., Lee, K. H., Kim, H. J., and 
Lim, Y ., “COX-2 Expression and Inflammatory Effects by Diesel Exhaust 
Particles In Vitro and In Vivo,” Toxicology Letters, vol. 176, pp. 178-187 
(2008). 
 
 
4. Alexis, N. E., Hu, S. C., Zeman, K., Alter, T ., and Bennett, W. D., “Induced 
Sputum Derives from the Central Airways: Confirmation Using a 
Radiolabeled Aerosol Bolus Delivery Technique,” American Journal of 
Respiratory and Critical Care Medicine,  vol. 164, pp. 1964-1970 (2005). 
 
 
5. Alexis, N. E., Lay, J.C., Zeman, K., Bennett, W. E., Peden, D. B., Soukup, 
J. M., Devlin, R. B., and Becker S., “Biological Material on Inhaled Coarse 
Fraction Particulate Matter Activates Airway Phagocytes In Vivo in Healthy 
Volunteers,” Journal of Allergy and Clinical Immunology, vol. 117, pp. 
1396-1403 (2006). 
 
 
6. Amakawa, K., Terashima, T ., Matsuzaki, T ., Matsumaru, A., Sagai, M., 
and Yamaguchi, K., “Suppressive Effects of Diesel Exhaust Particles on 
Cytokine Release from Human and Murine Alveolar Macrophages,” 
Experimental Lung Research, vol. 29, pp. 149-164 (2003). 
 
 
7. Anderson, H. R., “Health Effects of Air Pollution Episodes,” Air Pollution 
and Health, Holgate, S. T ., Samet, J. M., Koren, H. S., and Maynard, R. 
L., ed., Academic Press, London, 1999, pp. 461-475. 
 
 
 157 
8. Antczak, A., Kharitonov, S. A., Montuschi, P ., Gorski, P ., and Barnes, P . 
J., “Inflammatory response to sputum induction measured by exhaled 
markers.Respiration,” vol. 72, No. 6, pp. 594-599 (2005). 
 
 
9. Arimoto, T ., Kadiiska, M. B., Sato, K., Corbett, J., and Mason, R. P ., 
“Synergistic Production of Lung Free Radicals by Diesel Exhaust Particles 
and Endotoxin,” American Journal of Respiratory and Critical Care 
Medicine, vol. 171, No. 4, pp. 379-387 (2005). 
 
 
10. Arnoux, B., Durand, J., Rigaud, M., Vargaftig, B. B., and Benveniste, J., 
“Release of Platelet-Activating Factor (PAF-acether) and Arachidonic Acid 
Metabolites from Alveolar Macrophages,” Agents Actions, vol. 11, No. 6-7, 
pp. 555-556 (Dec. 1981). 
 
 
11. Badger, A. M., “Enhanced Superoxide Production by Rat Alveolar 
Macrophages Stimulated In Vitro with Biological Response Modifiers,” 
Journal of Leukocyte Biology, vol. 40, No. 6, pp. 725-736 (1986). 
 
 
12. Baggiolini, M., Walz, A., and Kunkel, S. L., “Neutrophil-Activating Peptide-
1/interleukin-8 a Novel Cytokine that Activates Neutrophils,” Journal of 
Clinical Investigation,  vol. 84, pp. 1045-1049 (1989). 
 
 
13. Baldwin, A. S., Jr., “Series Introduction: the Transcription Factor NF-κβ 
and Human Disease,” Journal of Clinical Investigation,  vol. 107, pp. 3-6 
(2001). 
 
 
14. Barrreto, M., Villa, M. P ., Corradi, M., Barberi, S., Monaco, G., Martella, 
S., Bohmerova, Z., Sabatino, G., and Ronchetti, R., “Non-invasive 
Assessment of Airway Inflammation in Ship-Engine Workers,” 
International Journal of Immunopathology and Pharmacology, vol. 19, No. 
3, pp. 601-608 (2006). 
 
 
15. Beck-Speier, I., Dayal, N., Karg, E., Maier, K. L., Roth, C., Ziesenis, A., 
and Heyder, J., “Agglomerates of Ultrafine Particles of Elemental Carbon 
and TiO2 Induce Generation of Lipid Mediators in Alveolar Macrophages,” 
Environmental Health Perspectives,  vol. 109, suppl. 4, pp. 613-618 (Aug. 
2001). 
 
 
 158 
16. Becker, S., Dailey, L. A., Soukup, J. M., Grambow, S. C., Devlin, R. B., 
and Huang, Y .C., “Seasonal Variations in Air Pollution Particle-Induced 
Inflammatory Mediator Release and Oxidative Stress,” Environmental 
Health Perspectives, vol. 113, pp. 1032-1038 (2005). 
 
 
17. Becker, S., Devlin, R. B., and Haskill, J. S., “Differential Production of 
Tumor Necrosis Factor, Macrophage Colony Stimulating Factor, and 
Interleukin 1 by Human Alveolar Macrophages,” Journal of Leukocyte 
Biology, Vol. 45, No. 4, pp. 353-361 (1989). 
 
 
18. Becker, S., Mundandhara, S., Devlin, R. B., and Madden, M. C., 
”Regulation of Cytokine Production in Human Alveolar Macrophages and 
Airway Epithelial Cells in Response to Ambient Air Pollution Particles: 
Further Mechanistic Studies,” Toxicology and Applied Pharmacology, vol. 
207, pp. S269-S275 (2005). 
 
 
19. Becker, S., Soukup, J. M., Gilmour, M. I., and Devlin, R. B., “Stimulation of 
Human and Rat Alveolar Macrophages by Urban Air Particulates: Effects 
on Oxidant Radical Generation and Cytokine Production,” Toxicology and 
Applied Pharmacology, vol. 141, pp. 637-648 (1996). 
 
 
20. Becker, S., Soukup, J. M., Sioutas, C., and Cassee, F . R., “Response of 
Human Alveolar Macrophages to Ultrafine, Fine, and Coarse Urban Air 
Pollution Particles,” Experimental Lung Research,  vol. 29, pp. 29-44 
(2003). 
 
 
21. Beharka, A. A., Crowther, J. E., McCormack, F . X., Denning, G. M., Lees, 
J., Tibesar, E., and Schlesinger, L.S., “Pulmonary Surfactant Protein A 
Activates a Phosphatidylinositol 3-Kinase/Calcium Signal Transduction 
Pathway in Human Macrophages: Participation in the Up-Regulation of 
Mannose Receptor Activity,” Journal of Immunology, vol. 175, No. 4, pp. 
2227-2236 (Aug. 2005). 
 
 
22. Bell, M. L. and Davis, D. L., “Reassessment of the Lethal London Fog of 
1952: Novel Indicators of Acute and Chronic Consequences of Acute 
Exposure to Air Pollution,” Environmental Health Perspectives,  vol. 109, 
suppl. 3, pp. 389-94 (June 2001). 
 
 
 159 
23. Bell, M. L., Peng, R. D., and Dominici, F., “The Exposure-Response Curve 
for Ozone and Risk of Mortality and the Adequacy of Current Ozone 
Regulations,” Environmental Health Perspectives,  vol. 114, No. 4, pp. 532-
536 (Apr. 2006). 
 
 
24. Bernard, G. R., Reines, H. D., Halushka, P . V., Higgins, S. B., Metz, C. A., 
Swindell, B. B., Wright, P . E., Watts, F. L., and Vrbanac, J. J., 
“Prostacyclin and Thromboxane A2 Formation is Increased in Human 
Sepsis Syndrome. Effects of cyclooxygenase inhibition,” American Review 
Of Respiratory Disease,  vol. 144, No. 5, pp. 1095-1101 (Nov. 1991). 
 
 
25. Berridge, M. J. and Irvine, R. F ., “Inositol Triphosphate, a Novel Second 
Messenger in Cellular Signal Transduction,” Nature,  vol. 312, pp. 315-321 
(1984). 
 
 
26. Binkova, B., Cerna, M., Pastorkova, A., Jelenek, R., Benes, I., Novak, J., 
and Sram, R. J., ”Biological Activities of Organic Compounds Adsorbed 
onto Ambient Air Particles: Comparison Between the Cities of Teplice and 
Prague During the Summer and Winter Seasons 2000-2001,” Mutation 
Research, vol. 525, pp. 43-59 (2003). 
 
 
27. Bligh, E. G. and Dyer, W. J., “A Rapid Method of Total Lipid Extraction and 
Purification,” Canadian Journal of Biochemistry and Physiology,  vol. 37, 
pp. 911-917 (1959). 
 
 
28. Bloemen, K., Lissens, G., Desager, K., and Schoeters, G., “Determinants 
of Variability of Protein Content, Volume and pH of Exhaled Breath 
Condensate,” Respiratory Medicine,  vol. 101, pp. 1331-1337 (2006). 
 
 
29. Boldo, E., Medina, S., LeTertre, A., Hurley, F ., Mucke, H. G., Ballester, F ., 
Aguilera, I., and Eilstein, D., “APHEIS Health Impact Assessment of Long-
term Exposure to PM(2.5) in 23 European Cities,” European Journal of 
Epidemiology, vol. 21, pp. 449-458 (2006). 
 
 
30. Bonnans, C. and Levy, B. D., “Lipid Mediators as Agonists for the 
Resolution of Acute Lung Inflammation and Injury,” American Journal of 
Respiratory Cell and Molecular Biology,  vol. 36, No. 2, pp. 201-205 (Feb. 
2007). 
 160 
31. Bringham, K. L. and Meyrick B., “Endotoxin and Lung Injury,” American 
Review of Respiratory Disease, vol. 133, pp. 913-927 (1986). 
 
 
32. Brown, D. M., Donaldson, K., Brom, P . J., Schins, R. P ., Dehnhardt, M., 
Gilmour, P ., Jimenez, L. A., and Stone, V., “Calcium and ROS-Mediated 
Activation of Transcription Factors and TNF-alpha Cytokine Gene 
Expression in Macrophages Exposed to Ultrafine Particles,” American 
Journal of Physiology - Lung Cellular and Molecular Physiology,  vol. 286, 
No. 2, pp. L344-L353 (2004). 
 
 
33. Brown, D. M., Hutchinson, L., Donaldson, K., and Stone, V., “The Effects 
of PM10 Particles and Oxidative Stress on Macrophages and Lung 
Epithelial Cells: Modulating Effects of Calcium-Signaling Antagonists,” 
American Journal of Physiology - Lung Cellular and Molecular Physiology,  
vol. 292, pp. 1444-1451, (2007). 
 
 
34. Brown, D. M., Stone, V., Findlay, P ., MacNee, W., and Donaldson, K., 
“Increased Inflammation and Intracellular Calcium Caused by Ultrafine 
Carbon Black is Independent of Transition Metals or Other Soluble 
Components,” Journal of Occupational and Environmental Medicine,  vol. 
57, No. 10, pp. 685-691 (Oct. 2000). 
 
 
35. Brown, G. P ., Monick, M. M., and Hunninghake, G. W., “Human Alveolar 
Macrophage Arachidonic Acid Metabolism,” American Journal of 
Physiology, vol. 254, pp. C809-C815 (1988). 
 
 
36. Brown, M. A. and Hural J., “Functions of IL-4 and Control of its 
Expression,” Critical Reviews in Immunology, vol. 17, pp. 1-32 (1997). 
 
 
37. Brunekreef, B., Dockery, D. W., and Krzyzanowski, M., “Epidemiologic 
studies on short-term effects of low levels of major ambient air pollution 
components,” Environmental Health Perspectives,  vol. 103, suppl. 2, pp. 
3-13 (Mar. 1995). 
 
 
38. Chauhan, A. J. and Johnston, S. L., “Air Pollution and Infection in 
Respiratory Illness,” British Medical Bulletin,  vol. 68, pp. 95-112 (2003). 
 
 
 161 
39. Carpagnano, G. E., Foschino-Barbaro M. P ., Mule, G., Resta, O., 
Tommasi, S., Mangia, A., Carpagnano, F., Stea, G., Susca, A., Di Gioia, 
G., De Lena, M., and Paradiso, A., “3p Microsatellite Alterations in 
Exhaled Breath Condensate from Patients with Non-Small Cell Lung 
Cancer,” American Journal of Respiratory and Critical Care Medicine,  vol. 
172, pp. 738-744 (2005). 
 
 
40. Carpagnano, G.E., Spanevello, A., Curci, C., Salerno, F ., Palladino, G. P ., 
Resta, O., Di Gioia, G., Carpagnano, F., and Foschino-Barbaro, M. P ., “IL-
2, TNF-alpha, and Liptin: Local Versus Systemic Concentrations in 
NSCLC Patients,” Oncology Research, vol. 16, pp. 375-381 (2007). 
 
 
41. Carter, J. D., Ghio, A. J., Samet, J. M., and Devlin, R. B., “Cytokine 
Production by Human Airway Epithelial Cells after Exposure to an Air 
Pollution Particle is Metal-Dependent,” Toxicology and Applied 
Pharmacology, vol. 146, No. 2, pp. 180-188 (1997). 
 
 
42. Carter, A. B., Monick, M. M., and Hunninghake, G. W., 
“Lipopolysaccharide-Induced NF-B Activation and Cytokine Release in 
Human Alveolar Macrophages Is PKC-Independent and TK- and PC-PLC-
dependent,” American Journal of Respiratory Cellular and Molecular 
Biology, vol. 18, pp. 384-391 (1998). 
 
 
43. Castranova, V., Ma, J. R., Yang, H. M., Antonin, J. M., Butterworth, L., 
Barger, M. W., Roberts, J., and Ma, J. K., “Effect of Exposure to Diesel 
Exhaust Particles on the Susceptibility of the Lung to Infection,” 
Environmental Health Perspectives,  vol. 109, suppl. 4, pp. 609-612 
(2001). 
 
 
44. Chabot, F., Mitchell, J. A., Gutteridge, J. M. C., and Evans, T . W., 
“Reactive Oxygen Species in Acute Lung Injury,” European Respiratory 
Journal, vol. 11,  pp. 745-757 (1998). 
 
 
45. Coffman, R. L., Ohara, J., Bond, M. W., Carty, J., Zlotnik, A., and Paul W. 
E., “B Cell Stimulatory Factor-1 Enhances the IgE Response of 
Lipopolysaccharide-Activated B Cells,” The Journal of Immunology,  vol. 
136, No. 12, pp. 4538-4541 (1986). 
 
 
 162 
46. Cohen, A. J. and Higgins, M. W. P ., “Health effects of diesel exhaust: 
Epidemiology,” Diesel Exhaust: A Critical Analysis of Emissions, 
Exposure, and Health Effects (A Special Report of the Institute's Diesel 
Working Group),  Health Effects Institute, Cambridge, Massachusetts, 
1995, pp. 251-292. 
 
 
47. de Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., 
Bennet, B., Culpepper, J., Dang, W., Zurwaski, G., and de Vries, J. E., 
“Effects of IL-13 on Phenotype, Ctyokine Production, and Cytotoxic 
Function of Human Monocytes,” Journal of Immunology, vol. 151, pp. 
6370-6381 (1993). 
 
 
48. Delfino, R. J., Murphy-Moulton, A. M., Burnett, R. T ., Brook, J. R., and 
Becklake, M. R., “Effects of Air Pollution on Emergency Room Visits for 
Respiratory Illnesses in Montreal, Quebec,” American Journal of 
Respiratory and Critical Care Medicine,  vol. 154, pp. 300-307 (1997). 
 
 
49. Devlin, R. B. and Koren, H. S., “The Use of Quantitative Two-Dimensional 
Gel Electrophoresis to Analyze Changes in Alveolar Macrophage Proteins 
in Humans Exposed to Ozone,” American Journal of Respiratory Cell and 
Molecular Biology, vol. 2, No. 3, pp. 281-288 (Mar. 1990). 
 
 
50. Diaz-Sanchez, D., Dotson, A. R., Takenaka, H., and Saxon, A., “Diesel 
Exhaust Particles Induce Local IgE Production In Vivo and Alter the 
Pattern of IgE Messenger RNA Isoforms,” Journal of Clinical 
Investigations, vol. 94, pp. 1417-1425 (1994). 
 
 
51. Diaz-Sanchez, D., Tsien, A., Casillas, A., Dotson, A. R., and Saxon, A., 
“Enhanced Nasal Cytokine Production in Human Beings After In Vivo 
Challenge with Diesel Exhaust Particles,” Journal of Allergy and Clinical 
Immunology, vol. 98, pp. 114-123 (1996). 
 
 
52. Diaz-Sanchez, D., Tsien,  A., Flemming, J., and Saxon, A., “Combined 
Diesel Exhaust Particulate and Ragweed Allergen Challenge Markedly 
Enhances Human In Vivo Nasal Ragweed-Specific IgE and Skews 
Cytokine Production to a T-helper Cell 2-type Pattern,” Journal of 
Immunology, vol. 158, pp. 2406-2413 (1997). 
 
 
 163 
53. Dick, C. A., Sing, P ., Daniels, M., Evansky, P ., Becker, S., and Gilmour, 
M. I., “Murine Pulmonary Inflammatory Responses Following Instillation of 
Size-Fractionated Ambient Particulate Matter,” Journal of  Toxicology and 
Environmental Health, Part A., vol. 66, pp. 2193-2207 (2003). 
 
 
54. Dobrovolskaia, M. A. and Vogel, S. N., “Toll receptors, CD14, and 
Macrophage Activation and Deactivation by LPS,” Microbes and Infection, 
vol. 4, pp. 903-914 (2002). 
 
 
55. Dockery, D. W., Speizer, F . E., Stram, D. O., Ware, J. H., Spengler, J. D., 
and Ferris, B. G., Jr., “Effects of Inhalable Particles on Respiratory Health 
of Children,” American Review of Respiratory Disease,  vol. 139. pp. 587-
594 (1989). 
 
 
56. Dolmetsch, R. E., Xu, K., and Lewis, R. S., “Calcium Oscillations Increase 
the Efficiency and Specificity of Gene Expression,” Nature,  vol. 392, pp. 
933-936 (1998). 
 
 
57. Dominici, F ., Peng, R. D., Bell, M. L., Pham, L., McDermott, A., Zeger, S. 
L., and Samet, J. M., “Fine Particulate Air Pollution and Hospital 
Admission for Cardiovascular and Respiratory Diseases,” Journal of the 
American Medical Association, vol. 295, pp. 1127-1134 (2006). 
 
 
58. Effros, R. M., Hoagland, K. W., Bosbous, M., Castillo, D., Foss, B., 
Dunning, M., Gare, M., Lin, W., and Sun, F ., “Dilution of Respiratory 
Solutes in Breath Condensates,” American Journal of Respiratory and 
Critical Care Medicine,  vol. 165, pp. 663-669 (2002). 
 
 
59. Eskelson, C. D., Chvapil, M., Strom, K. A., and Vostal, J. J., “Pulmonary 
Phospholipidosis in Rats Respiring Air Containing Diesel Particulates,” 
Environmental Research, vol. 44, pp. 260-271 (1984). 
 
 
60. Eyster, K. M., “The Membrane and Lipids as Integral Participants in Signal 
Transduction: Lipid Signal Transduction for the Non-Lipid Biochemist,” 
Advances in Physiology Education,  Vol. 31, pp. 5-16 (2007). 
 
 
61. Fadok, V. A., Voelker, D. R., Campbell, P . A., Cohen, J. J., Bratton, D. L., 
and Henson, P . M., “Exposure of Phosphatidylserine on the Surface of 
 164 
Apoptotic Lymphocytes Triggers Specific Recognition and Removal by 
Macrophages,” Journal of Immunology, vol. 148, No. 7, pp. 2207-16 
(1992). 
 
 
62. Fernandis, A. Z. and Wenk M. R., “Membrane Lipids as Signaling 
Molecules,” Current Opinion in Lipidology,  vol. 18, pp. 121-128 (2007). 
 
 
63. Finkel, T . H., Pabst, M. J., Suzuki, H., Guthrie, L. A., Forehand, J. R., 
Phillips, W. A., Johnston, R. B., Jr., Finkel, T . H., Pabst, M. J., Suzuki, H., 
Guthrie, L. A., Forehand, J. R., Phillips, W. A., and Johnston, R. B., Jr., 
“Priming of Neutrophils and Macrophages for Enhanced Release of 
Superoxide Anion by the Calcium Ionophore Ionomycin. Implications for 
Regulation of the Respiratory Burst,” Journal of Biological Chemistry,  vol. 
262, No. 26, pp. 12589-12596 (Sep. 1987). 
 
 
64. Forman, H. J. and Nelson, J., “Effect of Extracellular Calcium on 
Superoxide Release by Rat Alveolar Macrophages,” Journal of Applied 
Physiology, vol. 54, No. 5, pp. 1249-1253 (May 1983). 
 
 
65. Fukunaga, K., Kohli, P ., Bonnans, C., Fredenburgh, L. E., and Levy, B. D., 
“Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung 
Injury,“ The Journal of Immunology, vol. 174, No. 8, pp. 5033-5039 (Apr. 
2005). 
 
 
66. Fusco, D., Forastiere, F ., Michelozzi, P ., Spadea, T ., Ostro, B., Arca, M., 
and Perucci, C. A., “Air Pollution and Hospital Admissions for Respiratory 
Conditions in Rome, Italy,” European Respiratory Journal,  vol. 17, pp. 
1143-1150 (2001). 
 
 
67. Gessner, C., Kuhn, H., Seyfarth, H. J., Pankau, H., Winkler, J., Schauer, 
J., and Wirtz, H., “Factors influencing breath condensate,” Pneumologie,  
vol. 55, pp. 414-419 (2001). 
 
 
68. Gessner, C., Kuhn, H., Toepfer, K., Hammerschmidt, S., Schauer, J., and 
Wirtz, H., “Detection of p53 Gene Mutations in Exhaled Breath 
Condensate of Non-Small Cell Lung Cancer Patients,” Lung Cancer,  vol. 
43, pp. 215-222 (2004). 
 165 
69. Ghio, A. J., Bassett, M., Chall, A. N., Levin, D. G., and Bromber, P . A., 
“Bronchoscopy in Health Volunteers,” Journal of Bronchoscopy, vol. 5, pp. 
185-194 (1998). 
 
 
70. Ghio, A. J. and Devlin, R. B., “Inflammatory Lung Injury after Bronchial 
Instillation of Air Pollution Particles,” American Journal of Respiratory and 
Critical Care Medicine,  vol. 164, pp. 704-708 (2001). 
 
 
71. Ghio, A. J., Hall, A., Bassett, M. A., Cascio, W. E., and Devlin, R. B., 
“Exposure to Concentrated Ambient Air Particles Alters Hematologic 
Indices in Humans,” Inhalation Toxicology, vol. 15, pp. 1465-78 (2003). 
 
 
72. Ghio, A. J., Stonehuerner, J., Pritchard, R. J., Piantadosi, C. A., Quigley, 
D. R., Dreher, K. L., and Costa, D. L. “Humic-like Substances in Air 
Pollution Particulates Correlate with Concentrations of Transition Metals 
and Oxidant Generation,” Inhalation Toxicology, vol. 8, pp. 479-494 
(1996). 
 
 
73. Goldoni, M., Catalani, S., De Palma, G., Manini, P ., Acampa, O., Corradi, 
M., Bergonzi, R., Apostoli, P ., and Mutti, A., “Exhaled Breath Condensate 
as a Suitable Matrix to Assess Lung Dose and Effects in Workers 
Exposed to Cobalt and Tungsten,” Environmental Health Perspectives,  
vol. 112, No. 13, pp. 1293-1298 (Sep. 2004). 
 
 
74. Gowdy, K., Krantz, Q. T ., Daniels, M., Linak, W. P ., Jaspers, I., and 
Gilmour, M. I., “Modulation of Pulmonary Inflammatory Responses and 
Antimicrobial Defenses in Mice Exposed to Diesel Exhaust,” Toxicology 
and Applied Pharmacology, vol. 229, No. 3, pp. 310-319. (June 2008). 
 
 
75. Han, X., Yang, J., Cheng, H., Yang, K., Abendschein, D. R., and Gross, R. 
W., “Shotgun Lipidomics Identifies Cardiolipin Depletion in Diabetic 
Myocardium Linking Altered Substrate Utilization with Mitochondrial 
Dysfunction,” Biochemistry, vol. 44, No. 50, pp. 16684-16694 (Dec. 2005). 
 
 
76. Harrod, K. S., Jaramillo, R. J., Berger, J. A., Gigliotti, A. P ., Seilkop, S. K., 
and Reed, M. D., “Inhaled Diesel Engine Emissions Reduce Bacterial 
Clearance and Exacerbate Lung Disease to Pseudomonas Aeruginosa 
Infection In Vivo,” Journal of Toxicology Science, vol. 83, No. 1, pp. 155-
165 (Jan. 2005). 
 166 
77. Henderson, R. F ., Leung, H. W., Harmsen, A. G., and McClellan, R. O., 
“Species Differences in Release of Arachidonate Metabolites in Response 
to Inhaled Diluted Diesel Exhaust,”  Toxicology Letters, vol. 42, No. 3, pp. 
325-332 (Sep. 1988). 
 
 
78. Hetland, R. B., Casee, F . R., Lag, M., Refnes, M., Dybing, E., and 
Shwarze, P . R., “Cytokine Release from Alveolar Macrophages Exposure 
to Ambient Particulate Matter: Heterogeneity in Relation to Size, City, and 
Season,” Particle and Fibre Toxicology, vol. 2, pp. 4-19 (2005). 
 
 
79. Hiura, T . S., Kasuzubowski, M. P ., Li, N., and Nel, A. E., “Chemicals in 
Diesel Exhaust Particles Generate Reactive Oxygen Radicals and Induce 
Apoptosis in Macrophages,” Journal of Immunology, vol. 163, pp. 5582-
5591 (1999). 
 
 
80. Holgate, S. T ., Sandstrom, T ., Frew, A. J., Stenfors, N., Nordenhall, C., 
Slavi, S., Blomberg, A., Helliday, R., and Sodenberg, M., “Health Effects of 
Acute Exposure to Air Pollution Part I: Health and Asthmatic Subject 
Exposure to Diesel Exhaust,” Health Effects Institute,  vol. 112, pp. 1-30 
(2003). 
 
 
81. Holian, A., Hamilton, Jr., R. F ., Morandi, M. T ., Brown, S. D., and Li, L., 
“Urban Particle-Induced Apoptosis and Phenotype Shifts in Human 
Alveolar Macrophages,” Environmental Health Perspectives,  vol. 106, pp. 
127-132 (1998). 
 
 
82. Holz, Jörres, R. A., and Magnussen, H., “Monitoring Central and 
Peripheral Airway Inflammation in Asthma,” Respiratory Medicine, vol. 94, 
suppl. D, pp. S7-S12 (Sep. 2000). 
 
 
83. Horváth, I., Hunt, J., Barnes, P . J., Alving, K., Antczak, A., Baraldi, E., 
Becher, G., van Beurden, W. J., Corradi, M., Dekhuijzen, R., Dweik, R. A., 
Dwyer, T ., Effros, R., Erzurum, S., Gaston, B., Gessner, C., Greening, A., 
Ho, L. P ., Hohlfeld, J., Jöbsis, Q., Laskowski, D., Loukides, S., Marlin, D., 
Montuschi, P ., Olin, A. C., Redington, A. E., Reinhold, P ., van Rensen, E. 
L., Rubinstein, I., Silkoff, P ., Toren, K., Vass, G., Vogelberg, C., Wirtz, H.; 
ATS/ERS Task Force on Exhaled Breath Condensate, “Exhaled Breath 
Condensate: Methodological Recommendations and Unresolved 
Questions,” European Respiratory Journal,  vol. 26, no. 3, pp. 523-548 
(Sep. 2005). 
 167 
84. Hsieh, C. S., Macatonia, S. E., Tripp, C. S., Wolf, S. F ., O'Garra, A., and 
Murphy, K. M., “Development of TH1 CD4+ T Cells through IL-12 
Produced by Listeria-Induced Macrophages,” Science,  vol. 260, No. 5107, 
pp. 547-549 (1993). 
 
 
85. Huang, Y . C., Bassett, M. A., Levin, D., Montilla, T ., Ghio, A. J. “Acute 
Phase Reaction in Healthy Volunteers after Bronchoscopy with Lavage,” 
Chest, vol. 129, No. 6, pp. 1565-1569 (June 2006). 
 
 
86. Huber, L. C., Jüngel, A., Distler, J. H., Moritz, F ., Gay, R. E., Michel, B. A., 
Pisetsky, D. S., Gay, S., and Distler, O., “The Role of Membrane Lipids in 
the Induction of Macrophage Apoptosis by Microparticles,” Apoptosis,  vol. 
12, No. 2, pp. 363-374 (Feb. 2007). 
 
 
87. Ilbaca, M., Olaeta, I., Campos, E., Villaire, J., Tellez-Rojo, M. M., and 
Romieu, I., ”Association between Levels of Fine Particulate and 
Emergency Visits for Pneumonia and other Respiratory Illnesses Among 
Children in Santiago, Chile,” Journal of Air and Waste Management 
Association, vol. 49, pp. 154-163 (1999). 
 
 
88. Imrich, A., Ning, Y . Y ., Koziel, H., Coull, B., and Kobzik, L., 
“Lipopolysaccharide Priming Amplifies Lung Macrophage Tumor Necrosis 
Factor Production in Response to Air Particles,” Toxicology and Applied 
Pharmacology, vol. 159, pp. 117-124 (1999). 
 
 
89. Ishii, H., Fujii, T ., Hogg, J. C., Hayashi, S., Mukae, H., Vincent, R., and 
van Eeden, S. I., “Contribution of IL-1 Beta and TNF-alpha to the Initiation 
of the Peripheral Lung Response to Atmospheric Particles (PM10),” 
American Journal of Physiology - Lung Cellular and Molecular Physiology,  
vol. 287, pp. L176-L183 (2004). 
 
 
90. Jackson, A. S., Sandrini, A., Campbell, C., Chow, S., Thomas, P . S., and 
Yates, D. H., “Comparison of Biomarkers in Exhaled Breath Condensate 
and Bronchoalveolar Lavage,” American Journal of Respiratory and 
Critical Care Medicine,  vol. 175, pp. 222-227 (2007). 
 
 
91. Johnson, P . R. and Graham, J. J., “Analysis of Primary Fine Particle 
National Ambient Air Quality Standard Metrics,” The Journal of the Air & 
Waste Management Association, vol. 56, No. 2, pp. 206-18 (Feb. 2006). 
 168 
92. Juvin, P ., Fournier, T ., Grandsaigne, M., Desmonts, J. M., and Aubier, M., 
“Diesel Particles Increase Phosphatidylcholine Release through a NO 
Pathway in Alveolar Type II Cells,” American Journal of Physiology - Lung 
Cellular and Molecular Physiology,  vol. 282, No. 5, pp. L1075-L1081 (May 
2002). 
 
 
93. Kaul, N. and Forman, H. J., “Activation of NF KappaB byt the respiratory 
burst of macrophages,” Free Radical Biology and Medicine,  vol. 21, pp. 
410-405 (1996). 
 
 
94. Kleinman, M. T .,  Sioutas, C., Chang, M. C., Boere, A. G., and Cassee, F . 
R., “Ambient Fine and Coarse Particle Suppression of Alveolar 
Macrophage Functions,” Toxicology Letters, vol. 137, pp. 151-158 (2003). 
 
 
95. Laden, F ., Neas, L. M., Dockery, D. W., Schwartz, J., “Association of Fine 
Particulate Matter from Different Sources with Daily Mortality in Six U.S. 
Cities, “ Environmental Health Perspectives,  vol. 108, No. 10, pp. 941-947, 
(Oct. 2000). 
 
 
96. Levine, S. J., Whitsett, J. A., Gwozdz, J. A., Richardson, T . R., Fisher, J. 
H., Burhans, M. S., and Korfhagen, T. R., “Distinct Effects of Surfactant 
Protein A or D Deficiency during Bacterial Infection on the Lung,” Journal 
of Immunology, vol. 165, pp. 3944-3960 (2000). 
 
 
97. Levy, B. D., “Lipoxins and Lipoxin Analogs in Asthma,” Prostaglandins, 
Leukotrienes and Essential Fatty Acids, vol. 73, No. 3-4, pp. 231-237 
(Sep. 2005). 
 
 
98. Li, N., Venkatesan, M. I., Miguel, A., Kaplan, R., Gujuluva, C., Alam, J., 
and Nel, A., “Induction of heme oxygenase-1 expression in macrophages 
by diesel exhaust particle chemicals and quinones via the antioxidant-
responsive element,” Journal of Immunology, vol. 165, No. 6, pp. 3393-
3401 (Sep. 2000). 
 
 
99. Li, N., Wang, M., Oberley, T. D., Sempf, J. M., and Nel, A. E., 
“Comparison of the Pro-Oxidative and Proinflammatory Effects of Organic 
Diesel Exhaust Particle Chemicals in Bronchial Epithelial Cells and 
Macrophages,” Journal of Immunology, vol. 169, pp. 4531-4541 (2002). 
 
 169 
 
100. Lien, E., Means, T . K., Heine, H., Yoshimura, A., Kosumoto, S., Fukase, 
K., Fenton, M. J., Oikawa, M., Querishi, N., Monks, B., Finberg, R. W., 
Ingalls, R. R., and Golenbock, D. T ., “Toll-like Receptor 4 Imparts Ligand-
Specific Recognition of Bacterial Lipopolysaccharide,” Journal of Clinical 
Investigation, vol. 105, pp. 497-504 (2000). 
 
 
101. Lies, K. H., Hartung, A., Postulka, A., Gring, H., and Schulze, J., 
“Composition of diesel exhaust with particular reference to particle bound 
organics including formation of artifacts,” Developments in Toxicology & 
Environmental Science, vol. 13, pp. 65-82 (1986). 
 
 
102. Lohmann-Matthes, M. L., Steinmuller, C., and Franke-Ullmann, G., 
“Pulmonary macrophages,” European Respiratory Journal,  vol. 7, pp. 
1678-1689 (1994). 
 
 
103. Madden, M. C., Dailey, L. A., Stonehuerner, J. G., and Harris, D. B., 
“Responses of Cultured Human Airway Epithelial Cells Treated with Diesel 
Exhaust Extracts Will Vary with the Engine Load,” Journal of Toxicology 
and Environmental Health, Part A, vol. 66, pp. 2281-2297 (2003). 
 
 
104. Madden, M. C., Thomas, M. J., and Ghio, A. J., “Acetaldehyde production 
in rodent lung after exposure to metal-rich particles,” Free Radical Biology 
and Medicine, vol. 26, pp. 1569-1577 (1999). 
 
 
105. Maier, K. L., “How the lung deals with oxidants,” European Respiratory 
Journal, vol. 6, pp. 334-336 (1993). 
 
 
106. Maris, N. A., Dessing, M. C., de Vos, A. F., Bresser, P ., van der Zee, J. S., 
Jansen, H. M., Spek, C. A., and van der Poll, T ., ”Toll-like Receptor mRNA 
Level in AM After Inhalation of Endotoxin,” European Respiratory Journal,  
vol. 28, pp. 622-626 (2006). 
 
 
107. McCafferty, J. B., Bradshaw, T . A., Tate, S., Greening, A. P ., and Innes, J. 
A., “Effects of Breathing Pattern and Inspired Air Conditions on Breath 
Condensate Volume, pH, Nitrite, and Protein Concentrations,”  Thorax, vol. 
59, pp. 694-698 (2004). 
 170 
108. McCormack, F . X. and Whitsett, J. A., “The Pulmonary Collections, SP-A 
and SP-D, Orchestrate Innate Immunity in the Lung,” Journal of Clinical 
Investigation, vol. 109, pp. 707-712 (2002).  
 
 
109. Mijatovic, T ., Kruys, V., Caput, D., Defrance, P ., and Huez, G., ”Interleuk-4 
and -13 Inhibit Tumor Necrosis Factor α mRNA Translational Activation in 
Lipopolysaccharide-Induced Mouse Macrophages,” The Journal of Biology 
and Chemistry, vol. 272, pp.14394-14398 (1997). 
 
 
110. Moloney, E. D., Mumby, S. E., Gajdosci, R., Cranshaw, J. H., Kharitonov, 
S. A., Quinlan, G. J., and Giffiths, M. J., “Exhaled breath Condensate 
Detects Markers of Pulmonary Inflammation after Cardiothoracic Surgery,” 
American Journal of Critical Care Medicine,  vol. 169, pp. 64-69 (2004). 
 
 
111. Monick, M., Glazier, J., Hunninghake, G. W., “Human Alveolar 
Macrophages Suppress Interleukin-1 (IL-1) Activity Via the Secretion of 
Prostaglandin E2,” American Review of Respiratory Disease,  vol. 135, pp. 
72-77 (1987).   
 
 
112. Monick, M. M., Mallampalli, R. K., Carter, A. B., Flaherty, D. M., McCoy, 
D., Robeff, P . K., Peterson, M. W., Hunninghake, G. W., “Ceramide 
Regulates Lipopolysaccharide-Induced Phosphatidylinositol 3-Kinase and 
Akt Activity in Human Alveolar Macrophages,” Journal of Immunology, vol. 
167, No. 10, pp. 5977-5985 (Nov. 2001) 
 
 
113. Monn, C. and Becker, B., “Cytotoxicity and Induction of Proinflammatory 
Cytokines from Human Monocytes Exposed to Fine (PM2.5) and Coarse 
Particles (PM10-2.5) in Outdoor and Indoor Air,” Toxicology and Applied 
Pharmacology, vol. 155, pp. 245-252 (1999). 
 
 
114. Montuschi, P . and Barnes, P . J., “Analysis of Exhaled Breath Condensate 
for Monitoring Airway Inflammation,” Trends in Pharmacological Science, 
vol. 23, pp.232-7 (2002). 
 
 
115. Montuschi, P ., Corradi, M., Ciabattoni, G., Nightingale, J., Kharitonov, S. 
A., and Barnes, P . J., “Increased 8-Isoprostane, a Marker of Oxidative 
Stress, in Exhaled Condensate of Asthma Patients,” American Journal of 
Respiratory and Critical Care Medicine,  vol. 160, No. 1, pp. 216-220 (July 
1999). 
 171 
116. Moolgavkar, S. H., “Air Pollution and Daily Mortality in Two US Counties: 
Season-Specific Analysis and Exposure-Response Relationships,” 
Inhalation Toxicology, vol. 15, pp. 877-907 (2003). 
 
 
117. Mossmann, T . R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and 
Coffman, R. L., “Two Types of Murine Helper T-cell Clone. I. Definition 
According to Profiles of Lymphokine Activities and Secreted Proteins,” 
Journal of Immunology, vol. 136, pp. 2348-2357 (1986). 
 
 
118. Mundandhara, S. D., Becker, S., and Madden, M. C., ”Effects of Diesel 
Exhaust Particles on Human Alveolar Macrophage Ability to Secrete 
Inflammatory Mediators in Resposne to Lipopolysaccharide,” Toxicology in 
Vitro, vol. 20, pp. 614-624 (2005). 
 
 
119. Mutlu, G. M., Garey, K. W., Robbins, P . A., Danziga, L. H., and 
Rubenstein, I., “Collection and Analysis of Exhaled Breath Condensate in 
Humans,” American Journal of Respiratory and Critical Care Medicine,  
vol. 164, pp. 731-737 (2001). 
 
 
120. Mutti, A., Corradi, M., Goldoni, M., Vettori, M. V., Bernard, A., and 
Apostoli, P ., “Exhaled Metallic Elements and Serum Pneumoproteins in 
Asymptomatic Smokers and Patients with COPD or Asthma,” Chest, vol. 
129, pp. 1288-1297 (2006). 
 
 
121. Nakashima, J. M., Hyde, D. M., and Giri, S. N., “Epithelial Injury, 
Inflammation, and repair in the Hamster Lung following Intratracheal 
Instillation of Enzyme-Generated Oxidants,” Experimental Lung Research,  
vol. 17, pp. 569-587 (1991). 
 
 
122. National Institute of Standards and Technology, “Certificate of Analysis, 
Standard Reference Material 2975, Diesel Particulate Matter (Industrial 
Forklift),” https://srmors.nist.gov/certificates/2975.pdf , Gaithersburg, MD, 
1-8 (2008). 
 
 
123. National Institute of Standards and Technology, “Certificate of Analysis, 
Standard Reference Material (SRM) 1649a, Urban Dust,” 
https://srmors.nist.gov/certificates/1649A.pdf , Gaithersburg, MD, 1-22 
(2001). 
 172 
124. National Research Council, “Research Priorities for Airborne Particulate 
Matter. I. Immediate Priorities and a Long Range Research Portfolio,” 
National Academy Press, Washington, DC, pp. 1-195 (1998). 
 
 
125. National Research Council (U.S.). Development, Security, and 
Cooperation, National Academy of Engineering, Zhongguo Gong Cheng 
Yuan, National Academies Press, Zhongguo ke xue yuan, Zhongguo gong 
cheng yuan, Urbanization, Energy, and Air Pollution in China: The 
Challenges Ahead : Proceedings of a Symposium, National Academies 
Press, Washington, D.C., 2004. 
 
 
126. Nel, A. E., Diaz-Sanchez, D., and Li, N., “The Role of Particulate 
Pollutants in Pulmonary Inflammation and Asthma: Evidence for the 
Involvement of Organic Chemicals and Oxidative Stress,” Current Opinion 
in Pulmonary Medicine, vol. 7, pp. 20-26 (2001). 
 
 
127. Nightingale, J. A., Maggs, R., Cullinan, P ., Donnelly, L. E., Rogers, D. F ., 
Kinnersley, R., Chung, K. F .,  Barnes, P . J., Ashmore, M., and Newman-
Taylor, A., “Airway Inflammation after Controlled Exposure to Diesel 
Exhaust Particulates,” American Journal of Respiratory and Critical Care 
Medicine, vol. 162, pp. 161-166 (2000). 
 
 
128. Nordenhall, C., Pourazar, J., Blomberg, A., Levin, J. O., Sandstrom, T ., 
and Adelroth, Z., “Airway Inflammation following Exposure to Diesel 
Exhaust: a Study of Time Kintetics using Induced Sputum,” European 
Respiratory Journal,  vol. 15, pp. 1046-1051 (2000). 
 
 
129. Norris, G., YoungPong, S. N., Koenig, J. Q., Larson, T . V., Sheppard, L., 
and Stout, J. W., “An Association Between Fine Particles and Asthma 
Emergency Department Visits for Children in Seattle,” Environmental 
Health Perspectives, vol. 107, pp. 489-49 (1999). 
 
 
130. Ntziachiristos, L., Froines, J. R., Cho, A. K., and Sioutas, C., “Relationship 
between Redox Activity and Chemical Speciation of Size-Fractionated 
Particulate Matter,” Particle and Fibre Toxicology, vol. 4, pp. 5 (2007). 
 
 
131. Peel, J. L., Tolbert, P . E., Klein, M., Metzger, K. B., Flanders, W. D., Todd, 
K., Mulholland, J. A., Ryan, P . B., and Frumkin, H., “Ambient Air Pollution 
 173 
and Respiratory Emergency Department Visits,” Epidemiology, vol. 16, 
No. 2, pp. 164-74 (Mar. 2005). 
 
 
132. Pick, E. and Keisari, Y ., “Superoxide Anion and Hydrogen Peroxide 
Production by Chemically Elicited Peritoneal Macrophages--Induction By 
Multiple Nonphagocytic Stimuli,” Cellular Immunology,  vol. 59, No. 2, pp. 
301-318 (Apr. 1981). 
 
 
133. Pope, C. A., 3rd, “Respiratory Disease Associated with Community Air 
Pollution and a Steel Mill Utah Valley,” American Journal of Public Health,  
vol. 79, pp. 623-628 (1989). 
 
 
134. Pope, C. A., 3rd, Dockery, D. W., Spengler, J. D., and Raizenne, M. E., 
“Respiratory Health and PM10 Pollution. A Daily Time Series Analysis,” 
American Review Of Respiratory Disease, vol. 144, No. 3, pp. 668-674 
(Sep. 1991). 
 
 
135. Pope, C. A., 3rd, Thun, M. J., Namboodiri, M. M., Dockery, D. W., Evans, 
J. S., Speizer, F. E., and Heath, C. W., Jr., “Particulate Air Pollution as a 
Predictor of Mortality in a Prospective Study of U.S. Adults,” American 
Journal of Respiratory Critical Care Medicine,  vol. 151, No.3, pp. 669-674 
(1995). 
 
 
136. Pourazzar, J., Frew, A.J., Blomberg A.., Helleday R., Kelly F .J., Wilson, 
S., Sandstöm T., “Diesel Exhaust Exposure Enhances the Expression of 
IL-13 in the Bronchial Epithelium of Health Subjects,” Respiratory 
Medicine, vol. 98, No.9, pp821-825 (2004). 
 
 
137. Pueringer, R. J. and Hunninghake, G. W., “LPS Stimulates de Novo 
Synthesis of PGH Synthase in Human Alveolar Macrophage,” Annual 
Journal of Physiology, vol. 262, pp. L78-L85 (1992). 
 
 
138. Radassi, K., Berton, B., Petit, J. F., and Lemaire, G., “Role of Calcium in 
the Activation of Mouse Peritoneal Macrophages: Induction of NO 
Synthase by Calcium Ionophores and Thapsigargin,” Cellular Immunology,  
vol. 153, pp. 443-455 (1994). 
 
 
 174 
139. Ramieu, I., Meneses, F ., Ruiz, S., Sienra, J. J., Huerta, J., White, M. C., 
and Etzel, R. A., “Effects of Air Pollution on the Respiratory Health of 
Asthmatic Children Living in Mexico City, American Journal of Respiratory 
and Critical Care Medicine,  vol. 154, pp. 300-307 (1996). 
 
 
140. Rankin, J. A., Sylvester, I., Smith, S., Yoshimura, T., and Leonard, E. J., 
“Macrophages Cultured In Vitro Release Leukotriene B4 and Neutrophil 
Attractant/Activation Protein (Interleukin 8) Sequentially in Response to 
Stimulation with Lipopolysaccharide and Zymosan,” Journal of Clinical 
Investigation, vol. 86, pp. 1556-1564 (1990). 
 
 
141. Reed, C. E. and Milton, D. K., “Endotoxin-Stimulated Innate Immunity: a 
Contributing Factor for Asthma,” Journal of Allergy and Clinical 
Immunology, vol. 27, pp. 2634-2642 (2001). 
 
 
142. Robbins and Cotran, “General features of the immune system – 
cytokines,” Pathologic Basis of Disease,  6th ed., W. B. Saunders 
Company, 1999, pp. 191-192. 
 
 
143. Rosenau, M. J. and Amoss, H. L., “Organic Matter in the Expired Breath,”  
Journal of Medical Research,  Ed. Ernst, H.C., vol. 25, pp. 35-84 (Sep. 
1911-Feb. 1912). 
 
 
144. Rozy, A., Czerniawska, J., Stepniewska, A., Woźbińska, B., Goljan, A., 
Puścińska, E., Górecka, D., and Chorostowska-Wynimko, J., 
“Inflammatory Markers in the Exhaled Breath Condensate of Patients with 
Pulmonary Sarcoidosis,” Journal of Physiology and Pharmacology,  vol. 
57, suppl. 4, pp. 335-340 (2006). 
 
 
145. Rudell, B., Ledin, M. C., Hammarström, U., Stjernberg, N., Lundbäck, B., 
and Sandström, T ., “Effects on Symptoms and Lung Function in Humans 
Experimentally Exposed to Diesel Exhaust,” Occupational and 
Environmental Medicine, vol. 53, pp. 658-662 (1996). 
 
 
146. Sagai M, Saito H, Ichinose T, Kodama M, and Mori Y ., “Biological Effects 
of Diesel Exhaust Particles. I. In Vitro Production of Superoxide and In 
Vivo Toxicity in Mouse,” Free Radical Biology & Medicine, vol. 14, No. 1, 
pp. 37-47 (1993). 
 175 
147. Salvi, S., Blomberg, A., Rudell, B., Kelly, F ., Sandström, T ., Holdate, S. T ., 
and Frew, A., “Acute Inflammatory Responses in the Airways and 
Peripheral Blood after Short-term Exposure to Diesel Exhaust in Health 
Human Volunteers,” American Journal of Respiratory and Critical Care 
Medicine, vol. 159, pp. 702-709 (1999). 
 
 
148. Samet, J. M., Ghio, A. J., Costa, D. L., and Madden, M. C., “Increased 
Expression of Cyclooxygenase 2 Mediates Oil Fly Ash-Induced Lung 
Injury,” Experimental Lung Research, vol. 26, No. 1, pp. 57-69 (Jan.-Feb., 
2000). 
 
 
149. Samet, J. M., Reed, W., Ghio, A. J., Devlin, R. B., Carter, J. D., Dailey, L. 
A., Bromberg, P . A., and Madden, M. C., “Induction of Prostaglandin H 
Synthase 2 in Human Airway Epithelial Cells Exposed to Residual Oil Fly 
Ash,” Toxicology and Applied Pharmacology, vol. 141, No. 1, pp. 159-68 
(Nov. 1996). 
 
 
150. Sanderson, C. J., “Interleukin-5, Eosinophils, and Disease,” Blood,  vol. 79, 
No. 12, pp. 3101-3109 (June 1992). 
 
 
151. Sandstrom, T ., Stjernberg, N., Eklund, A., Ledin, M. C., Bjermer, L., 
Kolmodin-Hedman, B., Lindstrom, K., Rosenhall, L., and Angstrom, T ., 
”Inflammatory Cell Response in Bronchoalveolar Lavage Fluid after 
Nitrogen Dioxide Exposure of Healthy Subjects: a Dose-Response Study,” 
European Respiratory Journal,  vol. 4, pp. 332-339 (1991). 
 
 
152. Sawyer, K., Ghio, A., Madden, M. C., Abstract: “Ambient Particulate 
Matter Suppresses Alveolar Macrophage Cytokine Response to 
Lipopolysaccharide,” 47th Annual Meeting of the Society of Toxicology, 
Society of Toxiclogy (2008a). 
 
 
153. Sawyer, K., Samet, J. M., Ghio, A. J., Pleil, J. D., and Madden, M. C., 
“Responses Measured in the Exhaled Breath of Human Volunteers 
Acutely Exposed to Ozone and Diesel Exhaust,” Journal of Breath 
Research, E-published ahead of print (2008b). 
 
 
154. Saxena, Q. B., Saxena, R. K., Siegel, P . D., and Lewis, D.M., 
”Identification of Organic Fractions of Diesel Exhaust Particulate (DEP) 
 176 
which Inhibit Nitric Oxide (NO) Production from a Murine Macrophage Cell 
Line,” Toxicological Letters, vol. 143, pp. 317-322 (2003a). 
 
 
155. Saxena, R. K., Saxena, Q. B., Weissman, D. N., Simpson, J. P ., Bledsoe, 
T . A., and Lewis, D. M., “Effect of Diesel Exhaust Particulate on Bacillus 
Calmette-Guerin Lung Infection in Mice and Attendant Changes in Lung 
Interstitial Lymphoid Subpopulations and IFNgamma Response,” Journal 
of Toxicology Science, vol. 73, No. 1, pp. 66-71 (May 2003b). 
 
 
156. Scheideler, L., Manke, H. G., Schwulera, U., Inacker, O., and Hammerle, 
H., “Detection of Nonvolatile Macromolecules in Breath. A Possible 
Diagnostic Tool?,” American Review of Respiratory Disease, vol. 148, pp. 
778-784 (1993). 
 
 
157. Schober, W., Lubitz, S., Belloni, B., Gebauer, G., Lintelmann, J., 
Matuschek, G., Weichenmeir, I., Eberlein-König, B., Buters, J., and 
Behrendt, H., “Environmental Polycyclic Aromatic Hydrocarbons (PAHs) 
Enhance Allergic Inflammation by Acting on Human Basophils,” Inhalation 
Toxicology, vol. 19, suppl. 1, pp. 151-156 (2007). 
 
 
158. Schwartz, J., “Air Pollution and Hospital Admissions for Respiratory 
Disease,” Epidemiology, vol. 7, pp. 20-28 (1996). 
 
 
159. Schwartz, J., Slater, D., Larson, T . V., Pierson, W. E., and Koenig, J. Q., 
“Particulate Air Pollution and Hospital Emergency Room Visits for Asthma 
in Seattle,” American Review of Respiratory Disease, vol. 147, pp. 826-
831 (1993). 
 
 
160. Schwartz, D. A., Thorne, P . S., Jagielo, P . J., White, G. E., Bleuer, S. A., 
and Frees, K. L., ”Endotoxin Responsiveness and Grain Dust-Induced 
Inflammation in the Lower Respiratory Tract,” American Journal of 
Physiology, vol. 267, pp. L609-L617 (1994). 
 
 
161. Sibille, Y . and Reynolds, H. Y ., “Macrophage and Polymorphonuclear 
Neutroiples in Lung Defense and Injury,” American Review of Respiratory 
Disease, vol. 141, pp. 471-501 (1990).  
 
 
162. Sidorenko, G. I., Zborovskii, E. I., and Levina, D. I., “Surface-Active 
Properties of the Exhaled Air Condensate (a New Method of Studying 
 177 
Lung Function) [Article in Russian],” Terapevticheskii Arkhiv, vol. 52, pp. 65-
68 (1980). 
 
 
163. Siegel, P . D., Saxena, R. K., Saxena, Q. B., Ma, J. K., Ma, J. Y ., Yin, X. J., 
Castranova, V., Al-Humadi, N., and Lewis, D. M., “Effect of Diesel Exhaust 
Particulate (DEP) on Immune Responses: Contributions of Particulate 
Versus Organic Soluble Components,” Journal of Toxicology and 
Environmental Health, vol. 67, No. 3, pp. 221-231 (Feb. 2004). 
 
 
164. Piotrowski, W. J., Antczak, A., Marczak, J., Nawrocka, A., Kurmanowska, 
Z., and Górski, P ., “Eicosanoids in Exhaled Breath Condensate and BAL 
Fluid of Patients with Sarcoidosis,” Chest,  vol. 132, No. 2, pp. 589-596 
(Aug. 2007). 
 
 
165. Pourazar, J., Frew, A. J., Blomberg, A., Helleday, R., Kelly, F . J., Wilson, 
S., and Sandström, T ., “Diesel Exhaust Exposure Enhances the 
Expression of IL-13 in the Bronchial Epithelium of Healthy Subjects,” 
Respiratory Medicine, vol. 98, No. 9, pp. 821-825 (Sep. 2004). 
 
 
166. Standiford, T . J., Kunkel, S. L., Rolfe, M. W., Evanoff, H. L., Allen, R. M., 
and Strieter, R. M., ”Regulation of Human Alveolar Macrophage- and 
Blood Monocyte-derived Interleukin-8 by Prostaglandin E2 and 
Dexamethasone,” American Journal of Respiratory Cell and Molecular 
Biology, vol. 6, pp. 75-81 (1992). 
 
 
167. Steerenberg, P ., Verlaan, A., De Klerk, A., Boere, A., Loveren, H., and Cassee, 
F., “Sensitivity to Ozone, Diesel Exhaust Particles, and Standardized Ambient 
Particulate Matter in Rats with a Listeria Monocytogenes-Induced Respiratory 
Infection,” Inhalation Toxicology, vol. 16, No. 5, pp. 311-317 (May 2004). 
 
 
168. Stieb, D. M., Judek, S., and Burnett, R. T ., “Meta-Analysis of Time-Series 
Studies of Air Pollution and Mortality: Effects of Gases and Particles and 
the Influence of Cause of Death, Age, and Season,” Journal of Air and 
Waste Management Association, vol. 52, pp. 470-484 (2002). 
 
 
169. Stone, V., Tuinman, M., Vamvakopoulos, J. E., Shaw, J., Brown, D., 
Petterson, S., Faux, S. P ., Borm, P ., MacNee, W., Michaelangeli, F ., and 
Donaldson, K., “Increased Calcium Influx in a Monocytic Cell Line on 
Exposure to Ultrafine Carbon Black,” European Respiratory Journal,  vol. 
15, No. 2, pp. 297-303 (2000). 
 178 
170. Sun, H. L., Chou, M. C., and Lue, K. H., “The Relationship of Air Pollution 
to ED Visits for Asthma Differ between Children and Adults,” American 
Journal of Emergency Medicine, vol. 24, pp. 709-713 (2006). 
 
 
171. Takahashi, S., Futaki, N., Yokoyama, M., Yamakawa, Y ., Arai, I., Higuchi, 
S., and Otomo, S., “Expression of Prostaglandin H Synthase-2 in 
Endotoxic Shock Induced in Rats,” Archives Internationales de 
Pharmacodynamie et de Therapie, vol. 330, No. 1, pp. 102-115 (1995). 
 
 
172. Takano, H., Tanagisawa, R., Ichinose, T ., Sadakane, K., Yoshino, S., 
Yoshikawa, T ., and Morita, M., “Diesel Exhaust Particles Enhance Lung 
Injury Related to Bacterial Endotoxin through Expression of 
Proinflammatory Cytokines, Chemokines, and Intercellular Adhesion 
Molecule-1,” American Journal of Respiratory and Critical Care Medicine,  
vol. 165, pp. 1329-1335 (2002). 
 
 
173. Tao, F ., Gonzalez-Flexha, B., and Kobzik, L., “Reactive Oxygen Species 
in Pulmonary Inflammation by Ambient Particulates,” Free Radical Biology 
Medicine, vol. 35, pp. 327-340 (2003). 
 
 
174. Taylor, S. M., Laegreid, W. W., Englen, M. D., Dani, G. M., Silflow, R. M., 
Liggit, H. D., and Leid, R. W., “Influence of Extracellular Calcium on the 
Metabolism of Arachidonic Acid in Alveolar Macrophages,” Journal of 
Leukocyte Biology, vol. 48, pp. 502-511 (1990). 
 
 
175. te Velde, A. A., Huijbens R. J. F ., and de Vries, J. E., ”Interleukin-4 (IL-4) 
Inhibits Secretion of IL-1β, Tumor Necrosis Factor α, and Human IL-6 by 
Human Monocytes,” Blood, vol. 76, pp. 1392-1397 (1990). 
 
 
176. Tsien, A., Diaz-Sanchez, D., Ma, J., and Saxon, A., “The Organic 
Component of Diesel Exhaust Particles and Phenanthrene, a Major 
Polyaromatic Hydrocarbon Constituent, Enhances IgE Production by IgE-
Secreting EBV-Transformed Human B Cells In Vitro,” Toxicology and 
Applied Pharmacology, vol. 142, pp. 256-263 (1997). 
 
 
177. U.S. Environmental Protection Agency, “National Air Pollution Trends, 
1990-1998”, U.S. EPA-454-R-00-002 (2000). 
 
 
 179 
178. U.S. Environmental Protection Agency, “Health Assessment Document of 
Diesel Engine Exhaust,” U.S. EPA/600/8-90-057F (2002). 
 
 
179. U.S. Environmental Protection Agency, “Air Quality Criteria for Particulate 
Matte”, U.S. EPA/600/P-99/002aF (2004). 
 
 
180. Welti, R. and Wang, X., “Lipid Species Profiling: A High-throughput 
Approach to Identify Lipid Compositional Changes and Determine the 
Function of Genes Involved in Lipid Metabolism and Signaling,” Current 
Opinion in Plant Biology, vol. 7, pp. 337-344 (2004). 
 
 
181. Wong, T . W., Lau, T . S., Yu, T. S., Neller, A., Wong, S. L., Tam, W., and 
Pang, S. W., “Air Pollution and Hospital Admissions for Respiratory and 
Cardiovascular Diseases in Hong Kong,” Occupational and Environmental 
Medicine, vol. 56 pp. 679-683, (1999). 
 
 
182. Wood, C. D., Marklund, U., and Cantrell, D. A., “Dual Phospholipase 
C/Diaglycerol Requirement for Protein Kinase D1 Activation in 
Lymphocytes,” Journal of Biological Chemistry, vol. 280, pp. 6245-6251 
(2005). 
 
 
183. Wright, S. D., Ramos, R. A., Tobias, P . S., Ulevitch, R. J., and Mathison, 
J. C., “CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and 
LPS Binding Protein,” Science, vol. 249, pp. 1431-1433 (1990). 
 
 
184. Wu, H., Kuzmenko, A., Wan, S., Schaffer, L., Weiss, A., Fisher, J. H., Kim, 
K. S., and McCormack, F . X., “Surfactant Proteins A and D Inhibit the 
Growth of Gram-Negative Bacteria by Increasing Membrane 
Permeability,” Journal of Clinical Investigation,  vol. 111, No. 10, pp. 1589-
1602 (May 2003). 
 
 
185. Yang, H. M., Antonini, J. M., Barger, M. W., Butterworth, L., Roberts, J. R., 
Ma J. K. H., Castranova, V., and Ma, J. Y . C., “Diesel Exhaust Particles 
Suppress Macrophage Function and Slow the Pulmonary Clearance of 
Listeria monocytogenes in Rats,” Environmental Health Perspectives,  vol. 
109, pp. 515-521 (2001). 
 
 
 180 
186. Yang, H. M., Berge, M. W., Castranova, V., Ma, J. K. H., Yang, J. J., and 
Ma J. Y . C., “Effects of Diesel Exhaust Particles (DEP), Carbon Black, and 
Silica on Macrophage Responses to LPS: Evidence of DEP Suppression 
of Macrophage Activity,” Journal of Toxicology and Environmental Health, 
Part A, vol. 58, pp. 261-278 (1999). 
 
 
187. Yang, H. M., Ma, J. Y . C., Castranova, V., and Ma, J. K. H., “Effects of 
Diesel Exhaust Particles on the Release of Interleukin-1 and Tumor 
Necrosis Factor-Alpha from Rat Alveolar Macrophages,” Experimental 
Lung Research, vol. 23, pp. 269-284 (1997). 
 
 
188. Yin, X. J., Dong, C. C., Ma, J. Y . C., Antonini, J. M., Roberts, J. R., 
Stanley, C. F ., Schafer, R., and Ma, J. K. H., “Suppression of Cell-
Mediated Immune Responses to Listeria Infection by Repeated Exposure 
to Diesel Exhaust Particles in Brown Norway Rats,” Toxicological Science, 
vol. 77, pp.263-271 (2004). 
 
 
189. Yin, X. J., Dong, C. C., Ma, J. Y ., Antonini, J. M., Roberts, J. R., Barger M. 
W., and Ma, J. K., “Sustained Effect of Inhaled Diesel Exhaust Particles on 
T-Lymphocyte-Mediated Immune Responses against Listeria 
Monocytogenes,” Journal of Toxicology Science, vol. 88, No. 1, pp. 73-81 
(Nov. 2005). 
 
 
190. Yin, X. J., Schafer, R., Ma, J. Y ., Antonini, J. M., Weissman, D. D., Siegel, 
P . D., Barger, M. W., Roberts, J. R., and Ma, J. K., “Alteration of 
Pulmonary Immunity to Listeria Monocytogenes by Diesel Exhaust 
Particles (DEPs). I. Effects of DEPs on Early Pulmonary Responses,”  
Environmental Health Perspectives,  vol. 110, No. 11, pp. 1105-1111 (Nov. 
2002). 
 
 
191. Yin, X. J., Schafer, R., Ma, J. Y ., Antonini, J. M., Roberts, J. R., 
Weissman, D. N., Siegel, P . D., and Ma, J. K., “Alteration of Pulmonary 
Immunity to Listeria Monocytogenes by Diesel Exhaust Particles (DEPs). 
II. Effects of DEPs on T-Cell-Mediated Immune Responses in Rats,” 
Environmental Health Perspectives,  vol. 111, No. 4, pp. 524-530 (Apr. 
2003). 
 
 
192. Zhang, P ., Summer, W. R., Pagby, G. J., and Nelson, S., “Innate Immunity 
and Pulmonary Host Defense,” Immunological Review, vol. 173, pp. 39-51 
(2000). 
 181 
193. Zurawski, G. and de Vries, J. E., ”Interleukin 13, and Interleukin-4-like 
Cytokine that Acts on Monocytes and B cells, but not on T Cells,” 
Immunology Today, vol. 15, pp. 19-26 (1994). 
